<!DOCTYPE html>
<html lang="en" class="scroll-smooth">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Lipids - Brain And Scalpel</title>
    <link rel="preload" href="assets/background.jpg" as="image">
    <script src="https://cdn.tailwindcss.com"></script>
    <!-- HLS.js for M3U8 support -->
    <script src="https://cdn.jsdelivr.net/npm/hls.js@latest"></script>
    <style>
        
/* Liquid Glass Morphism Universal Theme - Enhanced */
:root {
  --glass-bg: rgba(0, 0, 0, 0.6);
  --glass-bg-light: rgba(255, 255, 255, 0.1);
  --glass-bg-medium: rgba(255, 255, 255, 0.15);
  --glass-bg-heavy: rgba(255, 255, 255, 0.2);
  --glass-border: rgba(255, 255, 255, 0.2);
  --glass-border-light: rgba(255, 255, 255, 0.1);
  --text-primary: rgba(255, 255, 255, 0.95);
  --text-secondary: rgba(255, 255, 255, 0.7);
  --text-tertiary: rgba(255, 255, 255, 0.5);
  --accent-blue: #60a5fa;
  --accent-purple: #a855f7;
  --accent-green: #34d399;
  --accent-orange: #fb923c;
  --accent-red: #f87171;
  --accent-yellow: #fbbf24;
}

* {
  margin: 0;
  padding: 0;
  box-sizing: border-box;
}

body {
  margin: 0;
  min-height: 100vh;
  font-family: system-ui, -apple-system, BlinkMacSystemFont, 'Segoe UI', sans-serif;
  background: url("assets/background.jpg") center center / cover no-repeat fixed;
  position: relative;
  overflow-x: hidden;
  color: var(--text-primary);
}

body::before {
  content: "";
  position: fixed;
  inset: 0;
  background: rgba(0, 0, 0, 0.4);
  backdrop-filter: blur(10px);
  -webkit-backdrop-filter: blur(10px);
  z-index: -1;
}

/* Glass morphism components */
.glass {
  background: var(--glass-bg);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid var(--glass-border);
  border-radius: 16px;
}

.glass-light {
  background: var(--glass-bg-light);
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid var(--glass-border-light);
  border-radius: 12px;
}

.glass-medium {
  background: var(--glass-bg-medium);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid var(--glass-border);
  border-radius: 16px;
}

.glass-heavy {
  background: var(--glass-bg-heavy);
  backdrop-filter: blur(25px);
  -webkit-backdrop-filter: blur(25px);
  border: 1px solid var(--glass-border);
  border-radius: 20px;
}

.glass-card {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid rgba(255, 255, 255, 0.15);
  border-radius: 20px;
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  box-shadow: 0 8px 32px rgba(0, 0, 0, 0.3);
}

.glass-card:hover {
  transform: translateY(-8px);
  background: rgba(255, 255, 255, 0.12);
  border-color: rgba(255, 255, 255, 0.25);
  box-shadow: 0 20px 60px rgba(0, 0, 0, 0.4);
}

.glass-button {
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.8), rgba(168, 85, 247, 0.8));
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid rgba(255, 255, 255, 0.2);
  border-radius: 12px;
  color: white;
  font-weight: 600;
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  box-shadow: 0 4px 20px rgba(96, 165, 250, 0.3);
  cursor: pointer;
  border: none;
}

.glass-button:hover {
  transform: translateY(-2px);
  box-shadow: 0 8px 30px rgba(96, 165, 250, 0.4);
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.9), rgba(168, 85, 247, 0.9));
}

.glass-button:disabled {
  opacity: 0.5;
  cursor: not-allowed;
  transform: none;
}

.glass-input {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid rgba(255, 255, 255, 0.2);
  border-radius: 12px;
  color: var(--text-primary);
  transition: all 0.3s ease;
}

.glass-input:focus {
  outline: none;
  border-color: var(--accent-blue);
  background: rgba(255, 255, 255, 0.12);
  box-shadow: 0 0 20px rgba(96, 165, 250, 0.3);
}

.glass-input::placeholder {
  color: var(--text-tertiary);
}

/* Performance analysis styles */
.performance-card {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid rgba(255, 255, 255, 0.15);
  border-radius: 20px;
  box-shadow: 0 8px 32px rgba(0, 0, 0, 0.3);
}

.score-circle {
  position: relative;
  width: 150px;
  height: 150px;
  margin: 0 auto;
}

.score-circle svg {
  transform: rotate(-90deg);
}

.score-circle .circle-bg {
  fill: none;
  stroke: rgba(255, 255, 255, 0.1);
  stroke-width: 8;
}

.score-circle .circle-progress {
  fill: none;
  stroke-width: 8;
  stroke-linecap: round;
  transition: stroke-dasharray 2s cubic-bezier(0.4, 0, 0.2, 1);
}

.score-text {
  position: absolute;
  top: 50%;
  left: 50%;
  transform: translate(-50%, -50%);
  text-align: center;
}

/* Review question styles */
.review-question {
  background: rgba(255, 255, 255, 0.05);
  border: 1px solid rgba(255, 255, 255, 0.1);
  border-radius: 16px;
  padding: 20px;
  margin-bottom: 20px;
}

.review-question.correct {
  border-left: 4px solid #22c55e;
}

.review-question.incorrect {
  border-left: 4px solid #ef4444;
}

.review-question.not-attempted {
  border-left: 4px solid #6b7280;
}

/* Gradient backgrounds for accents */
.gradient-blue {
  background: linear-gradient(135deg, var(--accent-blue), #3b82f6);
}

.gradient-purple {
  background: linear-gradient(135deg, var(--accent-purple), #8b5cf6);
}

.gradient-green {
  background: linear-gradient(135deg, var(--accent-green), #10b981);
}

.gradient-orange {
  background: linear-gradient(135deg, var(--accent-orange), #f97316);
}

.gradient-red {
  background: linear-gradient(135deg, var(--accent-red), #ef4444);
}

.gradient-yellow {
  background: linear-gradient(135deg, var(--accent-yellow), #f59e0b);
}

/* Navigation button styles */
.nav-btn-not-attempted {
  background: rgba(255, 255, 255, 0.1);
  border: 1px solid rgba(255, 255, 255, 0.2);
  color: rgba(255, 255, 255, 0.7);
}

.nav-btn-current {
  background: linear-gradient(135deg, var(--accent-blue), #3b82f6);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
  box-shadow: 0 0 20px rgba(96, 165, 250, 0.4);
}

.nav-btn-correct {
  background: linear-gradient(135deg, var(--accent-green), #10b981);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-incorrect {
  background: linear-gradient(135deg, var(--accent-red), #ef4444);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-bookmarked {
  background: linear-gradient(135deg, var(--accent-yellow), #f59e0b);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-marked-review {
  background: linear-gradient(135deg, var(--accent-purple), #8b5cf6);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-answered {
  background: linear-gradient(135deg, #6b7280, #4b5563);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

/* Option button styles - REVISED FOR INLINE FEEDBACK */
.option-button {
  background: rgba(255, 255, 255, 0.05);
  border: 1px solid rgba(255, 255, 255, 0.15);
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  position: relative;
  overflow: hidden;
  width: 100%;
  text-align: left;
  padding: 1rem;
  border-radius: 12px;
  color: var(--text-primary);
  cursor: pointer;
  display: flex;
  align-items: center;
  gap: 1rem;
  font-size: 1rem;
}

.option-button:hover {
  background: rgba(255, 255, 255, 0.1);
  border-color: rgba(96, 165, 250, 0.5);
  transform: translateX(8px);
}

.option-button.selected {
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.3), rgba(59, 130, 246, 0.3));
  border-color: var(--accent-blue);
  transform: translateX(8px);
}

#optionsContainer.answered .option-button:hover {
    transform: translateX(0); /* Disable hover effect after answering */
}

#optionsContainer.answered .option-button {
    cursor: not-allowed;
    pointer-events: none;
}

#optionsContainer.answered .option-button:not(.correct):not(.incorrect) {
    opacity: 0.5;
}

.option-button.correct {
    background: linear-gradient(135deg, #22c55e, #16a34a);
    border-color: #22c55e;
    color: white;
    transform: translateX(0);
}

.option-button.incorrect {
    background: linear-gradient(135deg, #ef4444, #dc2626);
    border-color: #ef4444;
    color: white;
    transform: translateX(0);
}

.option-letter {
  background: rgba(255, 255, 255, 0.1);
  border: 1px solid rgba(255, 255, 255, 0.2);
  transition: all 0.3s ease;
  width: 2.5rem;
  height: 2.5rem;
  border-radius: 50%;
  display: flex;
  align-items: center;
  justify-content: center;
  font-weight: bold;
  color: var(--text-primary);
  flex-shrink: 0;
}

.option-button.selected .option-letter {
  background: var(--accent-blue);
  border-color: var(--accent-blue);
  color: white;
}

.option-button.correct .option-letter, .option-button.incorrect .option-letter {
    background: rgba(255, 255, 255, 0.2);
    border-color: rgba(255, 255, 255, 0.3);
}

.option-text {
  flex: 1;
  font-size: 1rem;
  line-height: 1.5;
}

/* Stats bar responsive grid */
.stats-grid {
  display: grid;
  grid-template-columns: repeat(5, 1fr);
  gap: 1rem;
  align-items: center;
  justify-items: center;
}

@media (max-width: 768px) {
  .stats-grid {
    grid-template-columns: repeat(3, 1fr);
    gap: 0.5rem;
  }
  
  .stats-grid > div:nth-child(4),
  .stats-grid > div:nth-child(5) {
    grid-column: span 1;
  }
}

@media (max-width: 480px) {
  .stats-grid {
    grid-template-columns: repeat(2, 1fr);
  }
  
  .stats-grid > div:last-child {
    grid-column: span 2;
    justify-self: center;
  }
}

/* Animations */
@keyframes float {
  0%, 100% { transform: translateY(0px); }
  50% { transform: translateY(-20px); }
}

@keyframes pulse-glow {
  0%, 100% { box-shadow: 0 0 20px rgba(96, 165, 250, 0.3); }
  50% { box-shadow: 0 0 40px rgba(96, 165, 250, 0.6); }
}

@keyframes checkmark {
  0% { transform: scale(0) rotate(0deg); }
  50% { transform: scale(0.8) rotate(180deg); }
  100% { transform: scale(1) rotate(360deg); }
}

@keyframes cross {
  0% { transform: scale(0) rotate(0deg); }
  50% { transform: scale(0.8) rotate(90deg); }
  100% { transform: scale(1) rotate(180deg); }
}

.animate-float {
  animation: float 6s ease-in-out infinite;
}

.animate-pulse-glow {
  animation: pulse-glow 2s ease-in-out infinite;
}

.animate-checkmark {
  animation: checkmark 0.6s cubic-bezier(0.4, 0, 0.2, 1);
}

.animate-cross {
  animation: cross 0.6s cubic-bezier(0.4, 0, 0.2, 1);
}

/* Custom scrollbar */
::-webkit-scrollbar {
  width: 8px;
}

::-webkit-scrollbar-track {
  background: rgba(255, 255, 255, 0.05);
  border-radius: 4px;
}

::-webkit-scrollbar-thumb {
  background: rgba(255, 255, 255, 0.2);
  border-radius: 4px;
}

::-webkit-scrollbar-thumb:hover {
  background: rgba(255, 255, 255, 0.3);
}

/* Responsive utilities */
@media (max-width: 768px) {
  .glass-card {
    border-radius: 16px;
  }
  
  .glass {
    border-radius: 12px;
  }
}

    </style>
</head>
<body>
    <!-- Mode Selection Modal -->
    <div id="modeModal" class="fixed inset-0 bg-black bg-opacity-70 flex items-center justify-center z-50 backdrop-blur-sm">
        <div class="glass-heavy p-8 max-w-md w-full mx-4 shadow-2xl">
            <h2 class="text-2xl font-bold text-white mb-6 text-center">Choose Study Mode</h2>
            
            <div class="space-y-4">
                <button onclick="selectMode('study')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Study Mode</h3>
                            <p class="text-sm text-white text-opacity-70">Interactive learning with immediate feedback</p>
                        </div>
                        <div class="gradient-blue w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path d="M9 12l2 2 4-4m6 2a9 9 0 11-18 0 9 9 0 0118 0z"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('test')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Test Mode</h3>
                            <p class="text-sm text-white text-opacity-70">Practice test with performance analysis at end</p>
                        </div>
                        <div class="gradient-purple w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path d="M9 2a1 1 0 000 2h2a1 1 0 100-2H9z"></path>
                                <path fill-rule="evenodd" d="M4 5a2 2 0 012-2v1a1 1 0 001 1h6a1 1 0 001-1V3a2 2 0 012 2v6a2 2 0 01-2 2H6a2 2 0 01-2-2V5zm3 4a1 1 0 000 2h.01a1 1 0 100-2H7zm3 0a1 1 0 000 2h3a1 1 0 100-2h-3z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('timed_study')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Timed Study</h3>
                            <p class="text-sm text-white text-opacity-70">Study with time pressure and immediate feedback</p>
                        </div>
                        <div class="gradient-green w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path fill-rule="evenodd" d="M10 18a8 8 0 100-16 8 8 0 000 16zm1-12a1 1 0 10-2 0v4a1 1 0 00.293.707l2.828 2.829a1 1 0 101.415-1.415L11 9.586V6z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('timed_exam')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Timed Exam</h3>
                            <p class="text-sm text-white text-opacity-70">Real exam simulation with strict timing</p>
                        </div>
                        <div class="gradient-red w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path fill-rule="evenodd" d="M12.395 2.553a1 1 0 00-1.45-.385c-.345.23-.614.558-.822.88-.214.33-.403.713-.57 1.116-.334.804-.614 1.768-.84 2.734a31.365 31.365 0 00-.613 3.58 2.64 2.64 0 01-.945-1.067c-.328-.68-.398-1.534-.398-2.654A1 1 0 005.05 6.05 6.981 6.981 0 003 11a7 7 0 1011.95-4.95c-.592-.591-.98-.985-1.348-1.467-.363-.476-.724-1.063-1.207-2.03z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
            </div>
        </div>
    </div>

    <!-- Performance Analysis Modal -->
    <div id="performanceModal" class="hidden fixed inset-0 bg-black bg-opacity-80 flex items-center justify-center z-50 backdrop-blur-sm">
        <div class="glass-heavy p-8 max-w-4xl w-full mx-4 shadow-2xl max-h-[90vh] overflow-y-auto">
            <div class="flex items-center justify-between mb-8">
                <h2 class="text-3xl font-bold text-white">Performance Analysis</h2>
                <button onclick="closePerformanceModal()" class="glass-light p-2 rounded-lg text-white hover:bg-white hover:bg-opacity-20">
                    <svg class="w-6 h-6" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M4.293 4.293a1 1 0 011.414 0L10 8.586l4.293-4.293a1 1 0 111.414 1.414L11.414 10l4.293 4.293a1 1 0 01-1.414 1.414L10 11.414l-4.293 4.293a1 1 0 01-1.414-1.414L8.586 10 4.293 5.707a1 1 0 010-1.414z" clip-rule="evenodd"></path>
                    </svg>
                </button>
            </div>
            
            <!-- Score Overview -->
            <div class="grid grid-cols-1 md:grid-cols-3 gap-6 mb-8">
                <div class="performance-card p-6 text-center">
                    <div class="score-circle mb-4">
                        <svg width="150" height="150" class="mx-auto">
                            <circle class="circle-bg" cx="75" cy="75" r="65"></circle>
                            <circle id="scoreCircle" class="circle-progress" cx="75" cy="75" r="65" stroke="#22c55e" stroke-dasharray="0 408"></circle>
                        </svg>
                        <div class="score-text">
                            <div class="text-3xl font-bold text-white" id="accuracyScore">0%</div>
                            <div class="text-sm text-white text-opacity-70">Accuracy</div>
                        </div>
                    </div>
                </div>
                
                <div class="performance-card p-6">
                    <h3 class="text-lg font-bold text-white mb-4 text-center">Results Summary</h3>
                    <div class="space-y-3">
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Total Questions:</span>
                            <span class="text-white font-semibold" id="totalQuestionsResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-green-400">Correct:</span>
                            <span class="text-green-400 font-semibold" id="correctResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-red-400">Incorrect:</span>
                            <span class="text-red-400 font-semibold" id="incorrectResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-gray-400">Not Attempted:</span>
                            <span class="text-gray-400 font-semibold" id="notAttemptedResult">0</span>
                        </div>
                    </div>
                </div>
                
                <div class="performance-card p-6">
                    <h3 class="text-lg font-bold text-white mb-4 text-center">Time Analysis</h3>
                    <div class="space-y-3">
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Total Time:</span>
                            <span class="text-white font-semibold" id="totalTimeResult">0:00</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Avg per Question:</span>
                            <span class="text-white font-semibold" id="avgTimeResult">0:00</span>
                        </div>
                    </div>
                </div>
            </div>
            
            <!-- Action Buttons -->
            <div class="flex justify-center space-x-4 mb-8">
                <button onclick="reviewQuestions()" class="glass-button px-8 py-3 text-lg">
                    Review All Questions
                </button>
                <button onclick="retakeQuiz()" class="glass-light px-8 py-3 text-lg text-white hover:bg-white hover:bg-opacity-20">
                    Retake Quiz
                </button>
            </div>
            
            <!-- Question Review Section -->
            <div id="questionReviewSection" class="hidden">
                <h3 class="text-2xl font-bold text-white mb-6">Question Review</h3>
                <div id="reviewQuestionsContainer">
                    <!-- Review questions will be populated here -->
                </div>
            </div>
        </div>
    </div>

    <!-- Header -->
    <header class="glass sticky top-0 z-40 mb-6">
        <div class="container mx-auto px-6 py-4">
            <div class="flex items-center justify-between">
                <div class="flex items-center space-x-4">
                    <button onclick="goBack()" class="glass-light px-4 py-2 text-white hover:bg-white hover:bg-opacity-20 transition-all duration-300 flex items-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                            <path fill-rule="evenodd" d="M9.707 16.707a1 1 0 01-1.414 0l-6-6a1 1 0 010-1.414l6-6a1 1 0 011.414 1.414L5.414 9H17a1 1 0 110 2H5.414l4.293 4.293a1 1 0 010 1.414z" clip-rule="evenodd"></path>
                        </svg>
                        Back
                    </button>
                    <div id="quizHierarchy" class="text-sm text-white text-opacity-60">
                        Cerebellum / qBank / Biochemistry
                    </div>
                </div>
                
                <div class="flex items-center space-x-4">
                    <div class="glass-light px-3 py-1 text-sm text-white">
                        Question <span id="currentQuestion">1</span> of <span id="totalQuestions">113</span>
                    </div>
                    
                    <!-- Timer -->
                    <div id="timerContainer" class="hidden gradient-red px-3 py-1 text-sm text-white font-bold animate-pulse-glow">
                        <span id="timeDisplay">2:00</span>
                    </div>
                </div>
            </div>
        </div>
    </header>

    <!-- Progress Bar -->
    <div class="w-full h-1 bg-black bg-opacity-30 mb-6">
        <div id="progressBar" class="h-1 gradient-blue transition-all duration-500 ease-out" style="width: 0%"></div>
    </div>

    <!-- Stats Bar - Show only in study modes -->
    <div id="statsBar" class="glass-light mb-8">
        <div class="container mx-auto px-6 py-4">
            <div class="stats-grid">
                <div class="text-center">
                    <div class="text-lg font-bold text-green-400" id="correctCount">0</div>
                    <div class="text-xs text-white text-opacity-60">Correct</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-red-400" id="incorrectCount">0</div>
                    <div class="text-xs text-white text-opacity-60">Incorrect</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-blue-400" id="totalAttempted">0</div>
                    <div class="text-xs text-white text-opacity-60">Attempted</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-purple-400" id="accuracy">0%</div>
                    <div class="text-xs text-white text-opacity-60">Accuracy</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-orange-400" id="timeSpent">0:00</div>
                    <div class="text-xs text-white text-opacity-60">Time</div>
                </div>
            </div>
        </div>
    </div>

    <div class="flex container mx-auto px-6 gap-8">
        <!-- Question Navigation Sidebar -->
        <div class="w-80 glass p-6 h-fit sticky top-24">
            <h3 class="text-lg font-bold text-white mb-4">Question Navigator</h3>
            <div id="questionNav" class="grid grid-cols-5 gap-2 mb-6">
                <!-- Question numbers will be populated here -->
            </div>
            
            <div class="space-y-3 text-xs">
                <h4 class="text-sm font-medium text-white text-opacity-80 mb-3">Legend</h4>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-not-attempted rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Not Attempted</span>
                </div>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-current rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Current</span>
                </div>
                <div id="studyModeLegend" class="space-y-2">
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-correct rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Correct</span>
                    </div>
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-incorrect rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Incorrect</span>
                    </div>
                </div>
                <div id="testModeLegend" class="hidden space-y-2">
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-answered rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Answered</span>
                    </div>
                </div>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-bookmarked rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Bookmarked</span>
                </div>
                <div id="testModeReviewLegend" class="hidden items-center">
                    <div class="w-6 h-6 nav-btn-marked-review rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Marked for Review</span>
                </div>
            </div>
            
            <!-- Submit Quiz Button for test modes -->
            <div id="submitSection" class="hidden mt-6">
                <button onclick="submitQuiz()" class="glass-button w-full py-3 text-lg font-bold">
                    Submit Quiz
                </button>
            </div>
        </div>

        <!-- Main Quiz Interface -->
        <div class="flex-1 max-w-4xl">
            <div class="glass-card p-8 lg:p-12 mb-8 relative">
                <!-- Question Text -->
                <div id="questionText" class="text-xl lg:text-2xl leading-relaxed text-white mb-8">
                    Loading question...
                </div>

                <!-- Question Media -->
                <div id="questionMedia" class="mb-8"></div>

                <!-- Options -->
                <div id="optionsContainer" class="space-y-3 mb-8">
                    <!-- Options will be inserted here -->
                </div>

                <!-- Solution Display (only for study modes) -->
                <div id="solutionContainer" class="hidden glass-light p-6 border-l-4 border-green-400">
                    <h3 class="text-lg font-bold text-green-400 mb-3 flex items-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                            <path fill-rule="evenodd" d="M18 10a8 8 0 11-16 0 8 8 0 0116 0zm-7-4a1 1 0 11-2 0 1 1 0 012 0zM9 9a1 1 0 000 2v3a1 1 0 001 1h1a1 1 0 100-2v-3a1 1 0 00-1-1H9z" clip-rule="evenodd"></path>
                        </svg>
                        Explanation
                    </h3>
                    <div id="solutionText" class="text-white text-opacity-90 leading-relaxed mb-4"></div>
                    <!-- Explanation Video -->
                    <div id="solutionVideo" class="hidden">
                        <video id="explanationVideoPlayer" class="w-full rounded-lg" controls>
                            Your browser does not support the video tag.
                        </video>
                    </div>
                </div>
            </div>

            <!-- Controls -->
            <div class="flex justify-between items-center mb-8">
                <button onclick="previousQuestion()" id="prevBtn" class="glass-button px-6 py-3 flex items-center disabled:opacity-50 disabled:cursor-not-allowed">
                    <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M12.707 5.293a1 1 0 010 1.414L9.414 10l3.293 3.293a1 1 0 01-1.414 1.414l-4-4a1 1 0 010-1.414l4-4a1 1 0 011.414 0z" clip-rule="evenodd"></path>
                    </svg>
                    Previous
                </button>
                
                <div class="flex justify-center flex-grow">
                    <button onclick="toggleBookmark()" id="bookmarkBtn" class="glass-light px-6 py-3 text-white hover:bg-yellow-500 hover:bg-opacity-20 transition-all duration-300 flex items-center">
                        <svg class="w-5 h-5 mr-2" id="bookmarkIcon" fill="currentColor" viewBox="0 0 20 20">
                            <path d="M5 4a2 2 0 012-2h6a2 2 0 012 2v14l-5-2.5L5 18V4z"></path>
                        </svg>
                        <span id="bookmarkText">Bookmark</span>
                    </button>
                    
                    <button onclick="toggleMarkForReview()" id="markReviewBtn" class="hidden glass-light px-6 py-3 text-white hover:bg-purple-500 hover:bg-opacity-20 transition-all duration-300 flex items-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                           <path fill-rule="evenodd" d="M5 2a2 2 0 00-2 2v12a2 2 0 002 2h10a2 2 0 002-2V4a2 2 0 00-2-2H5zm0 2h10v12H5V4z" clip-rule="evenodd" />
                           <path d="M12.586 6.586a2 2 0 10-2.828 2.828l-3 3a2 2 0 102.828-2.828l3-3z" />
                        </svg>
                        <span id="markReviewText">Mark for Review</span>
                    </button>
                </div>
                
                <button onclick="nextQuestion()" class="glass-button px-6 py-3 flex items-center">
                    Next
                    <svg class="w-5 h-5 ml-2" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M7.293 14.707a1 1 0 010-1.414L10.586 10 7.293 6.707a1 1 0 011.414-1.414l4 4a1 1 0 010 1.414l-4 4a1 1 0 01-1.414 0z" clip-rule="evenodd"></path>
                    </svg>
                </button>
            </div>
        </div>
    </div>

    <script>
        let questionsData = [
  {
    "id": 8947,
    "choices": [
      {
        "id": 35755,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cardiolipin</span></span></span></p>"
      },
      {
        "id": 35756,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dipalmitoyl phosphatidyl choline</span></span></span></p>"
      },
      {
        "id": 35757,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Phosphatidyl ethanolamine</span></span></span></p>"
      },
      {
        "id": 35758,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Phosphatidyl inositol</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In a neonatal intensive care unit at a research-focused hospital in India, a preterm newborn is admitted with signs of respiratory distress. The baby&#39;s mother had a complicated pregnancy, which led to early labor. The neonatologist considers the biochemical aspects that could be contributing to the baby&#39;s condition, specifically focusing on the surfactant composition in the baby&rsquo;s lungs. A deficiency in one of the surfactant components is suspected.&nbsp;</span></span></span><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which lipid component could be deficient in this preterm newborn, contributing to respiratory distress?</span></span></span></p>",
    "unique_key": "Q4434814",
    "question_audio": null,
    "question_video": null,
    "map_id": 30258,
    "difficulty_level": "beginner",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dipalmitoyl phosphatidyl choline</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The<strong> major</strong> lipid of<strong> lung surfactant</strong> is produced by <strong>type II alveolar cells.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Surfactant reduces surface tension</strong> of the<strong> aqueous layer of lung</strong> and <strong>prevents collapse of lung alveoli. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Constituents of surfactants:<strong> Dipalmitoyl phosphatidylcholine (DPPC)</strong> or <strong>dipalmitoyl lecithin (DPL), phosphatidyl glycerol,</strong> <strong>cholesterol and surfactant proteins A, B and C. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">During fetal life,<strong> lung synthesizes sphingomyelin</strong> before <strong>28th week of GA</strong> &amp; when <strong>fetus matures,</strong> <strong>more lecithin</strong> is <strong>produced. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The<strong> lecithin-sphingomyelin (LS) ratio </strong>of a<strong>mniotic fluid</strong> is an index of <strong>fetal maturity. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">If the ratio is<strong> 2</strong>, it indicates <strong>full lung maturity. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Premature infants </strong>have a<strong> higher incidence of RDS </strong>because the<strong> immature lungs</strong> <strong>do not synthesize</strong> enough<strong> DPL. </strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Cardiolipin:</strong> or <strong>Di phosphatidylglycerol </strong>is a major lipid of <strong>mitochondrial membrane</strong> and extracted from <strong>myocardium.</strong> <strong>Decreased cardiolipin level </strong>results in<strong> mitochondrial dysfunction, heart failure, hypothyroidism, and myopathies. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Phosphatidyl ethanolamine: </strong>or<strong> Cephalin</strong><strong> </strong>is found in <strong>bio membranes</strong> and possess <strong>amphipathic</strong> properties.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Phosphatidyl inositol: </strong>or<strong> PIP2</strong><strong> </strong>is present in <strong>bio membranes </strong>and plays important role in <strong>mediation of hormone action</strong> on <strong>bio membranes</strong> and also <strong>acts as a second messenger.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Dipalmitoyl phosphatidylcholine (DPPC)</strong> is the major component of <strong>lung surfactant</strong>, which <strong>reduces surface tension</strong> in the<strong> alveoli,</strong> <strong>preventing collapse during exhalation</strong>. In <strong>preterm babies,</strong> <strong>surfactant</strong> production can be <strong>insufficient</strong>, leading to <strong>respiratory distress</strong> <strong>syndrome (RDS).</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e :&nbsp; p 216 , Lippincott 7/e : P 204</span></strong></span></span></p>",
    "correct_choice_id": 35756,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "TreatmentBased"
    ]
  },
  {
    "id": 9059,
    "choices": [
      {
        "id": 36203,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ascorbic acid</span></span></span></p>"
      },
      {
        "id": 36204,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Folic acid </span></span></span></p>"
      },
      {
        "id": 36205,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Arachidonic acid</span></span></span></p>"
      },
      {
        "id": 36206,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Linoleic acid</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 35-year-old man with abetalipoproteinemia presents with an abnormal blood picture showing acanthocytes, alongside symptoms of hyperkeratosis, acrodermatitis, and hypercholesterolemia. Considering the pathophysiology of abetalipoproteinemia and the patient&#39;s symptoms, the abnormal red cell morphology and associated clinical manifestations are most likely due to the malabsorption of which essential nutrient?</span></span></span></p>",
    "unique_key": "Q8880875",
    "question_audio": null,
    "question_video": null,
    "map_id": 30253,
    "difficulty_level": "intermediate",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Linoleic acid</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>genetic defect</strong> might result in <strong>malabsorption of two fatty acids</strong> given in the options, but <strong>only linoleic acid </strong>is strictly <strong>essential in the diet (EFA). </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Linoleic acid and linolenic acid cannot</strong> be synthesized in the<strong> body </strong>and have to be <strong>provided </strong>only in the<strong> food,</strong> so they are <strong>essential fatty acids. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Arachidonic acid </strong>can be formed from <strong>linoleic acid, </strong>if the<strong> dietary supply of it is sufficient. </strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">ABETALIPOPROTEINEMIA:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">All <strong>apo-B </strong>containing<strong> lipoproteins </strong>are <strong>decreased </strong>due to<strong> defect in microsomal triglyceride transfer protein </strong>&rarr; <strong>TAG</strong> is <strong>not</strong> incorporated into <strong>VLDL and chylomicrons </strong>&rarr;<strong> absence of LDL</strong> and<strong> no</strong> absorption of<strong> Fat-soluble vitamins</strong> (causing <strong>mental</strong> <strong>and physical retardation)</strong>.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><strong><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Low Serum triglycerides, cholesterol and phospholipids.</span></span></span></strong></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Blindness</strong> due to <strong>degenerative </strong>changes in<strong> retina. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Erythrocytes</strong> have <strong>spiny projections (acanthocytes)</strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Calibri, sans-serif\"><span style=\"font-size:16px\"><strong><u>Other Options:</u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Ascorbic acid and (B) Folic acid:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Absorption of<strong> water-soluble vitamins</strong> such as <strong>ascorbate and folate</strong> are <strong>not affected.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Arachidonic acid:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Due to the <strong>genetic defect</strong>, malabsorption of <strong>arachidonic acid is also affected </strong>but it&rsquo;s<strong> not an EFA</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Abetalipoproteinemia </strong>is a disorder characterized by the<strong> malabsorption and deficiency of fat-soluble vitamins</strong> and <strong>essential fatty</strong> <strong>acids</strong>, due to the<strong> inability </strong>to properly<strong> synthesize</strong> and <strong>secrete apolipoprotein B-containing lipoproteins.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Linoleic acid</strong> is a <strong>polyunsaturated fatty acid </strong>crucial for maintaining <strong>membrane integrity and function, </strong>including that of <strong>red blood</strong> <strong>cells. </strong>The<strong> deficiency in linoleic acid disrupts</strong> normal <strong>membrane structure</strong>,<strong> leading </strong>to the formation of <strong>acanthocytes.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Lippincott 6/e: p 182, 363.</span></strong></span></span></p>",
    "correct_choice_id": 36206,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "TreatmentBased"
    ]
  },
  {
    "id": 8951,
    "choices": [
      {
        "id": 35771,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Plasmalogens</span></span></span></p>"
      },
      {
        "id": 35772,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cardiolipin</span></span></span></p>"
      },
      {
        "id": 35773,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Phosphatidylinositol</span></span></span></p>"
      },
      {
        "id": 35774,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lecithin</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A medical researcher is exploring the immunological properties of different phospholipids. During a study designed to understand the role of phospholipids in autoimmune disorders, they isolate various phospholipids from cell membranes and assess their potential antigenic properties.&nbsp;</span></span></span><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following phospholipids possesses antigenic properties?</span></span></span></p>",
    "unique_key": "Q5881502",
    "question_audio": null,
    "question_video": null,
    "map_id": 30262,
    "difficulty_level": "beginner",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cardiolipin</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is the <strong>major lipid</strong> of <strong>Inner Mitochondrial Membranes </strong>and is the only <strong>Phospholipid </strong>which possesses <strong>antigenicity.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is recognized by<strong> antibodies raised against Treponema pallidum,</strong> which causes <strong>syphilis.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Decreased levels of cardiolipin</strong> or<strong> alteration</strong> in its<strong> structure </strong>or<strong> metabolism </strong>cause <strong>mitochondrial dysfunction.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;<strong>Plasmalogens </strong>are found in<strong> bio membranes in brain and muscle.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Phosphatidylinositol</strong> acts as a <strong>second messenger </strong>and plays a vital role in the <strong>mediation of hormone</strong> action on bio membranes.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Dipalmitoyl Lecithin / Di Palmitoyl Phosphatidyl Choline </strong>is the most <strong>abundant phospholipid of cell membrane,</strong> largest <strong>body store of choline</strong> and a major constituent of <strong>lung surfactant</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Cardiolipin </strong>is a <strong>phospholipid</strong> that has <strong>antigenic properties </strong>and can be involved in <strong>autoimmune responses</strong>, such as in the case of <strong>anti-phospholipid syndrome.</strong> It is commonly associated with<strong> syphilis,</strong> where it is the <strong>reactive agent</strong> in the <strong>Wassermann test,</strong> and with<strong> lupus,</strong> where it is targeted by<strong> anti-cardiolipin antibodies.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">: DM Vasudevan 9/e: p 108</span></strong></span></span></p>",
    "correct_choice_id": 35772,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 8946,
    "choices": [
      {
        "id": 35751,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Structure A and C</span></span></span></p>"
      },
      {
        "id": 35752,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Structure B</span></span></span></p>"
      },
      {
        "id": 35753,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Structure D</span></span></span></p>"
      },
      {
        "id": 35754,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Structure E</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Based on the schematic of various lipid structures as shown in below image, which structure(s) do emulsified lipids adopt prior to hydrolysis during digestion?</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"color:black\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/10/picture3_qYw1fq3.jpg\" style=\"height:194px; width:400px\" /></span></span></span></span></p>",
    "unique_key": "Q9081494",
    "question_audio": null,
    "question_video": null,
    "map_id": 30257,
    "difficulty_level": "intermediate",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Structure E</span></strong>&nbsp;&nbsp;&nbsp; </span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Structure E </strong>represents a<strong> micelle</strong>, which is the structure that<strong> emulsified lipids </strong>form<strong> prior to hydrolysis</strong> during <strong>digestion</strong>. <strong>Micelles </strong>are <strong>essential</strong> for the <strong>solubilization of lipids</strong> in the<strong> aqueous environment of the intestine</strong> and <strong>facilitate</strong> the <strong>action of lipases.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A:</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Structures A and C</strong> show <strong>lipid bilayers and liposomes</strong>, respectively, which are <strong>not </strong>the forms lipids take <strong>prior to hydrolysis</strong> in the digestive tract.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Structure B shows vesicles</strong>, which are involved in<strong> cellular transport</strong> but <strong>not</strong> in the initial stages of<strong> lipid digestion.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C:</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Structure D shows </strong>a <strong>lipid monolayer</strong>, which is <strong>more typical of lung surfactants </strong>or the <strong>tear film</strong> than of <strong>intestinal lipid</strong> <strong>digestion.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>During digestion,</strong> <strong>lipid droplets</strong> are<strong> emulsified</strong> by <strong>phospholipids</strong> and <strong>bile acids</strong> in the gut by their <strong>detergent action.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In <strong>micelle hydrophilic glycerol molecules </strong>form the <strong>outside </strong>with <strong>hydrophobic fatty acid chains </strong>on the inside.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Thereby <strong>increasing the surface area </strong>for the <strong>action of hydrolytic lipases</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e: p 479,480</span></strong></span></span></p>",
    "correct_choice_id": 35754,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "ImageBased",
      "TreatmentBased"
    ]
  },
  {
    "id": 9236,
    "choices": [
      {
        "id": 36911,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">1-b, 2-a, 3-d, 4-c</span></p>"
      },
      {
        "id": 36912,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">1-b, 2-d, 3-a, 4-c</span></p>"
      },
      {
        "id": 36913,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">1-a, 2-b, 3-c, 4-d</span></p>"
      },
      {
        "id": 36914,
        "text": "<p><span style=\"font-size:12pt;\">1-d, 2-a, 3-b, 4-c</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Match the following enzymes with the pathway they are involved in:</span></p><p style=\"text-align:justify;\">&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/19/screenshot-2024-04-19-160529.png\" alt=\"\" width=\"600\" height=\"206\"></span></p>",
    "unique_key": "Q1715880",
    "question_audio": null,
    "question_video": null,
    "map_id": 30246,
    "difficulty_level": "beginner",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ans. A)&nbsp;1-b, 2-a, 3-d, 4-c</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option A:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><ol><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>HMG CoA Reductase </strong>is a key enzyme in the <strong>biosynthesis of cholesterol</strong>, <strong>catalyzing </strong>the conversion of <strong>HMG-CoA to mevalonate</strong>, a <strong>rate-limiting step </strong>in <strong>cholesterol synthesis. </strong>Hence, <strong>1-b is correct</strong>.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>7-alpha-hydroxylase </strong>is the <strong>rate-limiting enzyme </strong>in the formation of <strong>bile acids from cholesterol</strong>. It <strong>catalyzes </strong>the introduction of a <strong>hydroxyl group </strong>at the <strong>7th position </strong>of the <strong>steroid</strong> nucleus of <strong>cholesterol, </strong>which is the<strong> first </strong>step in the <strong>classical pathway</strong> of <strong>bile acid synthesis</strong>. Thus,<strong> 2-a is correct.</strong></span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Thiophorase</strong>, also known as <strong>succinyl-CoA:3-ketoacid coenzyme A transferase (SCOT), </strong>is involved in <strong>ketolysis,</strong> particularly in the <strong>utilization of ketone bodies</strong> by the <strong>tissues</strong> <strong>outside</strong> the<strong> liver,</strong> converting <strong>acetoacetate into acetoacetyl-CoA.</strong> Therefore,<strong> 3-d is accurate.</strong></span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Carnitine acyl transferase I </strong>is a crucial enzyme in the<strong> beta-oxidation of fatty acids</strong>. It <strong>facilitates</strong> the <strong>transport of fatty</strong> <strong>acids</strong> into the <strong>mitochondria </strong>for <strong>oxidation </strong>by <strong>converting</strong> them into their <strong>acyl-carnitine derivatives</strong>, which can <strong>cross </strong>the <strong>mitochondrial membrane</strong>. Hence, <strong>4-c </strong>is <strong>correct.</strong></span></p></li></ol><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/19/screenshot-2024-04-19-160656.png\" alt=\"\" width=\"1000\" height=\"340\"></u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Ref</u>: DM Vasudevan 9/e: p 172,178</strong></span></p>",
    "correct_choice_id": 36911,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 8949,
    "choices": [
      {
        "id": 35763,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increase with the increase in degree of unsaturation</span></span></span></p>"
      },
      {
        "id": 35764,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Decrease with the increase in degree of unsaturation</span></span></span></p>"
      },
      {
        "id": 35765,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increase with the increase in molecular weight</span></span></span></p>"
      },
      {
        "id": 35766,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increase with the decrease in molecular weight</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">What is the relationship between the iodine number of a fat molecule and its degree of unsaturation?</span></span></span></p>",
    "unique_key": "Q9708483",
    "question_audio": null,
    "question_video": null,
    "map_id": 30260,
    "difficulty_level": "intermediate",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increase with the increase in degree of unsaturation</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The<strong> iodine number of a fat</strong> is a measure of the <strong>number of double bonds present,</strong> which is an indicator of <strong>unsaturation. </strong>The <strong>more</strong> <strong>double bonds a fat molecule</strong> has, the <strong>more iodine </strong>it can <strong>absorb,</strong> and thus, the<strong> higher its iodine number</strong> will be.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong> Incorrect</strong> because the i<strong>odine number actually increases</strong> with the <strong>degree of unsaturation.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Incorrect </strong>as the <strong>molecular weight</strong> does <strong>not</strong> directly affect the <strong>iodine numbe</strong>r; it&#39;s the <strong>unsaturation </strong>that matters.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Incorrect </strong>because the <strong>change in molecular weight </strong>does<strong> not</strong> necessarily correlate with <strong>iodine absorption;</strong> the focus should be on<strong> unsaturation.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Iodine number </strong>of a <strong>fat</strong> is defined as the <strong>number of grams of iodine</strong> taken up by <strong>100 grams of fat. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is an<strong> index </strong>of the<strong> degree of unsaturation and directly proportional</strong> to the content of <strong>unsaturated fatty acids. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">So <strong>higher the iodine number,</strong> <strong>higher is the degree of unsaturation</strong>, </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">e.g., <strong>Iodine number of butter : 28,</strong>&nbsp; <strong>sunflower oil:130.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">: DM Vasudevan 9/e: p 104</span></strong></span></span></p>",
    "correct_choice_id": 35763,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 9223,
    "choices": [
      {
        "id": 36859,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Formation of chylomicrons</span></span></span></p>"
      },
      {
        "id": 36860,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Excretion of bile salts &amp; Conjugation of bile acids</span></span></span></p>"
      },
      {
        "id": 36861,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The excretion of fats in the feces</span></span></span></p>"
      },
      {
        "id": 36862,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Recycling of bile salts</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 55-year-old obese woman visits her primary care physician complaining of recurrent episodes of mild epigastric pain and vomiting, particularly after consuming fatty meals. Physical examination reveals tenderness in the epigastric region. Given the patient&#39;s symptoms and risk factors, the physician suspects a biliary tract disorder and refers her for an abdominal ultrasound, which confirms the presence of gallstones in the gallbladder. One of the stones appears to be lodged in the upper part of the bile duct, potentially impacting bile flow and digestion.&nbsp;</span></span></span><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A gallstone obstructing the upper part of the bile duct would most likely lead to an increase in which of the following?</span></span></span></p>",
    "unique_key": "Q4504199",
    "question_audio": null,
    "question_video": null,
    "map_id": 30241,
    "difficulty_level": "intermediate",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The excretion of excess fats in the feces</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">An <strong>obstruction </strong>in the <strong>bile duct </strong>by a <strong>gallstone </strong>can lead to a <strong>decrease </strong>in the <strong>flow of bile </strong>into the <strong>intestine</strong>. Since <strong>bile </strong>is <strong>essential </strong>for the <strong>emulsification </strong>and <strong>absorption of dietary fats</strong>, a <strong>blockage </strong>can result in <strong>malabsorption of fats</strong>. This malabsorption, in turn, leads to an <strong>increase </strong>in the <strong>excretion of fats </strong>in the <strong>feces</strong>, a condition known as <strong>steatorrhea.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Formation of chylomicrons</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: <strong>Chylomicrons </strong>are formed in the <strong>intestinal cells </strong>to transport <strong>absorbed fats</strong>, including <strong>triglycerides, cholesterol, and fat-soluble vitamins</strong>, from the<strong> intestines </strong>to <strong>other parts</strong> of the <strong>body</strong>.<strong> Bile duct obstruction </strong>does <strong>not</strong> directly affect <strong>chylomicron formation</strong> but impacts<strong> fat absorption,</strong> which <strong>indirectly </strong>could affect <strong>chylomicron</strong> content.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Excretion of bile salts &amp; Conjugation of bile acids</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Bile salts and bile acids are involved in the <strong>emulsification of fats </strong>and are <strong>recycled</strong> via the <strong>enterohepatic circulation.</strong> While <strong>obstruction </strong>can lead to <strong>decreased bile flow</strong> into the<strong> intestine, </strong>it <strong>primarily </strong>affects <strong>fat absorption</strong> rather than the <strong>excretion or conjugation</strong> of <strong>bile components.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: Recycling of bile salts</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: The recycling of <strong>bile salts</strong> is part of the <strong>enterohepatic circulation,</strong> where <strong>bile salts</strong> are <strong>reabsorbed</strong> from the<strong> intestines </strong>and <strong>returned to the liver. </strong>A <strong>blockage</strong> in the<strong> bile duct</strong> might <strong>disrupt</strong> this <strong>recycling process</strong>, but the <strong>more</strong> <strong>immediate effect</strong> is on<strong> fat absorption </strong>and <strong>fecal fat excretion.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Gallstones</strong> are made up of<strong> cholesterol, calcium bilirubinate and bile salts.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">All the above given details such as<strong> female, middle-aged, and overweight</strong> shows the patient has <strong>gallbladder disease. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">FUNCTION</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: The <strong>gallbladder stores bile salts</strong> produced by the<strong> liver </strong>and when it is <strong>contracted </strong>by the<strong> entry of food </strong>&rarr; <strong>bile</strong> <strong>salts </strong>travel through the<strong> bile duct to the duodenum </strong></span><span style=\"font-family:Wingdings\">&rarr;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> causes<strong> emulsification of fats</strong>, thereby helping in <strong>digestion of fat. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">When the<strong> solutes </strong>in the <strong>gallbladder precipitate</strong>, they form <strong>gallstones.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Patients may have<strong> pain</strong> from the <strong>gallstones,</strong> usually after a <strong>fatty meal</strong>. The<strong> pain</strong> sites are <strong>epigastric or right upper</strong> <strong>quadrant, </strong>which <strong>radiates to the right shoulder</strong>. Also, <strong>cholecystitis and pancreatitis</strong> (<strong>stones &rarr; bile duct</strong> -<strong>&gt;</strong> <strong>obstruct biliary flow </strong>&rarr; <strong>jaundice or irritate </strong>the <strong>pancreas</strong>).</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Obstruction</strong> of <strong>bile duct</strong> &rarr; <strong>bile salts cannot </strong>enter the <strong>digestive tract</strong> &rarr; <strong>recycling and excretion</strong> of <strong>bile salts</strong>, <strong>digestion</strong> of <strong>fats</strong> and formation of <strong>chylomicrons are decreased </strong>&rarr;&nbsp; <strong>fats </strong>in the <strong>feces </strong>are <strong>increased (Steatorrhea).</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e: p 255-257, 149-150.</span></strong></span></span></p>",
    "correct_choice_id": 36861,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 8950,
    "choices": [
      {
        "id": 35767,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Liposome</span></span></span></p>"
      },
      {
        "id": 35768,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lipid Bilayer </span></span></span></p>"
      },
      {
        "id": 35769,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Micelle </span></span></span></p>"
      },
      {
        "id": 35770,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Aquasome</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Identify the given diagram:</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"color:black\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/10/picture4_WCNZEse.jpg\" style=\"height:272px; width:300px\" /></span></span></span></span></p>",
    "unique_key": "Q5775566",
    "question_audio": null,
    "question_video": null,
    "map_id": 30261,
    "difficulty_level": "difficult",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Liposome</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Liposomes </strong>are microscopic<strong> spherical vesicles</strong> formed when <strong>phospholipid</strong>s are mixed in <strong>water</strong> under special conditions, they <strong>arrange </strong>themselves to <strong>form a bilayer membrane </strong>which<strong> encloses</strong> some of the <strong>water in a phospholipid sphere. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Unilamellar or multilamellar liposomes</strong> may be <strong>formed.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">They <strong>act as carriers</strong> for<strong> drugs, proteins, enzymes, genes</strong>, etc. which may be <strong>encapsulated</strong> by the <strong>liposomes </strong>and taken to <strong>target organs.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:16px\"><strong><u>Other Options:</u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Lipid Bilayer:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;The self-assembly of <strong>phospholipids molecules into monolayers </strong>with the <strong>polar heads </strong>in one <strong>direction </strong>and the <strong>nonpolar tails </strong>in the<strong> opposite direction </strong>to <strong>form bilayers.</strong> They<strong> act as detergents, emulsifying agents</strong>, and <strong>pulmonary surfactants</strong> etc. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/10/picture5_X4GK80P.jpg\" style=\"height:319px; width:602px\" /></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Micelle:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">These are <strong>molecular</strong> <strong>aggregate</strong>s formed when <strong>phospholipids </strong>are distributed in<strong> water and their hydrophobic parts</strong> <strong>keep away from water</strong> and are involved in <strong>solubilization of lipids</strong> in<strong> aqueous media and in digestion and absorption of lipids.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Aquasome:</strong>&nbsp;These are<strong> nanoparticulate carrier systems</strong> with <strong>three layered self-assembled structures </strong>comprise the <strong>central</strong> <strong>solid nanocrystalline core coated </strong>with <strong>polyhydroxy oligomers</strong> onto which biochemically<strong> active molecules </strong>are <strong>adsorbed</strong>. They <strong>act </strong>as a <strong>carrier system </strong>for <strong>delivery of insulin</strong>, <strong>haemoglobin </strong>and <strong>various antigens </strong>etc.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Liposome,</strong> which is a <strong>spherical vesicle</strong> having at<strong> least one lipid bilayer. </strong>The liposome can be <strong>used to deliver drugs or genetic material</strong> into a<strong> cell.</strong> It is <strong>composed of phospholipids </strong>that form a <strong>bilayer similar to the cell membrane </strong>with an<strong> aqueous interior;</strong> this <strong>structure </strong>is ideal for <strong>encapsulating aqueous solutions </strong>of <strong>hydrophilic drugs.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">: DM Vasudevan 9/e: p 105.</span></strong></span></span></p>",
    "correct_choice_id": 35767,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "ImageBased",
      "TreatmentBased"
    ]
  },
  {
    "id": 8953,
    "choices": [
      {
        "id": 35779,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">0.5&nbsp; </span></span></span></p>"
      },
      {
        "id": 35780,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1&nbsp; </span></span></span></p>"
      },
      {
        "id": 35781,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1.5 </span></span></span></p>"
      },
      {
        "id": 35782,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">2</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A neonatologist is called to attend to a 36-week preterm neonate experiencing respiratory distress. The baby shows increased respiratory rate, chest wall retraction, cyanosis, pallor, and his condition deteriorates despite oxygen support. The Chest X ray findings is shown below.&nbsp;</span></span></span><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following lecithin-sphingomyelin (LS) ratios in amniotic fluid indicates full lung maturity?</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/10/1_jehyIDJ.jpg\" style=\"height:198px; width:234px\" /></span></span></span></p>",
    "unique_key": "Q5211199",
    "question_audio": null,
    "question_video": null,
    "map_id": 30263,
    "difficulty_level": "intermediate",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">2</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Major lipid </strong>of <strong>lung surfactant</strong> produced by <strong>type II alveolar cells.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Surfactant</strong> &rarr; <strong>reduces surface tension</strong> of the aqueous layer of lung &rarr;<strong> prevents collapse of lung alveoli. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is composed of<strong> Dipalmitoyl phosphatidylcholine (DPPC) or dipalmitoyl lecithin (DPL), phosphatidyl glycerol, cholesterol</strong> and<strong> surfactant proteins A, B and C. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">During <strong>fetal life,</strong> the<strong> lung synthesizes sphingomyelin</strong> before<strong> 28th week of GA</strong> &amp; when the <strong>fetus matures,</strong> <strong>more lecithin </strong>is produced. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The<strong> lecithin-sphingomyelin (LS)</strong> ratio of <strong>amniotic fluid</strong> is an index of <strong>fetal maturity </strong>and if ratio is<strong> 2,</strong> it indicates <strong>full lung</strong> <strong>maturity. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Premature infants</strong> have a <strong>higher incidence of RDS </strong>because the <strong>immature lungs do not synthesize enough DPL.</strong> </span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> An <strong>LS ratio of 0.5 indicates </strong>significant <strong>immaturity of the lungs.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> An<strong> LS ratio of 1 </strong>is <strong>borderline</strong>; however, it <strong>does not</strong> assure <strong>full lung maturity.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> An<strong> LS ratio of 1.5 </strong>is <strong>approaching maturity</strong> but is <strong>not</strong> the threshold for <strong>full maturity.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">An<strong> LS ratio of 2 </strong>or <strong>greater in amniotic fluid </strong>is generally considered indicative of <strong>full lung maturity</strong>. This <strong>suggests </strong>sufficient <strong>surfactant</strong> <strong>production to lower surface tension </strong>in the <strong>alveoli,</strong> <strong>reducing</strong> the<strong> risk of alveolar collapse and RDS.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">: DM Vasudevan 9/e: p 106.</span></strong></span></span></p>",
    "correct_choice_id": 35782,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "ImageBased",
      "TreatmentBased"
    ]
  },
  {
    "id": 8967,
    "choices": [
      {
        "id": 35835,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">PUFA is essential for membrane structure</span></span></span></p>"
      },
      {
        "id": 35836,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Biologically arachidonic acid is essential to life</span></span></span></p>"
      },
      {
        "id": 35837,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hydrogenated vegetable oils contain trans fatty acid</span></span></span></p>"
      },
      {
        "id": 35838,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Naturally occurring unsaturated FA exist as trans isomer</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">FALSE statement about fatty acid: </span></span></span></p>",
    "unique_key": "Q8383948",
    "question_audio": null,
    "question_video": null,
    "map_id": 30239,
    "difficulty_level": "intermediate",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Naturally occurring unsaturated FA exist as trans isomer</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The<strong> false</strong> statement is that <strong>naturally occurring unsaturated fatty acids</strong> typically <strong>exist </strong>in the <strong>trans isomer form</strong>. In fact, most <strong>unsaturated fatty acids</strong> in<strong> nature</strong> are in the <strong>cis configuration</strong>. The <strong>cis configuration</strong> causes a <strong>bend in the fatty acid chain</strong>, which <strong>prevents</strong> the <strong>molecules from packing tightly together,</strong> thus contributing to the<strong> fluidity of cell membranes.</strong> <strong>Trans fatty acids,</strong> which can be formed during the<strong> industrial process of hydrogenation </strong>or occasionally found in <strong>small amounts in some animal fats</strong>, have a <strong>straighter shape</strong> that allows them to <strong>pack more closely together,</strong> resembling the behavior of <strong>saturated fats.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: PUFA is essential for membrane structure</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This is <strong>true</strong>. <strong>Polyunsaturated fatty acids </strong>are crucial for maintaining the <strong>fluidity</strong> and<strong> functionality of cell membranes.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Biologically arachidonic acid is essential to life</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This is<strong> true</strong>. <strong>Arachidonic acid</strong> is important for the <strong>synthesis of eicosanoids</strong>, which are involved in various <strong>physiological functions</strong>, including<strong> inflammation and immune response.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Hydrogenated vegetable oils contain trans fatty acid</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This is<strong> true. </strong>The process of <strong>hydrogenating vegetable oils,</strong> which is used to <strong>convert them into semi-solid forms</strong> for use in <strong>various food products</strong>, often results in the <strong>formation of trans fatty acids.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Most<strong> naturally</strong> occurring<strong> unsaturated fatty acids</strong> are in the <strong>cis configuration,</strong> which<strong> impacts cell membrane fluidity </strong>and <strong>overall</strong> <strong>metabolic health</strong>, as<strong> opposed</strong> to <strong>trans fatty acids</strong> that are <strong>largely </strong>produced <strong>industrially</strong> and have <strong>negative health implications.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e p241</span></strong></span></span></p>",
    "correct_choice_id": 35838,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 8977,
    "choices": [
      {
        "id": 35875,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Carbohydrates</span></span></span></p>"
      },
      {
        "id": 35876,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Triglycerides</span></span></span></p>"
      },
      {
        "id": 35877,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lecithin</span></span></span></p>"
      },
      {
        "id": 35878,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cholesterol</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The eukaryotic plasma membrane is a dynamic structure crucial for maintaining the integrity of the cell, facilitating communication, and transporting substances into and out of the cell. Its composition is diverse, including various types of molecules that contribute to its fluid mosaic model. Among the following options, which one is NOT typically found as a component of the eukaryotic plasma membrane? </span></span></span></p>",
    "unique_key": "Q5717320",
    "question_audio": null,
    "question_video": null,
    "map_id": 30244,
    "difficulty_level": "difficult",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Triglycerides</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Triglycerides </strong>are<strong> not</strong> a typical component of the<strong> eukaryotic plasma membrane. </strong>The<strong> plasma membrane</strong> is mainly composed of a <strong>phospholipid bilayer, </strong>in which the phospholipids (such as lecithin) have a <strong>glycerol backbone, two fatty acid tails, and a phosphate</strong> <strong>group </strong>with various <strong>head groups.</strong> <strong>Triglycerides,</strong> on the other hand, consist of a <strong>glycerol backbone </strong>and <strong>three fatty acid tails</strong> and are <strong>primarily </strong>involved in <strong>energy storage in adipose cells</strong>, <strong>not</strong> in forming the <strong>structure of plasma membranes.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/10/picture10_FCLrY6O.jpg\" style=\"height:311px; width:602px\" /></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Carbohydrates</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Carbohydrates are typically <strong>attached to proteins (glycoproteins) or lipids (glycolipids) </strong>on the <strong>extracellular</strong> <strong>surface of the plasma membrane</strong>, playing key roles in <strong>cell recognition, signaling, and adhesion.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Lecithin</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Lecithin (a type of <strong>phospholipid</strong>) is a <strong>major component</strong> of the <strong>plasma membrane,</strong> contributing to <strong>its fluidity</strong> and<strong> </strong><strong>structural integrity.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: Cholesterol</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Cholesterol is <strong>interspersed </strong>among the<strong> phospholipids of the plasma membrane, </strong>where it serves to <strong>modulate</strong> <strong>fluidity and mechanical stability.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Plasma membranes </strong>are <strong>complex structures</strong> made of <strong>Lipids, Proteins, and Carbohydrates.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>major lipids </strong>seen in our <strong>mammalian membranes</strong> include<strong> phospholipids, glycosphingolipids, and cholesterol.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Major phospholipids </strong>present in membranes are <strong>phosphoglycerides, </strong>among which <strong>lecithin</strong> is most <strong>abundantly seen.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e p478 </span></strong></span></span></p>",
    "correct_choice_id": 35876,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 8980,
    "choices": [
      {
        "id": 35887,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Phosphatidylinositol</span></span></span></p>"
      },
      {
        "id": 35888,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Phosphatidyl ethanolamine</span></span></span></p>"
      },
      {
        "id": 35889,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Phosphatidylcholine</span></span></span></p>"
      },
      {
        "id": 35890,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">None</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In the context of cell signaling pathways, second messengers play a crucial role in amplifying and propagating signals within the cell. These molecules are often produced as a result of receptor activation on the cell surface. From which of the following molecules is a well-known second messenger commonly produced?</span></span></span></p>",
    "unique_key": "Q5604901",
    "question_audio": null,
    "question_video": null,
    "map_id": 30245,
    "difficulty_level": "intermediate",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Phosphatidylinositol</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Phosphatidylinositol, </strong>specifically <strong>phosphatidylinositol 4,5-bisphosphate (PIP2),</strong> is a precursor for the<strong> second messengers inositol</strong> <strong>1,4,5-trisphosphate (IP3) </strong>and <strong>diacylglycerol (DAG)</strong> in the <strong>phosphoinositide signaling pathway</strong>. Upon activation of <strong>certain G-protein</strong> <strong>coupled receptors,</strong> the enzyme<strong> phospholipase C (PLC) is activated,</strong> which then<strong> cleaves PIP2 to generate IP3 and DAG</strong>.<strong> IP3</strong> <strong>diffuses </strong>through the <strong>cytosol to the endoplasmic reticulum,</strong> where it <strong>binds </strong>to and <strong>opens calcium channels,</strong> thereby<strong> increasing intracellular</strong> <strong>calcium levels</strong> and <strong>activating downstream signaling cascades</strong>.<strong> DAG </strong>remains in the<strong> plasma membrane and, together with calcium,</strong> <strong>activates protein kinase C (PKC),</strong> leading to further <strong>cellular responses.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Phosphatidyl ethanolamine</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: While an important <strong>phospholipid in the membrane</strong>, it is<strong> not </strong>directly involved in the <strong>generation of second messengers.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Phosphatidylcholine</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: It can be <strong>involved in signaling pathways,</strong> for instance, through <strong>its breakdown by phospholipase D</strong> to produce<strong> phosphatidic acid</strong>, but it is <strong>not </strong>the <strong>classical route for second messenger </strong>production like<strong> phosphatidylinositol.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Phosphatidylinositol</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is present in the<strong> cell membrane</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Plays an important role in <strong>cell signalling, membrane trafficking</strong> and as a <strong>precursor of second messenger </strong>in hormonal pathways.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Diacylglycerol and Inositol Trisphosphate IP3 </strong>act as <strong>second messengers.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e p216</span></strong></span></span></p>",
    "correct_choice_id": 35887,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "TreatmentBased"
    ]
  },
  {
    "id": 8982,
    "choices": [
      {
        "id": 35895,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cerebroside</span></span></span></p>"
      },
      {
        "id": 35896,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Plasmalogen</span></span></span></p>"
      },
      {
        "id": 35897,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sphingomyelin</span></span></span></p>"
      },
      {
        "id": 35898,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lecithin</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cell membranes are composed of various lipids that contribute to their structural integrity and functionality. Among these, glycolipids play a special role in cell recognition, signalling, and interaction with the extracellular environment. Based on your understanding of membrane lipids, which of the following options is classified as a glycolipid?</span></span></span></p>",
    "unique_key": "Q1026103",
    "question_audio": null,
    "question_video": null,
    "map_id": 30247,
    "difficulty_level": "intermediate",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cerebroside</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Cerebrosides</strong> are a type of<strong> glycolipid </strong>that consist of a<strong> ceramide backbone linked</strong> to a <strong>single sugar molecule, </strong>either <strong>glucose</strong> or <strong>galactose</strong>. They are primarily found in the <strong>outer layer of the plasma membrane</strong> and are <strong>abundant in the myelin sheath of nerve cells.</strong> <strong>Glycolipids</strong> like <strong>cerebrosides</strong> are involved in <strong>cell recognition, cell signaling, </strong>and serve as <strong>markers for cellular interactions.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Plasmalogen</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Plasmalogens are a <strong>type of phospholipid </strong>characterized by the <strong>presence of an ether bond</strong> at the <strong>sn-1</strong> position of the<strong> glycerol backbone</strong>, not a glycolipid.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Sphingomyelin</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Sphingomyelin is a <strong>type of sphingophospholipid</strong> that contains<strong> phosphocholine</strong> or <strong>phosphoethanolamine</strong> as<strong> its head group.</strong> It is <strong>not classified </strong>as a <strong>glycolipid</strong> because<strong> it lacks a sugar moiety.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: Lecithin</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Lecithin, also known as<strong> phosphatidylcholine</strong>, is a<strong> phospholipid </strong>that is a <strong>major component </strong>of <strong>cell membranes</strong> but <strong>does not </strong>contain a <strong>sugar group</strong>, thus <strong>not a glycolipid.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Glycolipids or Glycosphingolipids</strong> include<strong> Cerebroside, Globoside and Ganglioside.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e p218</span></strong></span></span></p>",
    "correct_choice_id": 35895,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 9044,
    "choices": [
      {
        "id": 36143,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Less free fatty acids are delivered from the expanded adipose tissue to the liver</span></span></span></p>"
      },
      {
        "id": 36144,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Decreased insulin levels promote fatty acid synthesis in the liver</span></span></span></p>"
      },
      {
        "id": 36145,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increased Insulin resistance causes increased LPL activity</span></span></span></p>"
      },
      {
        "id": 36146,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Reduced clearance of chylomicron and VLDL due to reduced LPL activity</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 50-year-old woman with poorly controlled type 2 diabetes reports fatigue and difficulty losing weight, without classic symptoms of polyuria, polydipsia, or polyphagia. Her blood sugar levels and lipid profile are abnormal. Considering the relationship between obesity and lipid metabolism, which of the following statements is accurate?</span></span></span></p>",
    "unique_key": "Q7946525",
    "question_audio": null,
    "question_video": null,
    "map_id": 30249,
    "difficulty_level": "intermediate",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D)</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Reduced clearance of chylomicron and VLDL due to reduced LPL activity</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The<strong> increase in adipocyte mass </strong>and accompanying <strong>decrease in insulin sensitivity </strong>associated<strong> with obesity</strong> has <strong>multiple</strong> <strong>effects on lipid metabolism.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Less free fatty acids are delivered from the expanded adipose tissue to the liver:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>More free fatty acids</strong> are delivered from the<strong> expanded adipose tissue </strong>to the <strong>liver</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Decreased insulin levels promote fatty acid synthesis in the liver:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The<strong> increased insulin levels</strong> promote <strong>fatty acid synthesis</strong> in the <strong>liver.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Increased Insulin resistance causes increased LPL activity:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Increased Insulin resistance</strong> causes<strong> reduced LPL </strong>activity which causes <strong>reduced clearance of chylomicron and VLDL </strong>&rarr;&nbsp; results in<strong> hypertriglyceridemia.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Obesity,</strong> particularly with <strong>insulin resistance</strong>, often<strong> leads to decreased activity </strong>of the enzyme<strong> lipoprotein lipase (LPL),</strong> <strong>impairing fat</strong> <strong>clearance</strong> from the <strong>blood</strong> and contributing to<strong> dyslipidemia</strong>. <strong>Contrary </strong>to <strong>other possibilities, </strong>this condition typically results in <strong>increased free fatty acids</strong> to the<strong> liver </strong>and <strong>does not </strong>promote <strong>fatty acid synthesis </strong>due to <strong>decreased, not increased, LPL activity.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Lippincott 7/e: 351-355.</span></strong></span></span></p>",
    "correct_choice_id": 36146,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "TreatmentBased"
    ]
  },
  {
    "id": 9056,
    "choices": [
      {
        "id": 36191,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glycogen phosphorylase</span></span></span></p>"
      },
      {
        "id": 36192,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glycerol kinase</span></span></span></p>"
      },
      {
        "id": 36193,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hormone-sensitive triacylglycerol lipase</span></span></span></p>"
      },
      {
        "id": 36194,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Phosphatidate phosphatase</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Following a substantial meal, an individual&#39;s metabolic processes adjust to manage the influx of nutrients. In adipocytes, specifically, one enzyme becomes particularly active to facilitate the storage of excess energy. Which enzyme is primarily activated in adipocytes postprandially?</span></span></span></p>",
    "unique_key": "Q1461779",
    "question_audio": null,
    "question_video": null,
    "map_id": 30251,
    "difficulty_level": "difficult",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Phosphatidate phosphatase</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This enzyme converts<strong> phosphatidic acid to DAG</strong> during synthesis of <strong>triacylglycerol (TAG).</strong> </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The function of adipose tissue is the<strong> storage of FA&rsquo;s as TAGs</strong><strong> </strong>in <strong>fed state </strong>and the<strong> release of fatty acids </strong>during times of <strong>fasting or starvation. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Fatty acids</strong> taken in by<strong> adipocytes</strong> are stored by esterification to<strong> glycerol-3-phosphate </strong>(derived almost entirely from the <strong>glycolytic intermediate DHAP</strong> through the <strong>action of glycerol-3-phosphate dehydrogenase</strong>).</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Calibri, sans-serif\"><span style=\"font-size:16px\"><strong><u>Other Options:</u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Glycolytic enzymes </strong>are <strong>active</strong> in<strong> adipocytes</strong> during <strong>triglyceride synthesis</strong>, but those of <strong>glycogen degradation</strong> (<strong>low levels</strong> in <strong>adipocytes</strong>) and<strong> gluconeogenesis </strong>(<strong>glucose-6-phosphatase</strong>) are <strong>not.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> It is<strong> not</strong> present much in <strong>adipocytes</strong>, so that <strong>glycerol released</strong> during<strong> lipolysis</strong> is<strong> not </strong>used to <strong>reesterify </strong>the <strong>fatty acids </strong>being <strong>freed.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><br />\r\n<span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> It is turned on by<strong> phosphorylation by a cyclic AMP-dependent protein kinase </strong>following <strong>epinephrine</strong> stimulation in <strong>fasting</strong> <strong>state.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Phosphatidate phosphatase</strong> plays a crucial role in <strong>adipocytes</strong> following a <strong>heavy meal by catalyzing the dephosphorylation</strong> of <strong>phosphatidic acid to diacylglycerol</strong>, which is a key step in the<strong> synthesis of triacylglycerol</strong> (the storage form of fats). </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Postprandially</strong>, when there is an<strong> abundance of dietary fats and carbohydrates,</strong> the body prioritizes the <strong>storage of excess energy </strong>as <strong>fat in adipocytes,</strong> and <strong>phosphatidate phosphatase </strong>is <strong>instrumental</strong> in this process.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Vasudevan 9 /ed: p 160.</span></strong></span></span></p>",
    "correct_choice_id": 36194,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 9095,
    "choices": [
      {
        "id": 36347,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pancreatic Lipase</span></span></span></p>"
      },
      {
        "id": 36348,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lipoprotein Lipase</span></span></span></p>"
      },
      {
        "id": 36349,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lysosomal Lipase</span></span></span></p>"
      },
      {
        "id": 36350,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hormone sensitive Lipase</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which enzyme is primarily responsible for hydrolyzing stored triacylglycerols in adipose tissue to release fatty acids for energy? </span></span></span></p>",
    "unique_key": "Q8637856",
    "question_audio": null,
    "question_video": null,
    "map_id": 30240,
    "difficulty_level": "intermediate",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hormone sensitive lipase</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Hormone-sensitive lipase (HSL) </strong>plays a crucial role in<strong> mobilizing stored fats within adipose tissue</strong>. Under the influence of<strong> hormonal</strong> signals like <strong>catecholamines</strong> during<strong> fasting or exercise,</strong> <strong>HSL</strong> is <strong>activated </strong>to <strong>hydrolyze</strong> stored <strong>triacylglycerols, </strong>releasing <strong>free fatty acids</strong> and <strong>glycerol</strong> into the<strong> bloodstream </strong>for<strong> energy</strong> use by<strong> other tissues.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Pancreatic Lipase</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This enzyme functions primarily in the <strong>digestive system</strong> to break down<strong> dietary fats</strong> into <strong>free fatty acids</strong> and <strong>monoglycerides</strong>, which can then be <strong>absorbed</strong> by the <strong>intestinal mucosa.</strong> It is <strong>not </strong>involved in the <strong>mobilization of stored</strong> <strong>triacylglycerols</strong> within<strong> adipose tissue.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Lipoprotein Lipase</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: <strong>Found</strong> on the<strong> surface of endothelial cells</strong> lining<strong> blood vessels, lipoprotein lipase</strong> acts on <strong>circulating</strong> <strong>lipoproteins</strong>, such as<strong> chylomicrons and VLDL, hydrolyzing</strong> their triglycerides to <strong>release free fatty acids</strong> for<strong> uptake</strong> by<strong> adjacent tissues.</strong> It is <strong>not</strong> directly involved in<strong> hydrolyzing stored triacylglycerols within adipocytes.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Lysosomal Lipase</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Also known as <strong>acid lipase</strong>, this enzyme is <strong>located within lysosomes </strong>and is involved in the <strong>intracellular</strong> breakdown of <strong>lipids</strong>, including the <strong>hydrolysis of cholesteryl esters</strong> and<strong> triglycerides</strong> within the <strong>lysosomes</strong>. While it does play a role in <strong>lipid metabolism</strong>, it is<strong> not</strong> the primary enzyme for<strong> mobilizing stored triacylglycerols in adipose tissue.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Hormone sensitive lipase hydrolyze stored TGs </strong>in<strong> adipose tissue </strong>under <strong>fasting/starvation conditions.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This enzyme is <strong>activated by glucagon</strong> and <strong>inhibited by insulin.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e p263</span></strong></span></span></p>",
    "correct_choice_id": 36350,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "TreatmentBased"
    ]
  },
  {
    "id": 9180,
    "choices": [
      {
        "id": 36687,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glycocholic acid is a conjugate of cholic acid and glycine</span></span></span></p>"
      },
      {
        "id": 36688,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">7&alpha;-hydroxylase is the regulatory enzyme in bile salt synthesis</span></span></span></p>"
      },
      {
        "id": 36689,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">7&alpha;-hydroxy cholesterol is a precursor of both chenodeoxycholate and cholate</span></span></span></p>"
      },
      {
        "id": 36690,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Taurochenodeoxy cholate is derived from cholic acid</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A pediatric gastroenterologist is assessing a child with liver failure. As part of the diagnostic workup, serum bile acid analysis is performed to evaluate liver function and bile acid metabolism. The gastroenterologist is explaining to the medical trainees that understanding bile salt synthesis is crucial for interpreting these results. She poses a question to the trainees to identify the incorrect statement regarding the synthesis of bile salts:</span></span></span></p>",
    "unique_key": "Q2106248",
    "question_audio": null,
    "question_video": null,
    "map_id": 30250,
    "difficulty_level": "difficult",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Taurochenodeoxycholate is derived from cholic acid&nbsp;</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The primary <strong>bile acids are cholic acid and chenodeoxycholic acid </strong>synthesized in the <strong>liver </strong>from <strong>cholesterol </strong>and are conjugated with either <strong>glycine or taurine </strong>to form <strong>Glycocholic acid, taurocholic acid, lycol chenodeoxy cholic acid </strong>and <strong>tauro chenodeoxy cholic acid.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>7&alpha;-hydroxylation </strong>of <strong>cholesterol </strong>is the regulatory step in the <strong>biosynthesis of bile acids </strong>and is catalysed by <strong>7 alpha-hydroxylase</strong>.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>7&alpha;-hydroxycholestrol </strong>is a precursor of <strong>both chenodeoxy cholate and cholate</strong>.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Secondary bile acids</strong>:&nbsp; <strong>Cholic acid </strong>is converted to <strong>deoxycholic acid and chenodeoxy cholic acid </strong>to <strong>lithocholic acid</strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Glycocholic acid is a conjugate of cholic acid and glycine</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This is <strong>correct</strong>. <strong>Glycocholic acid </strong>is indeed a <strong>bile salt </strong>formed by the conjugation of <strong>cholic acid with glycine</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: 7&alpha;-hydroxylase is the regulatory enzyme in bile salt synthesis</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: <strong>True, 7&alpha;-hydroxylase </strong>is a key enzyme in the synthesis of <strong>bile acids</strong>, which is the <strong>initial and rate-limiting step </strong>in the <strong>bile acid synthesis pathway </strong>from <strong>cholesterol</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: 7&alpha;-hydroxy cholesterol is a precursor of both chenodeoxycholate and cholate</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This is also <strong>true. 7&alpha;-hydroxy cholesterol </strong>is an intermediate in the synthesis pathway of <strong>both cholic acid </strong>and <strong>chenodeoxycholic acid</strong>, which are <strong>primary bile acids</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Taurochenodeoxycholate </strong>is <strong>incorrectly </strong>stated as being <strong>derived </strong>from <strong>cholic acid</strong>. In reality, <strong>taurochenodeoxycholate </strong>is a <strong>conjugate </strong>of <strong>chenodeoxycholic acid </strong>with <strong>taurine</strong>, <strong>not cholic acid</strong>. <strong>Bile salts </strong>are formed by the <strong>conjugation of bile acids </strong>(like cholic acid and chenodeoxycholic acid) with <strong>amino acids </strong>such as <strong>glycine or taurine</strong>, which <strong>enhances </strong>their <strong>solubility </strong>and function in the <strong>emulsification of lipids</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e: p 273, Vasudevan 9/e: p 231</span></strong></span></span></p>",
    "correct_choice_id": 36690,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 9191,
    "choices": [
      {
        "id": 36731,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Carbohydrate</span></span></span></p>"
      },
      {
        "id": 36732,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cholesterol</span></span></span></p>"
      },
      {
        "id": 36733,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Unsaturated fat </span></span></span></p>"
      },
      {
        "id": 36734,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Saturated fat</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 52-years-old man weighing 90 kg doing sedentary work denies any health issues.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Routine blood test results were all normal except for plasma total cholesterol of 288 mg/dl. He was not willing to take treatment for his hypercholesterolemia. So, analysis of his 1-day dietary chart comes as follows:</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/22/screenshot-2024-04-22-123952.png\" style=\"height:96px; width:500px\" /></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">So, which of the following can be decreased from the diet to reduce the high plasma cholesterol levels?</span></span></span></p>",
    "unique_key": "Q9844371",
    "question_audio": null,
    "question_video": null,
    "map_id": 30255,
    "difficulty_level": "difficult",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Saturated fat</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>intake </strong>of <strong>saturated fat </strong>most likely influences <strong>plasma cholesterol </strong>in the given <strong>diet</strong>.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The patient is consuming a <strong>high-calorie, high-fat diet </strong>with <strong>35-40% </strong>of the fat as <strong>saturated fat.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The most important <strong>dietary </strong>recommendations are <strong>reducing the total calorie intake</strong>, <strong>substitute MUFA </strong>&amp; <strong>PUFA </strong>for <strong>saturated fats </strong>and also <strong>increase dietary fibre</strong>. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Though a <strong>decrease </strong>in <strong>dietary cholesterol </strong>can have effects on the <strong>lipid profile</strong>, it is always a <strong>secondary option </strong>to <strong>saturated fat</strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:16px\"><strong>Other Options:</strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Carbohydrate:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It provides almost <strong>60&ndash;65% of total calories </strong>and <strong>dietary fibre</strong>, which <strong>improves bowel motility</strong>, <strong>prevents constipation</strong>, and <strong>decreases </strong>the <strong>reabsorption </strong>of <strong>bile acids </strong>thereby <strong>reducing the cholesterol level</strong> and <strong>improves glucose tolerance</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Cholesterol:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is always <strong>advised to reduce </strong>that<strong> dietary intake of cholesterol </strong>due to its<strong> atherogenic effect </strong>and the <strong>risk </strong>of developing <strong>coronary artery disease</strong>. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><br />\r\n<span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Unsaturated fat:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Saturated fats increase </strong>the <strong>serum cholesterol </strong>and <strong>unsaturated fats </strong>(vegetable oils and fish oils) <strong>reduces</strong> it. Especially <strong>PUFAs </strong>causes <strong>esterification </strong>and <strong>excretion of cholesterol</strong>, thereby <strong>reducing the cholesterol </strong>level in <strong>blood</strong>. Hence they are <strong>antiatherogenic</strong> and always preferred in the diet.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A<strong> reduction in saturated fat </strong>intake is often recommended to <strong>lower plasma cholesterol levels</strong>. Saturated fats can <strong>increase low-density lipoprotein (LDL) cholesterol, </strong>which is a <strong>major risk </strong>factor for <strong>coronary artery disease</strong>. The patient&#39;s diet, with <strong>78g </strong>of <strong>saturated fat</strong>, significantly exceeds the <strong>American Heart Association&#39;s </strong>recommendation of <strong>5-6% of total daily calories </strong>from <strong>saturated fat.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Lippincott 7/e: P 360-364.</span></strong></span></span></p>",
    "correct_choice_id": 36734,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "ImageBased"
    ]
  },
  {
    "id": 9207,
    "choices": [
      {
        "id": 36795,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bile salt formation</span></span></span></p>"
      },
      {
        "id": 36796,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Micelle formation</span></span></span></p>"
      },
      {
        "id": 36797,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pancreatic and gastric lipase</span></span></span></p>"
      },
      {
        "id": 36798,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Absorption of Free fatty acids</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 30-year-old obese woman started with Tab. Orlistat, as she fails to follow the lifestyle modifications advised by her physician. Which of the following steps of digestion and absorption of fats is directly inhibited by Orlistat?</span></span></span></p>",
    "unique_key": "Q4247859",
    "question_audio": null,
    "question_video": null,
    "map_id": 30259,
    "difficulty_level": "difficult",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pancreatic and gastric lipase</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Orlistat</strong> inhibits<strong> gastric and pancreatic lipases</strong>, thus preventing the <strong>digestion and absorption of fats.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sequence of events in digestion: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Triglycerides</strong> are <strong>emulsified </strong>by <strong>bile salts</strong> &rarr; then<strong> acted</strong> on by <strong>lipases. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The product of <strong>digestion</strong> is <strong>absorbed</strong> &rarr; <strong>re-esterified/ resynthesis</strong> of <strong>TAG</strong> in the<strong> intestinal mucosal cells</strong> &rarr; <strong>TAG </strong>is then packed in the <strong>chylomicrons</strong> &rarr; <strong>transported </strong>to the <strong>peripheral cells for utilization</strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Effect of orlistat:</span></strong> </span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Triglycerides</strong> are <strong>left undigested </strong>and <strong>unabsorbed</strong> &rarr; resulting in<strong> bulky stools.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Orlistat </strong>therapy if given for a <strong>long time</strong> &rarr;<strong> induce deficiency of fat-soluble vitamins.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:16px\"><strong>Other Options:</strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Bile salt formation</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: <strong>Bile salts </strong>are produced in the <strong>liver </strong>from <strong>cholesterol </strong>and play a crucial role in <strong>emulsifying fats </strong>in the <strong>small intestine </strong>to <strong>aid </strong>in their <strong>digestion</strong>. <strong>Orlistat </strong>does <strong>not </strong>directly <strong>inhibit bile salt </strong>formation; its action is focused on <strong>blocking </strong>the <strong>enzymes </strong>that <strong>break down fats </strong>into <strong>absorbable units</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Micelle formation</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Micelles are formed in the <strong>small intestine </strong>and are <strong>essential </strong>for the <strong>absorption of digested fats</strong>. They are composed of <strong>bile salts, fatty acids, cholesterol, </strong>and other lipids. While <strong>Orlistat&rsquo;s </strong>action <strong>reduces </strong>the amount of <strong>free fatty acids </strong>available for<strong> micelle formation </strong>(by <strong>inhibiting lipase activity</strong>), it does <strong>not </strong>directly <strong>inhibit </strong>the formation of <strong>micelles themselves</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: Absorption of Free fatty acids</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:<strong> Orlistat indirectly </strong>affects the <strong>absorption </strong>of <strong>free fatty acids </strong>by <strong>inhibiting </strong>their release from <strong>dietary fats</strong>. However, the drug does <strong>not </strong>directly <strong>inhibit </strong>the <strong>cellular mechanisms </strong>responsible for the <strong>absorption of free fatty acids across </strong>the intestinal lining.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The key takeaway is that <strong>Orlistat </strong>specifically <strong>inhibits </strong>the action of <strong>pancreatic and gastric lipases</strong>, enzymes critical for the <strong>breakdown of dietary fats </strong>into <strong>smaller, absorbable </strong>molecules like <strong>free fatty acids </strong>and <strong>monoglycerides</strong>. By doing so, it <strong>reduces </strong>the overall absorption of <strong>fats </strong>from the <strong>diet</strong>, <strong>aiding in weight </strong>management. It does <strong>not </strong>directly affect <strong>bile salt formation</strong>, <strong>micelle formation, </strong>or the <strong>absorption </strong>mechanism of <strong>free fatty acids</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Lippincott 6/e: p 175-177.</span></strong></span></span></p>",
    "correct_choice_id": 36797,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 9241,
    "choices": [
      {
        "id": 36931,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Amino acids through transamination reactions</span></span></span></p>"
      },
      {
        "id": 36932,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Isoprene units through condensation reactions </span></span></span></p>"
      },
      {
        "id": 36933,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fatty acids through elongation processes </span></span></span></p>"
      },
      {
        "id": 36934,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glucose molecules through glycolysis</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following best describes the precursors used in the synthesis of carotenoids?</span></span></span></p>",
    "unique_key": "Q9856342",
    "question_audio": null,
    "question_video": null,
    "map_id": 30248,
    "difficulty_level": "intermediate",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Isoprene units through condensation reactions</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Carotenoids</strong> are <strong>synthesized</strong> from<strong> isoprene</strong> units, which are<strong> five-carbon compounds</strong>. The <strong>synthesis</strong> involves the condensation of these units to form the <strong>40-carbon skeleton</strong> that characterizes <strong>carotenoids. </strong>Specifically, <strong>eight isoprene</strong> units are condensed to form the<strong> carotenoid structure</strong>, through the <strong>tail-to-tail linkage of two geranylgeranyl pyrophosphate (GGPP)</strong> molecules, each comprising <strong>four isoprene units.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\">&nbsp;</span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Amino acids</strong> are <strong>not</strong> directly involved in the<strong> synthesis of carotenoids.</strong> While <strong>amino acids</strong> are crucial for <strong>protein synthesis</strong> and other <strong>metabolic functions</strong>, they<strong> do not</strong> serve as precursors for<strong> carotenoid synthesis. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:&nbsp;<strong>Fatty acids</strong> are involved in various <strong>metabolic processes</strong>, including <strong>energy storage and membrane synthesis,</strong> but they are <strong>not</strong> directly <strong>converted into carotenoids</strong>. The elongation of <strong>fatty acids </strong>refers to the process of adding <strong>carbon units to a fatty acid</strong> chain, <strong>not </strong>the <strong>synthesis of carotenoids. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Glucose </strong>is a<strong> central molecule </strong>in energy metabolism, participating in pathways such as <strong>glycolysis and the citric acid cycle.</strong> However, glucose is<strong> not</strong> directly used in the<strong> synthesis of carotenoids. </strong>While some of th<strong>e intermediates </strong>from<strong> glucose metabolism</strong> might contribute to the<strong> pool of precursors for isoprene unit synthesis, glucose</strong> itself is <strong>not</strong> a <strong>direct precursor for carotenoids.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Isoprene units</strong> are precursors to many <strong>Isoprenoid compounds</strong> such as </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Vitamin A</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Vitamin K</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Carotenoids</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ubiquinone (a component of electron transport chain) </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dolichol (a compound involved in glycoprotein synthesis)</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Pankaja Naik 6/e: p276.</span></strong></span></span></p>",
    "correct_choice_id": 36932,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 9225,
    "choices": [
      {
        "id": 36867,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">LDL cholesterol &lt; 100 mg/dl</span></span></span></p>"
      },
      {
        "id": 36868,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Saturated fat &lt;7 % of total calories</span></span></span></p>"
      },
      {
        "id": 36869,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dietary cholesterol &lt; 300 mg/day</span></span></span></p>"
      },
      {
        "id": 36870,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;Avoid Alcohol</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 75-year-old male with a history of coronary artery disease (CAD), who recently underwent coronary artery bypass grafting (CABG), is scheduled for a postoperative follow-up visit. During the visit, the cardiologist reviews the patient&#39;s postoperative recovery and emphasizes the importance of dietary and lifestyle modifications to manage his CAD and reduce the risk of future cardiac events. The cardiologist outlines several recommendations but also wants to clarify a common misconception about dietary guidelines for patients with a high risk of coronary heart disease.&nbsp;</span></span></span><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following dietary goals is NOT typically recommended for patients with a high risk of coronary heart disease?</span></span></span></p>",
    "unique_key": "Q5618213",
    "question_audio": null,
    "question_video": null,
    "map_id": 30242,
    "difficulty_level": "difficult",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Dietary cholesterol &lt; 300 mg/day</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">While mindful consumption of <strong>dietary cholesterol </strong>is part of a <strong>heart-healthy lifestyle</strong>, recent guidelines have shifted focus towards <strong>reducing saturated and trans fats</strong>. The specific limit of <strong>&lt;300 mg/day</strong> is <strong>not</strong> emphasized as <strong>stringently</strong> for <strong>CAD patients</strong> as managing overall<strong> dietary patterns</strong> and <strong>saturated fat intake</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation: </span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: LDL cholesterol &lt; 100 mg/dl</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This target is recommended for individuals with <strong>CAD to reduce the risk </strong>of further <strong>coronary</strong> <strong>events</strong>.<strong> Lowering LDL cholesterol</strong> is a key focus in managing<strong> CAD </strong>because<strong> elevated LDL levels </strong>are<strong> directly</strong> linked to an<strong> increased risk</strong> of <strong>atherosclerosis</strong> and subsequent <strong>heart problems.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Saturated fat &lt;7% of total calories</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: <strong>Reducing saturated fat </strong>intake is crucial for individuals with <strong>CAD </strong>as<strong> saturated fats </strong>can <strong>raise LDL cholesterol </strong>levels, contributing to the <strong>buildup of plaques in arteries. </strong>Limiting <strong>saturated fats </strong>to <strong>less </strong>than <strong>7% </strong>of <strong>total daily calories </strong>is part of a <strong>heart-healthy diet </strong>aimed at <strong>reducing cardiovascular risk</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: Avoid Alcohol</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:<strong> Moderation </strong>in <strong>alcohol consumption </strong>is generally advised for the <strong>general population</strong>. For patients with <strong>CAD,</strong> alcohol should be consumed<strong> with caution</strong> due to <strong>its potential effects</strong> on <strong>blood pressure, triglyceride levels, and caloric intake.</strong> While <strong>moderate alcohol intake</strong> may have some <strong>cardiovascular benefits</strong> in<strong> certain individuals, avoiding excessive alcohol </strong>is <strong>crucial,</strong> especially for those with <strong>CAD </strong>or those who have<strong> difficulty consuming alcohol </strong>in <strong>moderation.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">For managing <strong>coronary artery disease</strong>, <strong>dietary</strong> recommendations emphasize <strong>reducing saturated fat intake</strong> and maintaining <strong>LDL cholesterol levels below 100 mg/dl.</strong> The strict <strong>limit on dietary cholesterol (&lt;300 mg/day) </strong>is<strong> less</strong> <strong>emphasized,</strong> while<strong> moderation </strong>in<strong> alcohol consumption </strong>is advised for overall <strong>heart health.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Vasudevan 9/e: p 253.</span></strong></span></span></p>",
    "correct_choice_id": 36869,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "TreatmentBased"
    ]
  },
  {
    "id": 9229,
    "choices": [
      {
        "id": 36883,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Vitamin D</span></span></span></p>"
      },
      {
        "id": 36884,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Estrogen</span></span></span></p>"
      },
      {
        "id": 36885,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Adrenaline</span></span></span></p>"
      },
      {
        "id": 36886,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Progesterone</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 50-year-old female patient visits your clinic for a routine health check-up. During the consultation, she expresses her concern about high cholesterol levels and its implications on her health. She is particularly interested in understanding which substances in her body, related to her health concerns, do not contain cholesterol. Based on this context, which of the following does not have cholesterol?</span></span></span></p>",
    "unique_key": "Q9085405",
    "question_audio": null,
    "question_video": null,
    "map_id": 30243,
    "difficulty_level": "beginner",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Adrenaline</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Adrenaline, </strong>also known as <strong>epinephrine</strong>, is a <strong>hormone and a neurotransmitter </strong>that <strong>does not </strong>derive from <strong>cholesterol</strong>. It is <strong>synthesized </strong>from the <strong>amino acid tyrosine </strong>in the <strong>adrenal medulla </strong>and certain <strong>neurons </strong>within the <strong>central nervous system</strong>. <strong>Adrenaline </strong>is involved in the body&#39;s <strong>&quot;fight-or-flight&quot; response</strong>, <strong>increasing heart rate</strong>, <strong>contracting blood vessels, </strong>and <strong>dilating air passages</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:16px\"><strong>Other Options:</strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Vitamin D </strong>is <strong>synthesized </strong>from <strong>7-dehydrocholesterol</strong>, a <strong>derivative </strong>of <strong>cholesterol</strong>, in the <strong>skin </strong>under the influence of <strong>sunlight (UVB radiation).</strong></span></span></span><br />\r\n&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong> Estrogen </strong>is a <strong>steroid </strong>hormone that is <strong>synthesized </strong>from <strong>cholesterol</strong>. The <strong>steroid hormones </strong>are all <strong>derived </strong>from <strong>cholesterol </strong>and include the <strong>sex hormones </strong>and those produced by the <strong>adrenal cortex. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Progesterone</strong>, like <strong>estrogen</strong>, is a <strong>steroid hormone synthesized </strong>from <strong>cholesterol</strong>. It plays a role in the <strong>menstrual cycle</strong>, <strong>pregnancy</strong>, and <strong>embryogenesis </strong>of humans and other species.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Specialized Products formed from Cholesterol includes</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bile Acids </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Vitamin D</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sex Hormones</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Corticosteroids</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e p267</span></strong></span></span></p>",
    "correct_choice_id": 36885,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "TreatmentBased"
    ]
  },
  {
    "id": 9210,
    "choices": [
      {
        "id": 36807,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cholesterol esterase</span></span></span></p>"
      },
      {
        "id": 36808,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lipoprotein lipase</span></span></span></p>"
      },
      {
        "id": 36809,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hormone sensitive lipase</span></span></span></p>"
      },
      {
        "id": 36810,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pancreatic lipase</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 3-years-old female child has complaints of chronic diarrhoea with oily stools and failure to thrive. Her mother gave history of breastfeeding for 2 years and had no problems until she was weaned off. Which of the following enzyme is deficient followed by secretin stimulation?</span></span></span></p>",
    "unique_key": "Q1385101",
    "question_audio": null,
    "question_video": null,
    "map_id": 30264,
    "difficulty_level": "intermediate",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pancreatic lipase</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>patient&rsquo;s symptoms </strong>are consistent with an <strong>inability to absorb triglycerides</strong>, which would <strong>eliminate Cholesterol esterase</strong>. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Since the patient <strong>does not </strong>have any problem while <strong>on breast-feeding </strong>&rarr;the most likely enzyme to be <strong>deficient is pancreatic lipase</strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:16px\"><strong>Other Options:</strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Cholesterol esterase:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> The patient has <strong>inability to absorb triglycerides, </strong>which <strong>eliminates Cholesterol esterase </strong>from consideration.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Lipoprotein lipase and Option C: Hormone sensitive lipase</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Neither<strong> hormone sensitive lipase </strong>nor <strong>lipoprotein lipase </strong>is a digestive enzyme. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Pancreatic lipase deficiency </strong>can lead to <strong>impaired fat digestion and absorption</strong>, resulting in symptoms like <strong>chronic diarrhea </strong>with <strong>oily stools </strong>and <strong>failure to thrive</strong>, particularly becoming <strong>evident </strong>when <strong>dietary fats </strong>from <strong>solid foods </strong>are introduced after <strong>weaning off breast milk</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e:&nbsp; p 599.</span></strong></span></span></p>",
    "correct_choice_id": 36810,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "TreatmentBased"
    ]
  },
  {
    "id": 9185,
    "choices": [
      {
        "id": 36707,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Amorphous cholesterol monohydrate</span></span></span></p>"
      },
      {
        "id": 36708,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Crystalline cholesterol monohydrate</span></span></span></p>"
      },
      {
        "id": 36709,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Amorphous cholesterol dehydrate + potassium bilirubinate</span></span></span></p>"
      },
      {
        "id": 36710,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Crystalline Cholesterol dihydrate</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 30-year-old woman with no significant medical history is referred to a gastroenterologist after experiencing recurrent episodes of intense epigastric pain that often radiates to the right shoulder, especially after meals rich in fat. Her laboratory workup reveals signs of jaundice, and an ultrasound of the abdomen shows cholelithiasis with cholecystitis and concurrent pancreatitis. During the consultation, the gastroenterologist educates the patient on the nature of the gallstones implicated in her condition:</span></span></span></p>",
    "unique_key": "Q4150144",
    "question_audio": null,
    "question_video": null,
    "map_id": 30252,
    "difficulty_level": "difficult",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Crystalline cholesterol monohydrate </span></strong>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Components: <strong>cholesterol monohydrate crystals, calcium bilirubinate</strong>, and <strong>bile salts.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Small changes </strong>in the composition of <strong>bile </strong>can result in crystallization of<strong> cholesterol as gallstones</strong> and it is also formed when the solutes in the <strong>gallbladder precipitate</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cholesterol stones (80% of gallstones)&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">are usually <strong>yellow-green</strong> in appearance</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">C/F:<strong> pain</strong> (<strong>epigastric or right upper quadrant</strong> and <strong>radiating</strong> to the <strong>right shoulder</strong>) from the <strong>gallstones,</strong> usually after a <strong>fatty meal. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">If the <strong>gallbladder </strong>becomes <strong>inflamed </strong>or <strong>infected</strong>, <strong>cholecystitis </strong>can result. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>stones </strong>can also travel through the <strong>bile duct and obstruct biliary flow </strong>leading to <strong>jaundice</strong>, or <strong>irritate </strong>the <strong>pancreas </strong>and cause <strong>pancreatitis</strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\"><br />\r\n<span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:16px\"><strong>Other Options:</strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Amorphous cholesterol monohydrate</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: <strong>Gallstones </strong>are typically <strong>crystalline</strong>, <strong>not </strong>amorphous, which means they have a <strong>defined structure and shape.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Amorphous cholesterol dehydrate + potassium bilirubinate</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: <strong>Cholesterol stones </strong>are usually in the form of <strong>cholesterol monohydrate</strong>, and while <strong>bilirubinate </strong>can be a component of <strong>pigment stones, </strong>it is <strong>not </strong>typically associated with <strong>cholesterol stones</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: Crystalline Cholesterol dihydrate</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: <strong>Cholesterol gallstones </strong>are <strong>predominantly </strong>made of the <strong>monohydrate </strong>form, <strong>not dihydrate</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The majority of<strong> gallstones </strong>are composed of <strong>crystalline cholesterol monohydrate. </strong>These <strong>stones </strong>form when there is an <strong>imbalance </strong>in the composition of <strong>bile</strong>, leading to the <strong>precipitation of cholesterol</strong>. <strong>Cholesterol gallstones </strong>are often associated with <strong>obesity, rapid weight loss, </strong>or other <strong>metabolic </strong>conditions and are known to cause <strong>symptoms, </strong>particularly after the <strong>ingestion of fatty foods</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e: p 537</span></strong></span></span></p>",
    "correct_choice_id": 36708,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 9189,
    "choices": [
      {
        "id": 36723,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Below 280</span></span></span></p>"
      },
      {
        "id": 36724,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&lt;250</span></span></span></p>"
      },
      {
        "id": 36725,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">200</span></span></span></p>"
      },
      {
        "id": 36726,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Below 200</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 65-year-old man, recently treated with angioplasty for coronary artery disease (CAD), is being counseled by his cardiologist on discharge. The cardiologist emphasizes the importance of secondary prevention through lifestyle modifications to manage his cardiovascular risk factors. As part of the comprehensive plan, the cardiologist advises the patient on the optimal cholesterol levels he should aim to maintain to reduce the risk of future cardiac events:</span></span></span></p>",
    "unique_key": "Q3900244",
    "question_audio": null,
    "question_video": null,
    "map_id": 30254,
    "difficulty_level": "intermediate",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Below 200</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">For patients with<strong> coronary artery disease</strong>, maintaining a <strong>low level of serum cholesterol </strong>is critical for<strong> reducing </strong>the risk of future <strong>cardiac </strong>events. The <strong>American Heart Association </strong>recommends that such patients keep their <strong>total cholesterol below 200 mg/dl </strong>to <strong>minimize </strong>the risk of <strong>atherosclerosis progression </strong>and subsequent <strong>cardiac complications</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/19/screenshot-2024-04-19-145604.png\" style=\"height:373px; width:1000px\" /></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In<strong> healthy persons</strong>, <strong>cholesterol level </strong>varies from <strong>150 to 200 mg/dL </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">With <strong>risk </strong>factors - cholesterol level should be kept <strong>below 180 mg/dL. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Values around<strong> 220 mg/dL - moderate risk </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Values <strong>above 240 mg/dL </strong>- needs <strong>active treatment.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Fundamentals of Clinical Chemistry 6/e p 419, DM Vasudevan 7/e: p 140-141</span></strong></span></span></p>",
    "correct_choice_id": 36726,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 9200,
    "choices": [
      {
        "id": 36767,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cholic acid and chenodeoxycholic acid</span></span></span></p>"
      },
      {
        "id": 36768,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cholic acid and deoxycholic acid</span></span></span></p>"
      },
      {
        "id": 36769,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Deoxycholic acid and lithocholic acid</span></span></span></p>"
      },
      {
        "id": 36770,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lithocholic acid and chenodeoxycholic acid</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Secondary bile acids are:</span></span></span></p>",
    "unique_key": "Q2546579",
    "question_audio": null,
    "question_video": null,
    "map_id": 30256,
    "difficulty_level": "intermediate",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Deoxycholic acid and lithocholic acid</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Secondary bile acids</strong>, which include <strong>deoxycholic acid and lithocholic acid</strong>, are formed by the <strong>bacterial action </strong>on <strong>primary bile acids </strong>in the <strong>intestine</strong>. <strong>Primary bile acids</strong>, such as <strong>cholic acid and chenodeoxycholic acid</strong>, are <strong>synthesized </strong>in the <strong>liver</strong>. When they are <strong>secreted </strong>into the <strong>intestine, gut bacteria </strong>can <strong>modify </strong>them to form <strong>secondary bile acids</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:16px\"><strong>Other Options:</strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Cholic acid and chenodeoxycholic acid</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: These are <strong>primary bile acids </strong>synthesized in the <strong>liver from cholesterol</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Cholic acid and deoxycholic acid</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: <strong>Cholic acid </strong>is a <strong>primary bile acid</strong>, whereas <strong>deoxycholic acid </strong>is a <strong>secondary bile acid</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: Lithocholic acid and chenodeoxycholic acid</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: <strong>Lithocholic acid is a secondary bile acid</strong>, while <strong>chenodeoxycholic acid </strong>is a <strong>primary bile acid.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Primary Bile Acids: Formed in Liver </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ol>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Cholic Acid </strong>(Most abundant bile acids in mammals)</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><strong><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chenodeoxycholic Acid </span></span></span></strong></li>\r\n</ol>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Secondary Bile acids: Formed in Intestine</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ol>\r\n\t<li style=\"text-align:justify\"><strong><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Deoxycholic Acid</span></span></span></strong></li>\r\n\t<li style=\"text-align:justify\"><strong><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lithocholic Acid</span></span></span></strong></li>\r\n</ol>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">: DM Vasudevan 9/e: p 232.</span></strong></span></span></p>",
    "correct_choice_id": 36769,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 9220,
    "choices": [
      {
        "id": 36847,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cholesterol</span></span></span></p>"
      },
      {
        "id": 36848,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fatty acid</span></span></span></p>"
      },
      {
        "id": 36849,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bilirubin</span></span></span></p>"
      },
      {
        "id": 36850,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Proteins</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bile acids are primarily synthesized from which of the following substances?</span></span></span></p>",
    "unique_key": "Q3828838",
    "question_audio": null,
    "question_video": null,
    "map_id": 30238,
    "difficulty_level": "beginner",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cholesterol</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Bile acids</strong> are<strong> synthesized</strong> from <strong>cholesterol in the liver</strong>. This process involves<strong> multiple enzymatic </strong>steps that convert <strong>cholesterol into</strong> primary <strong>bile acids</strong>, such as <strong>cholic acid and chenodeoxycholic acid</strong>. These <strong>bile acids </strong>play a critical role in the<strong> digestion and absorption</strong> of <strong>dietary fats</strong> and <strong>fat-soluble vitamins</strong> in the<strong> intestine.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:16px\"><strong>Other Options:</strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Fatty acid</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Fatty acids are key components of<strong> fats</strong> and are involved in <strong>various metabolic processes</strong>, but they are <strong>not </strong>the precursors for<strong> bile acid synthesis.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Bilirubin</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Bilirubin is a <strong>breakdown </strong>product of <strong>heme from hemoglobin </strong>in <strong>red blood cells</strong>. It is <strong>excreted </strong>in <strong>bile </strong>but is <strong>not </strong>a precursor to <strong>bile acid synthesis.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: Proteins</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Proteins serve <strong>numerous functions </strong>in the <strong>body</strong>, including <strong>acting </strong>as <strong>enzymes and structural components</strong>, but they are <strong>not </strong>directly involved in the <strong>synthesis of bile acids</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Bile acids </strong>are <strong>synthesized </strong>from <strong>cholesterol </strong>in <strong>liver</strong>. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Rate limiting enzyme</strong>: seven <strong>&alpha; hydroxylase</strong>, Microsomal enzyme: <strong>Cyt P450, O2, NADPH, Vit C</strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/ed ,pg 273 </span></strong></span></span></p>",
    "correct_choice_id": 36847,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 8954,
    "choices": [
      {
        "id": 35783,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Gaucher\u2019s disease</span></p>"
      },
      {
        "id": 35784,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Niemann Pick disease</span></p>"
      },
      {
        "id": 35785,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Tay-Sachs disease</span></p>"
      },
      {
        "id": 35786,
        "text": "<p><span style=\"font-size:12pt;\">Sandhoff's disease</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt;\">A pediatrician evaluating a 6-month-old girl brought in by her mother. The baby has a history of repeated infections, fever, vomiting, and one seizure episode. There's a significant family history: an elder brother passed away at 3 years old from an undiagnosed condition. The baby appears lethargic and hypotonic, with bilateral nystagmus and a cherry red spot visible in both eyes. A blood examination reveals a decreased level of Hexosaminidase A enzyme, prompting the pediatrician to consider a genetic metabolic disorder. What is the most probable diagnosis for this baby?</span></p><p style=\"text-align:justify;\">&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/10/2_8cdDTT6.jpg\" alt=\"\" width=\"202\" height=\"152\"></p>",
    "unique_key": "Q9509446",
    "question_audio": null,
    "question_video": null,
    "map_id": 30236,
    "difficulty_level": "beginner",
    "subjects_id": [
      1
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C. Tay-Sachs disease</strong></span></p><p><span style=\"font-size:12.0pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\"><strong>Option C:</strong></span></p><p><span style=\"font-size:12.0pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\">It is a sphingolipidoses or lipid storage disease, due to deficiency of the enzyme Hexosaminidase A.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">C/F: Mental retardation, Cherry red spot in the macula and progressive deterioration. Death by 3\u20134 years</span></p><p><span style=\"font-size:12.0pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\"><strong><u>Explanation</u></strong>:</span></p><p><span style=\"font-size:12.0pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\"><strong>Option A: Gaucher\u2019s disease type 1</strong>:&nbsp;Due to deficiency of beta-glucocerebrosidase, C/F: Enlarged liver and spleen, erosion of long bones, no mental retardation, no cherry red spot&nbsp;</span></p><p><span style=\"font-size:12.0pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\"><strong>Option B: Niemann Pick disease</strong>:&nbsp;Due to deficiency of Sphingomyelinase. C/F: Mental retardation, blindness, muscular weakness, hepatosplenomegaly with Cherry red spot in macula. Death by 2 years of age.</span></p><p><span style=\"font-size:12.0pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\"><strong>Option D: Sandhoff\u2019s disease</strong>:&nbsp;Due to deficiency of Hexosaminidase A and B, c/f: Neurological deficit and MR with cherry red spot.</span></p><p><span style=\"font-size:12.0pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\"><strong><u>Educational Objective:</u></strong></span></p><p><span style=\"font-size:12.0pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\">Tay-Sachs disease is a genetic disorder characterized by the absence or insufficient activity of an enzyme called Hexosaminidase A, leading to the accumulation of GM2 ganglioside within lysosomes, causing progressive neurological damage.</span></p><p><span style=\"font-size:12.0pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\">Ref: Harper 30/e: p 68,251.</span></p>",
    "correct_choice_id": 35785,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "ImageBased"
    ]
  },
  {
    "id": 8948,
    "choices": [
      {
        "id": 35759,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A and R both are right, but R is not the Correct explanation of A</span></span></span></p>"
      },
      {
        "id": 35760,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A and R both are wrong </span></span></span></p>"
      },
      {
        "id": 35761,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A is wrong but R is a right statement</span></span></span></p>"
      },
      {
        "id": 35762,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A as well as R are right, and R is a correct explanation of A</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Assertion (A)</span></u></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>:</strong> Niemann-Pick disease is a glycogen storage disease characterized by mental retardation, organomegaly, etc.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><br />\r\n<span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong><u>Reasoning (R)</u>: </strong>This is due to deficiency of enzyme hexosaminidase A.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Choose the appropriate response.</span></span></span></p>",
    "unique_key": "Q9129312",
    "question_audio": null,
    "question_video": null,
    "map_id": 30234,
    "difficulty_level": "intermediate",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A and R both are wrong</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Niemann-Pick disease</strong> is a <strong>sphingolipidoses </strong>due to <strong>deficiency</strong> of the enzyme <strong>Sphingomyelinase </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Lipid accumulating</strong> - <strong>Sphingomyelin</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">C/F: <strong>Enlarged liver and spleen, mental retardation</strong> and highly <strong>fatal in early life</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Niemann-Pick disease </strong>is <strong>not </strong>a <strong>glycogen storage disease;</strong> a type of <strong>lysosomal storage disorder</strong> characterized by the <strong>accumulation</strong> of <strong>sphingomyelin</strong> due to the <strong>deficiency of the enzyme sphingomyelinase</strong>. This leads to symptoms such as <strong>mental retardation </strong>and <strong>organomegaly. Hexosaminidase A deficiency, </strong>on the <strong>other hand,</strong> causes <strong>Tay-Sachs disease,</strong> <strong>not</strong> Niemann-Pick disease.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e page 251</span></strong></span></span></p>",
    "correct_choice_id": 35760,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "TreatmentBased"
    ]
  },
  {
    "id": 8952,
    "choices": [
      {
        "id": 35775,
        "text": "<p><span style=\"font-size:12.0pt;\">Tay-Sachs disease</span></p>"
      },
      {
        "id": 35776,
        "text": "<p><span style=\"font-size:12.0pt;\">Niemann-Pick disease</span></p>"
      },
      {
        "id": 35777,
        "text": "<p><span style=\"font-size:12.0pt;\">Gaucher\u2019s disease</span></p>"
      },
      {
        "id": 35778,
        "text": "<p><span style=\"font-size:12.0pt;\">GM 1 gangliosidoses</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt;\">Which of the following diseases is least likely to include neurological symptoms in its classic presentation?</span></p>",
    "unique_key": "Q5942082",
    "question_audio": null,
    "question_video": null,
    "map_id": 30235,
    "difficulty_level": "beginner",
    "subjects_id": [
      1
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C)&nbsp;Gaucher\u2019s disease</strong></span></p><p><span style=\"font-size:12.0pt;\"><strong>&nbsp;</strong></span></p><p><span style=\"font-size:12.0pt;\"><strong>Option C:</strong></span></p><p><span style=\"font-size:12.0pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\">It is a AR disorder.</span></p><p><span style=\"font-size:12.0pt;\">Due to deficiency of beta-glucocerebrosidase&nbsp;</span></p><p><span style=\"font-size:12.0pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\"><strong>C/</strong>F:</span></p><p><span style=\"font-size:12.0pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\">Bony pain, pathological fracture</span></p><p><span style=\"font-size:12.0pt;\">No MR (as beta-glucosylceramide is present in extra neutral tissue)</span></p><p><span style=\"font-size:12.0pt;\">Hepatosplenomegaly present</span></p><p><span style=\"font-size:12.0pt;\">Large amounts of glucosylceramide accumulated in macrophages causing: Eccentric nucleus and Cytoplasm\u2019s Crumpled tissue paper appearance&nbsp;</span></p><p><span style=\"font-size:12.0pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\"><strong><u>Explanation</u></strong>:</span></p><p><span style=\"font-size:12.0pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\"><strong>Option A:&nbsp;Tay-Sachs disease</strong>: C/F: Neurological Symptoms, Mental retardation. Cherry red spot&nbsp;in the macula. Progressive deterioration No Hepatosplenomegaly.</span></p><p><span style=\"font-size:12.0pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\"><strong>Option B:&nbsp;Niemann-Pick disease</strong>: C/F:&nbsp; Severe CNS damage, mental retardation, hepatosplenomegaly, Cherry red spot in macula.&nbsp;</span></p><p><span style=\"font-size:12.0pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\"><strong>Option D:&nbsp;GM1 gangliosidoses</strong>: C/F: Mental retardation, hepatomegaly, skeletal deformities. Angiokeratoma. Cherry red spot in the retina.</span></p><p><span style=\"font-size:12.0pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\"><strong><u>Educational Objective:</u></strong></span></p><p><span style=\"font-size:12.0pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\">Gaucher's disease, particularly type 1, which is the most common form, does not usually present with neurological symptoms. This type is known as non-neuronopathic and primarily affects the spleen, liver, and bones.</span></p><p><span style=\"font-size:12.0pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\">Ref: DM Vasudevan 9/e: p 260, 261.</span></p>",
    "correct_choice_id": 35777,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "TreatmentBased"
    ]
  },
  {
    "id": 8965,
    "choices": [
      {
        "id": 35827,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glucocerebrosidase</span></span></span></p>"
      },
      {
        "id": 35828,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sphingomyelinase</span></span></span></p>"
      },
      {
        "id": 35829,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hexosaminidase A</span></span></span></p>"
      },
      {
        "id": 35830,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Beta-galactosidase</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 6-year-old child is brought to the pediatric clinic by his parents, who report that he has been experiencing unusual fatigue, frequent bruising, and episodes of bone pain over the last few months. The child has also been less active than usual, preferring to sit rather than play with his peers. On examination, the pediatrician notes pallor, and palpation reveals an enlarged liver and spleen. A complete blood count confirms anemia and thrombocytopenia. A bone marrow biopsy is performed, and light microscopy of the sample shows cells with a &quot;crumpled tissue paper&quot; appearance. Given these findings, which enzyme defect is most likely responsible for this child&#39;s condition?</span></span></span></p>",
    "unique_key": "Q6130833",
    "question_audio": null,
    "question_video": null,
    "map_id": 30231,
    "difficulty_level": "beginner",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glucocerebrosidase</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Gaucher&rsquo;s Disease</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Most common <strong>Lysosomal Storage Disorder</strong> due to <strong>Glucocerebrosidase defect</strong> &rarr; accumulation of <strong>glucocerebroside</strong> in <strong>lysosomes. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">C/F: <strong>No cherry red spot in the macula, No mental deterioration (Type I)</strong>, Haematological features: <strong>Pancytopenia,</strong> <strong>bleeding manifestation, Hepatosplenomegaly, Bone Pain and Pathological Fractures of long bones</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">X-ray<strong> Femur Erlenmeyer Flask Deformity</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Bone Marrow Biopsy:&nbsp;</strong> <strong>Gaucher cell with Wrinkled paper appearance</strong>/<strong>crumpled tissue paper </strong>appearance.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Sphingomyelinase</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: <strong>Deficiency of sphingomyelinase </strong>is associated with <strong>Niemann-Pick disease</strong>, which also<strong> presents </strong>with <strong>hepatosplenomegaly</strong> but typically includes <strong>neurological symptoms </strong>due to the <strong>accumulation of sphingomyelin in neurons,</strong> which is <strong>not</strong> indicated in this<strong> scenario.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Hexosaminidase A</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: <strong>Deficiency in Hexosaminidase A enzyme</strong> is related to <strong>Tay-Sachs disease,</strong> which primarily presents with <strong>progressive neurological symptoms </strong>due to the accumulation of<strong> GM2 ganglioside</strong> in the <strong>neuronal cells,</strong> <strong>not</strong> the features described in the<strong> presented case.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: Beta-galactosidase</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: A<strong> deficiency </strong>in this enzyme leads to<strong> GM1 gangliosidosis,</strong> which includes <strong>severe neurological</strong> <strong>impairment and skeletal abnormalities</strong> in its<strong> presentation, distinct from</strong> the scenario described.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>clinical presentation </strong>of <strong>Gaucher&#39;s disease</strong>, a <strong>lysosomal storage disorder</strong> caused by a <strong>deficiency </strong>of the enzyme <strong>glucocerebrosidase</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">: DM Vasudevan 9/e: p 260, 261</span></strong></span></span></p>",
    "correct_choice_id": 35827,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "TreatmentBased"
    ]
  },
  {
    "id": 8944,
    "choices": [
      {
        "id": 35743,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is a basic structure of sphingophospholipids</span></span></span></p>"
      },
      {
        "id": 35744,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sphingosine + fatty acid forms sphingomyelin </span></span></span></p>"
      },
      {
        "id": 35745,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is a basic structure of&nbsp; Glycosphingolipids</span></span></span></p>"
      },
      {
        "id": 35746,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">There are 2 types of glycolipids &ndash; cerebroside &amp; ganglioside</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Based on the picture shown to you, which of the following statements is correct?</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"color:black\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/10/picture1_Zrl1GM1.jpg\" style=\"height:243px; width:300px\" /></span></span></span></span></p>",
    "unique_key": "Q7473015",
    "question_audio": null,
    "question_video": null,
    "map_id": 30233,
    "difficulty_level": "intermediate",
    "subjects_id": [
      1
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is a basic structure of Glycosphingolipids</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Options C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>structure depicted </strong>is a general representation of <strong>glycosphingolipids</strong>, which are composed of <strong>sphingosine, a fatty acid, </strong>and<strong> one</strong> or <strong>more sugar residues.</strong> They play a critical role in<strong> cell-cell communication</strong> and are<strong> found in the myelin sheath of nerve cells</strong>. <strong>Defects</strong> in the metabolism of <strong>glycosphingolipids</strong> can<strong> lead</strong> to various <strong>neurological disorders.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Incorrect </strong>because <strong>sphingophospholipids </strong>have a <strong>phosphate group</strong>, which is<strong> not </strong>shown in the<strong> picture. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><br />\r\n<span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Option B:</strong> <strong>Incorrect </strong>because <strong>sphingomyelin</strong> is a <strong>type of sphingophospholipid</strong> and would include a <strong>phosphocholine</strong> or <strong>phosphoethanolamine </strong>group, <strong>not</strong> shown in the <strong>diagram.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><br />\r\n<span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Option D: Correct</strong> in the <strong>classification of glycolipids</strong> but <strong>not</strong> relevant to the structure<strong> shown in the image.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Glycosphingolipids (Glycolipids)</strong> <strong>do not</strong> contain <strong>phosphoric acid; </strong>instead contain <strong>carbohydrates and Ceramide</strong> (<strong>sphingosine + fatty acid&nbsp;</strong> in <strong>amide linkage</strong>)</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Contains<strong> 2 major subtypes</strong> :<strong> Glucocerebroside &amp; Galactocerebroside </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Sphingomyelins </strong>are the only<strong> sphingolipid</strong> that contain<strong> phosphate</strong> and have<strong> no sugar moiety</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e: p 250, Vasudevan 9/ed: p 108</span></strong></span></span></p>",
    "correct_choice_id": 35745,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "ImageBased",
      "TreatmentBased"
    ]
  },
  {
    "id": 8956,
    "choices": [
      {
        "id": 35791,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Gaucher&rsquo;s disease </span></span></span></p>"
      },
      {
        "id": 35792,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Niemann Pick disease</span></span></span></p>"
      },
      {
        "id": 35793,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tay-Sachs disease</span></span></span></p>"
      },
      {
        "id": 35794,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sandhoffs disease</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A general practitioner examines a 5-year-old boy who has been brought in due to concerns about his slow development and physical health. The child has noticeable abdominal swelling and a history of unsteady gait leading to frequent falls. Recently, he experienced a convulsive episode that prompted this visit. Clinical examination reveals significant hepatosplenomegaly. Laboratory investigations, including a bone marrow biopsy, show lipid-laden foam histiocytes, and an enzyme assay indicates sphingomyelinase deficiency in the child&#39;s white blood cells?</span></span></span></p>",
    "unique_key": "Q8255380",
    "question_audio": null,
    "question_video": null,
    "map_id": 30237,
    "difficulty_level": "beginner",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Niemann Pick disease</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Due to <strong>deficiency of Sphingomyelinase. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">C/F:<strong> Mental retardation, blindness, muscular weakness, hepatosplenomegaly </strong>with <strong>Cherry red spot in macula. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Death</strong> by <strong>2 years of age.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Gaucher&rsquo;s disease type 1:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Due to <strong>deficiency of beta-glucocerebrosidase,</strong> C/F: <strong>Enlarged liver and spleen, erosion of long</strong> <strong>bones, mental retardation</strong> in infants but<strong> </strong><strong>no cherry red spot</strong> </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Tay-Sachs disease:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Due to<strong> deficiency </strong>of enzyme <strong>Hexosaminidase</strong> <strong>Options A.</strong>&nbsp;</span></span></span><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">C/F:<strong> Mental retardation, Cherry red spot</strong> in the<strong> macula and progressive deterioration.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: Sandhoff&rsquo;s disease:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Due to <strong>deficiency of Hexosaminidase Options A</strong> and <strong>Options&nbsp; B</strong>, c/f: <strong>Neurological deficit and MR </strong>with <strong>cherry red spot.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Niemann-Pick disease</strong> is associated with <strong>sphingomyelinase deficiency</strong>, leading to the accumulation of <strong>sphingomyelin in cells</strong> and <strong>tissues</strong>. The child&#39;s symptoms, including <strong>developmental delay, hepatosplenomegaly,</strong> <strong>difficulty walking,</strong> <strong>falls, seizures,</strong> and findings of<strong> lipid-laden foam histiocytes</strong> on <strong>bone marrow</strong> <strong>biopsy,</strong> are characteristic of this disorder.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e: p 68,251.</span></strong></span></span></p>",
    "correct_choice_id": 35792,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 8960,
    "choices": [
      {
        "id": 35807,
        "text": "<p><span style=\"font-size:12.0pt;\">A and R both are right but R is not the Correct explanation of A</span></p>"
      },
      {
        "id": 35808,
        "text": "<p><span style=\"font-size:12.0pt;\">A and R both are wrong</span></p>"
      },
      {
        "id": 35809,
        "text": "<p><span style=\"font-size:12.0pt;\">A is wrong but R is a right statement</span></p>"
      },
      {
        "id": 35810,
        "text": "<p><span style=\"font-size:12.0pt;\">A as well as R are right and R is a correct explanation of A</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt;\">Assertion (A): Metachromatic leukodystrophy is a glycogen storage disease characterized by mental retardation, organomegaly, etc.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Reasoning (R): This is due to deficiency of enzyme hexosaminidase A.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Select the correct option:</span></p>",
    "unique_key": "Q1636907",
    "question_audio": null,
    "question_video": null,
    "map_id": 30228,
    "difficulty_level": "intermediate",
    "subjects_id": [
      1
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B. A and R both are wrong</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Assertion (A) is wrong</strong> because <strong>Metachromatic Leukodystrophy (MLD)</strong> is <strong>not a glycogen storage disease</strong>. It is a <strong>lysosomal storage disorder</strong> that belongs to the group of <strong>sphingolipidoses</strong>, caused by a deficiency in the enzyme <strong>arylsulfatase A</strong>. This leads to the <strong>accumulation of sulfatides</strong>, particularly <strong>sulfogalactocerebroside</strong>, resulting in <strong>demyelination of white matter</strong>, particularly in the central and peripheral nervous systems.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Clinical features of MLD include:</span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">Progressive <strong>neurological deterioration</strong></span></li><li><span style=\"font-size:12.0pt;\"><strong>Behavioral changes</strong>, <strong>motor regression</strong></span></li><li><span style=\"font-size:12.0pt;\"><strong>Demyelination</strong>, often leading to spasticity and paralysis</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Reason (R) is also wrong</strong> because <strong>hexosaminidase A deficiency</strong> is the cause of <strong>Tay-Sachs disease</strong>, not MLD.</span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\"><strong>Tay-Sachs</strong> is another <strong>lysosomal storage disorder</strong>, characterized by <strong>accumulation of GM2 gangliosides</strong> due to hexosaminidase A deficiency.</span></li><li><span style=\"font-size:12.0pt;\">It presents with <strong>progressive neurodegeneration</strong>, <strong>cherry-red spot in macula</strong>, and <strong>no hepatosplenomegaly</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\"><strong>MLD</strong>: Caused by <strong>arylsulfatase A deficiency</strong>, leading to <strong>sulfatide accumulation</strong>, affects myelin, results in <strong>leukodystrophy</strong>.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Tay-Sachs</strong>: Caused by <strong>hexosaminidase A deficiency</strong>, results in <strong>ganglioside accumulation</strong>, primarily a <strong>neurodegenerative condition</strong> without organ enlargement.</span></li></ul>",
    "correct_choice_id": 35808,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 8963,
    "choices": [
      {
        "id": 35819,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Step A</span></span></span></p>"
      },
      {
        "id": 35820,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Step B</span></span></span></p>"
      },
      {
        "id": 35821,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Step C</span></span></span></p>"
      },
      {
        "id": 35822,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Step E</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Niemann-Pick disease involves the accumulation of a specific phospholipid due to an enzyme deficiency. This phospholipid&#39;s accumulation occurs at which step in its metabolic pathway? </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:center\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/29/image-20230529161958-1.png\" style=\"float:left; height:258px; width:400px\" /></p>",
    "unique_key": "Q6978674",
    "question_audio": null,
    "question_video": null,
    "map_id": 30229,
    "difficulty_level": "beginner",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Step C</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Ceramide </strong>is the basic unit composing all <strong>sphingolipids</strong>, which include <strong>sphingomyelin and gangliosides. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sphingomyelin</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">, which usually <strong>contains phosphocholine </strong>as a<strong> polar head group</strong>, is the only phospholipid that<strong> does not</strong> have a <strong>glycerol backbone. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>defect </strong>in <strong>Niemann-Pick disease </strong>is in the <strong>enzyme sphingomyelinase, resulting in accumulation of ceramide-phosphocholine (sphingomyelin).&nbsp;</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>&nbsp;Step A </strong>represents the c<strong>onversion of palmitoyl CoA to sphingosine,</strong> which is <strong>not</strong> the site of accumulation in<strong> Niemann-Pick</strong> <strong>disease. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Step B</strong> is the conversion of <strong>sphingosine into ceramide;</strong> while important in <strong>sphingolipid metabolism,</strong> it is <strong>not</strong> the site of <strong>blockage in Niemann-Pick disease. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>&nbsp;Step E</strong>, which shows the conversion of <strong>ceramide to gangliosides,</strong> is also <strong>not</strong> the site of the<strong> metabolic block in Niemann-Pick disease</strong>. However<strong>, gangliosides</strong> do accumulate in other <strong>lysosomal storage disorders</strong>, such as <strong>GM2 gangliosidoses.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In <strong>Niemann-Pick disease type A and B</strong>, there is an accumulation of <strong>sphingomyelin</strong> due to a <strong>deficiency</strong> in the enzyme <strong>sphingomyelinase. </strong>This<strong> enzyme</strong> is responsible for the <strong>breakdown of sphingomyelin into ceramide.</strong> In the diagram, &quot;<strong>Step C&quot;</strong> represents the <strong>conversion of ceramide into sphingomyelin,</strong> which is the s<strong>tep before the blockage</strong> occurs due to the <strong>enzyme</strong> <strong>deficiency</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">: DM Vasudevan 9/e: p 260, 261</span></strong></span></span></p>",
    "correct_choice_id": 35821,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "ImageBased"
    ]
  },
  {
    "id": 8964,
    "choices": [
      {
        "id": 35823,
        "text": "<p><span style=\"font-size:12.0pt;\">Gaucher\u2019s disease</span></p>"
      },
      {
        "id": 35824,
        "text": "<p><span style=\"font-size:12.0pt;\">Niemann Pick disease</span></p>"
      },
      {
        "id": 35825,
        "text": "<p><span style=\"font-size:12.0pt;\">Tay-Sachs disease</span></p>"
      },
      {
        "id": 35826,
        "text": "<p><span style=\"font-size:12.0pt;\">Sandhoff's disease</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A 20-year-old man presents to the emergency department with an episode of sudden rectal hemorrhage. His medical history is non-specific, but on examination, he is found to have hepatosplenomegaly. A complete blood count reveals thrombocytopenia, and a liver biopsy shows abnormal cells within Glisson's capsule. Given these findings, the medical team suspects a lysosomal storage disorder and further diagnostic tests are conducted. Which of the following metabolic disorders is the patient least likely to have, given the clinical findings?</span></p><p style=\"text-align:justify;\">&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/1230123.jpg\" width=\"528\" height=\"398\"></p>",
    "unique_key": "Q7335887",
    "question_audio": null,
    "question_video": null,
    "map_id": 30230,
    "difficulty_level": "intermediate",
    "subjects_id": [
      1
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C. Tay-Sachs disease</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Tay-Sachs disease</strong> is the <strong>least likely diagnosis</strong> in this clinical scenario. It is a <strong>lysosomal storage disorder</strong>, its classic features include:</span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\"><strong>Neurodegeneration</strong></span></li><li><span style=\"font-size:12.0pt;\"><strong>Cherry-red spot on the macula</strong></span></li><li><span style=\"font-size:12.0pt;\"><strong>Developmental regression</strong></span></li><li><span style=\"font-size:12.0pt;\"><strong>No hepatosplenomegaly</strong></span></li><li><span style=\"font-size:12.0pt;\"><strong>No thrombocytopenia</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In contrast, this patient has <strong>hepatosplenomegaly</strong>, <strong>thrombocytopenia</strong>, and <strong>abnormal liver histology</strong>, which are <strong>not characteristic of Tay-Sachs</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\"><strong>Option A. Gaucher\u2019s disease</strong>:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12.0pt;\"><strong>Consistent</strong> with hepatosplenomegaly and thrombocytopenia</span></li><li><span style=\"font-size:12.0pt;\">Presence of <strong>Gaucher cells</strong> (lipid-laden macrophages) in liver biopsy</span></li><li><span style=\"font-size:12.0pt;\">Neurological symptoms are <strong>absent in Type 1</strong> (non-neuronopathic form), which can occur in adults</span></li></ul></li><li><span style=\"font-size:12.0pt;\"><strong>Option B. Niemann-Pick disease</strong>:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12.0pt;\">Can show <strong>cherry-red spots</strong>, <strong>hepatosplenomegaly</strong>, and <strong>neurologic signs</strong></span></li><li><span style=\"font-size:12.0pt;\">Liver involvement is common</span></li></ul></li><li><span style=\"font-size:12.0pt;\"><strong>Option D. Sandhoff\u2019s disease</strong>:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12.0pt;\">Similar to Tay-Sachs but with <strong>systemic features</strong> including hepatosplenomegaly</span></li><li><span style=\"font-size:12.0pt;\"><strong>Cherry-red spot</strong> may be seen</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Differentiate <strong>lysosomal storage disorders</strong> based on systemic vs. neurological findings:</span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\"><strong>Tay-Sachs</strong>: Purely <strong>neurological</strong>, <strong>no organomegaly</strong>, presents in infancy</span></li><li><span style=\"font-size:12.0pt;\"><strong>Gaucher\u2019s disease</strong>: Can present with <strong>hepatosplenomegaly</strong>, <strong>thrombocytopenia</strong>, and <strong>bone involvement</strong>, especially in <strong>Type 1</strong></span></li></ul><p><span style=\"font-size:12.0pt;\"><strong>Niemann-Pick</strong> and <strong>Sandhoff</strong>: Share <strong>both visceral and neurological</strong> features including <strong>cherry-red spots</strong></span></p>",
    "correct_choice_id": 35825,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ImageBased",
      "TreatmentBased"
    ]
  },
  {
    "id": 8975,
    "choices": [
      {
        "id": 35867,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">GM2 ganglioside</span></span></span></p>"
      },
      {
        "id": 35868,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">GM1 ganglioside</span></span></span></p>"
      },
      {
        "id": 35869,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glucocerebroside</span></span></span></p>"
      },
      {
        "id": 35870,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Galactocerebroside</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following substances accumulates in the neurons of patients with Tay-Sachs disease?</span></span></span></p>",
    "unique_key": "Q8704755",
    "question_audio": null,
    "question_video": null,
    "map_id": 30232,
    "difficulty_level": "intermediate",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">GM2 ganglioside.</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Tay-Sachs disease</strong> is caused by a <strong>deficiency</strong> in the enzyme<strong> Hexosaminidase A,</strong> leading to the accumulation of<strong> GM2 ganglioside </strong>within the<strong> lysosomes of neurons.</strong> This accumulation<strong> disrupts normal cellular function </strong>and results in the<strong> neurodegenerative symptoms</strong> characteristic of <strong>Tay-Sachs disease, </strong>including the<strong> loss of motor skills, increased startle response</strong>, and the <strong>hallmark cherry-red spot</strong> on the<strong> retina.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: GM1 ganglioside</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: <strong>Accumulation</strong> of<strong> GM1 ganglioside </strong>is characteristic of <strong>GM1 gangliosidosis</strong>, <strong>not Tay-Sachs disease</strong>. This is due to a <strong>deficiency </strong>in a different enzyme<strong>, &beta;-galactosidase.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Glucocerebroside</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: <strong>Accumulation </strong>of <strong>glucocerebroside</strong> is seen in<strong> Gaucher&#39;s disease</strong>, which results from a <strong>deficiency</strong> in the enzyme <strong>glucocerebrosidase.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: Galactocerebroside</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: <strong>Accumulation </strong>of<strong> galactocerebroside</strong> is observed in <strong>Krabbe disease </strong>due to a <strong>deficiency</strong> in the enzyme <strong>galactocerebrosidase,</strong> leading to damage in the<strong> myelin sheath of nerve cells.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tay-Sachs disease is due to the<strong> deficiency </strong>of enzyme <strong>Hexosaminidase A</strong> </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>lipid </strong>accumulated is <strong>Ganglioside (GM2)</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;C/F:<strong> Mental retardation, cherry red spot in the macula, progressive deterioration</strong>, and <strong>death by 3&ndash;4 years.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">: DM Vasudevan 9/e: p 260 ,261.</span></strong></span></span></p>",
    "correct_choice_id": 35867,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 9216,
    "choices": [
      {
        "id": 36831,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Cholesterol</span></p>"
      },
      {
        "id": 36832,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Prostaglandins</span></p>"
      },
      {
        "id": 36833,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Glycolipids</span></p>"
      },
      {
        "id": 36834,
        "text": "<p><span style=\"font-size:12pt;\">Phospholipids</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">A teenage boy, self-conscious about his weight, decides to follow a fat-free diet in hopes of improving his physique. After adhering to this dietary regimen for several weeks, he visits a nutritionist for a consultation. Concerned about potential nutritional deficiencies and their impact on lipid metabolism, the nutritionist reviews the boy's diet and decides to assess his body's ability to synthesize various essential lipids that might be affected by his restrictive diet:</span></p>",
    "unique_key": "Q8161227",
    "question_audio": null,
    "question_video": null,
    "map_id": 30284,
    "difficulty_level": "difficult",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ans. B)&nbsp;Prostaglandins</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option B:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Prostaglandins</strong> are <strong>synthesized </strong>from <strong>essential fatty acids, </strong>such as<strong> arachidonic acid, </strong>which are typically obtained from<strong> dietary fats. </strong>A <strong>fat-free diet</strong> could lead to a<strong> deficiency in essential fatty acids</strong>, impacting the body's ability to<strong> synthesize prostaglandins</strong>. <strong>Prostaglandins</strong> play various roles in the<strong> body</strong>, including i<strong>nflammation, pain modulation, and regulation of blood flow.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option A: Cholesterol</strong>: The body can <strong>synthesize cholesterol endogenously</strong>, primarily in the<strong> liver,</strong> and its <strong>synthesis is less</strong> likely to be <strong>directly </strong>affected by a <strong>fat-free diet.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option C: Glycolipids</strong>: <strong>Glycolipids </strong>are composed of a <strong>carbohydrate and a lipid</strong>. While <strong>dietary fats </strong>influence <strong>lipid components,</strong> the body can <strong>also synthesize</strong> these from <strong>other sources.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option D: Phospholipids</strong>: Phospholipids can be <strong>synthesized endogenously</strong> from <strong>glycerol, fatty acids, and phosphate</strong>. The body can <strong>adapt to variations</strong> in dietary <strong>fat intake</strong> to maintain <strong>phospholipid synthesis.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><ul><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Prostaglandins </strong>are <strong>synthesized</strong> from <strong>arachidonic acid.</strong></span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Arachidonic acid </strong>is <strong>synthesized</strong> from<strong> linoleic acid, </strong>which is an <strong>essential fatty acid </strong>supplied from <strong>dietary lipids</strong> in <strong>adequate amounts.</strong></span></p></li></ul><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Ref</u>: Harper 30/e: p 213-215, 238-240.</strong></span></p>",
    "correct_choice_id": 36832,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "TreatmentBased"
    ]
  },
  {
    "id": 9212,
    "choices": [
      {
        "id": 36815,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Thromboxane from arachidonic acid</span></span></span></p>"
      },
      {
        "id": 36816,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Leukotrienes from Arachidonic acid</span></span></span></p>"
      },
      {
        "id": 36817,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Phospholipids from Arachidonic acid</span></span></span></p>"
      },
      {
        "id": 36818,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Arachidonic acid from Linoleic acid</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 40-year-old woman with a family history of ischemic heart disease (IHD) presents to the emergency room with chest pain. After thorough evaluation, including blood tests and ECG, which were found to be normal, she is kept under observation due to her risk factors. Considering her family history and presenting symptoms, the attending physician decides to initiate a preventive treatment regimen. She is prescribed a low dose of Aspirin, a well-known cardio-protective medication, which acts by inhibiting the cyclooxygenase (COX) enzyme. The physician explains the importance of COX in the synthesis of certain molecules from arachidonic acid and how Aspirin&#39;s action helps in her condition:</span></span></span></p>",
    "unique_key": "Q3751082",
    "question_audio": null,
    "question_video": null,
    "map_id": 30294,
    "difficulty_level": "intermediate",
    "subjects_id": [
      1
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Thromboxane from arachidonic acid</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Aspirin irreversibly acetylates cyclo-oxygenase-1 </strong>of platelets and <strong>inhibits </strong>the enzyme &rarr;<strong>Thromboxane (TxA2) </strong>is <strong>not </strong>formed &rarr;<strong>no vasoconstriction </strong>and <strong>no platelet aggregation </strong>&rarr;<strong>Prevent thrombus formation</strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/19/picture1.jpg\" style=\"height:712px; width:600px\" /></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Aspirin </strong>also <strong>inhibits </strong>production of<strong> Prostacyclin (PGI2) </strong>by <strong>endothelial cells</strong> &rarr; <strong>prevents platelet aggregation</strong> &rarr; produces <strong>vasodilatation. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">But unlike <strong>platelets</strong>, the <strong>endothelial cells </strong>regenerate <strong>cyclooxygenase</strong> within a<strong> few hours.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Aspirin is clinically <strong>used for prevention</strong> and <strong>management of Angina, myocardial infarction, stroke, and Transient</strong> <strong>Ischaemic attacks (TIA).&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:16px\"><strong>Other Options:</strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Leukotrienes from Arachidonic acid:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">These are formed from <strong>lipo-oxygenase pathway</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Phospholipids from Arachidonic acid:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>PGs </strong>are <strong>stored </strong>in membranes as <strong>phospholipids </strong>and <strong>arachidonic acid </strong>is released by the action of <strong>phospholipase A2 </strong>on <strong>phospholipids</strong>. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: Arachidonic acid from Linoleic acid:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Linoleic acid </strong>can be converted to <strong>arachidonic acid </strong>by <strong>elongation and desaturation </strong>(with the help of<strong> desaturase and elongase</strong>) and if the<strong> dietary</strong> supply of <strong>linoleic acid is sufficient.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Aspirin&rsquo;s cardio-protective</strong> effect is attributed to<strong> its ability</strong> to<strong> inhibit the COX enzyme</strong>, thereby <strong>decreasing</strong> the production of <strong>thromboxane A2 </strong>from <strong>arachidonic acid.</strong> This action <strong>reduces platelet aggregation</strong> and <strong>vasoconstriction,</strong> <strong>lowering</strong> the <strong>risk </strong>of <strong>thrombotic events</strong> in patients with a<strong> high risk of ischemic heart disease.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e:&nbsp; p 239-240, 720.</span></strong></span></span></p>",
    "correct_choice_id": 36815,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 8961,
    "choices": [
      {
        "id": 35811,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Linoleic acid&mdash;plants </span></span></span></p>"
      },
      {
        "id": 35812,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Oleic acid&mdash;animals </span></span></span></p>"
      },
      {
        "id": 35813,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Palmitoleic acid&mdash;animals </span></span></span></p>"
      },
      {
        "id": 35814,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Linolenic acid&mdash;animals</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A premature infant is prone to have fatty acid deficiencies. So, the Infant&rsquo;s parents were advised to feed the baby on formula feeds supplemented with these deficient compounds. Which among the following is a nutritionally EFA with its usual dietary source? </span></span></span></p>",
    "unique_key": "Q7568415",
    "question_audio": null,
    "question_video": null,
    "map_id": 30285,
    "difficulty_level": "intermediate",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Linoleic acid&mdash;plants</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Linoleic acid</strong> is an essential <strong>polyunsaturated fatty acid (PUFA) </strong>found in <strong>plant oils</strong> (e.g., <strong>corn oil, soybean oil, and sunflower oil</strong>). It is a<strong> nutritionally essential fatty acid</strong> because the <strong>human body cannot synthesize </strong>it, making it necessary to obtain it through the diet.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>&nbsp;Oleic acid</strong> is a<strong> monounsaturated fatty acid</strong> predominantly found in <strong>animal fats and oils, olive oil, and other plant oils.</strong> It is <strong>not </strong>classified as<strong> essential </strong>because the <strong>human body can synthesize it</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Palmitoleic acid</strong> is a<strong> monounsaturated fatty acid</strong> found in <strong>animal fats and some plant oils</strong>. Like <strong>oleic acid, </strong>it is <strong>not</strong> an <strong>essential fatty acid</strong> because the<strong> body can produce it.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Linolenic acid</strong>, particularly<strong> alpha-linolenic acid (ALA</strong>), is an <strong>essential fatty acid found in plants,</strong> <strong>not animals</strong>. Sources include <strong>flaxseeds, chia seeds, and walnuts. </strong>This option is<strong> incorrect </strong>because it <strong>wrongly associates linolenic acid with animal sources</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Linoleic and &alpha;-linolenic acid&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">are nutritionally <strong>essential fatty acids</strong>, <strong>cannot</strong> be synthesized by the <strong>body</strong> and have to be <strong>supplied in the diet.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">They are<strong> polyunsaturated fatty acids</strong> which <strong>cannot</strong> be made by most <strong>animals </strong>but only by<strong> plants</strong><strong> </strong>and<strong> </strong>are <strong>present in good</strong> <strong>quantities</strong> in<strong> vegetable oils e.g. sunflower oil </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Oleic acid&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(C18, 1 double bond) and <strong>palmitoleic acid</strong> (C16, 1 double bond)<strong> </strong>can be produced by introduction of a <strong>double</strong> <strong>bond </strong>at the <strong>&Delta;9 position of a saturated fatty acid </strong>and are<strong> present in human body fat,</strong> as well as many <strong>vegetable oils.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">These<strong> essential unsaturated fatty acids</strong> are required for <strong>synthesis of prostaglandin, thromboxane, leukotriene,</strong> and <strong>lipoxin.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Vasudevan 9/e p: 254, Murray p: 223-228.</span></strong></span></span></p>",
    "correct_choice_id": 35811,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "TreatmentBased"
    ]
  },
  {
    "id": 8970,
    "choices": [
      {
        "id": 35847,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Arachidonic acid</span></span></span></p>"
      },
      {
        "id": 35848,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Gamma-linolenic acid</span></span></span></p>"
      },
      {
        "id": 35849,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Alpha-linolenic acid</span></span></span></p>"
      },
      {
        "id": 35850,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Linoleic acid</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Omega fatty acids play crucial roles in our health and are categorized based on their chemical structure. Among the following options, which fatty acid does not belong to the &omega;6 (omega-6) series? </span></span></span></p>",
    "unique_key": "Q1856381",
    "question_audio": null,
    "question_video": null,
    "map_id": 30287,
    "difficulty_level": "intermediate",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Alpha linolenic acid</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Options C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Alpha-linolenic acid </strong>does <strong>not</strong> belong to the <strong>&omega;6 series;</strong> it is an<strong> &omega;3 (omega-3) fatty acid. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Omega-3 and omega-6 fatty acids</strong> are <strong>both</strong> <strong>essential polyunsaturated fats, </strong>which means they <strong>cannot</strong> be <strong>synthesized </strong>by the <strong>human</strong> <strong>body</strong> and must be obtained from the <strong>diet. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The key difference between them is the position of the <strong>first double bond from the methyl end of the fatty acid chain</strong>. In <strong>omega-6</strong> <strong>fatty acids</strong>, the<strong> first double bond</strong> is at the<strong> sixth carbon atom,</strong> whereas in <strong>omega-3 fatty acids</strong>, it is at the <strong>third carbon atom. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Alpha-linolenic acid </strong>is a precursor to other<strong> omega-3 fatty acids</strong>, such as <strong>eicosapentaenoic acid (EPA) </strong>and <strong>docosahexaenoic acid</strong> (<strong>DHA)</strong>, which are critical for<strong> cardiovascular health, anti-inflammatory processes, and brain function.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Arachidonic acid</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Belongs to the <strong>&omega;6 series </strong>and is a <strong>precursor </strong>for various <strong>eicosanoids,</strong> which are important <strong>signaling</strong> <strong>molecules</strong> involved in <strong>inflammation and immunity.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Gamma-linolenic acid</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Also part of the <strong>&omega;6 series, gamma-linolenic acid </strong>is found in certain<strong> plant-based oils</strong> and is used by the <strong>body to produce substances</strong> that <strong>reduce inflammation and cell growth.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: Linoleic acid</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This is an <strong>essential fatty acid </strong>in the <strong>&omega;6 series</strong>, serving as a<strong> precursor for arachidonic acid </strong>and playing a vital role in<strong> cell membrane structure and function.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/18/screenshot-2024-04-18-170806.png\" style=\"height:301px; width:1000px\" /></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e p214</span></strong></span></span></p>",
    "correct_choice_id": 35849,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "TreatmentBased"
    ]
  },
  {
    "id": 8972,
    "choices": [
      {
        "id": 35855,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Palmitic acid</span></span></span></p>"
      },
      {
        "id": 35856,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Linoleic acid</span></span></span></p>"
      },
      {
        "id": 35857,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Oleic acid</span></span></span></p>"
      },
      {
        "id": 35858,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Isovaleric acid</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Considering the role of essential fatty acids in numerous physiological processes, including the formation of cell membranes, production of signaling molecules, and involvement in inflammatory responses, which of the following fatty acids is considered essential for humans? </span></span></span></p>",
    "unique_key": "Q2609389",
    "question_audio": null,
    "question_video": null,
    "map_id": 30289,
    "difficulty_level": "beginner",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Linoleic acid</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Linoleic acid </strong>is an <strong>essential fatty acid</strong> for<strong> humans, </strong>classified as an <strong>omega-6 fatty acid.</strong> It is termed &quot;<strong>essential</strong>&quot; because the <strong>human</strong> body<strong> cannot</strong> <strong>synthesize it</strong>; it must be <strong>obtained</strong> through the <strong>diet</strong>. <strong>Linoleic acid </strong>is a <strong>precursor to other omega-6 fatty acids, </strong>including <strong>arachidonic acid</strong>, which is involved in <strong>inflammatory and immune responses</strong>, as well as in the maintenance of the <strong>skin barrier, cellular</strong> <strong>structure,</strong> and the<strong> production of signaling molecules.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Palmitic acid</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This is a<strong> saturated fatty acid</strong>, the<strong> most </strong>common in <strong>animals and plants. </strong>The <strong>body can synthesize palmitic</strong> acid, so it is <strong>not</strong> considered <strong>essential.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Oleic acid</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: <strong>Oleic acid </strong>is a <strong>monounsaturated omega-9 fatty acid</strong>. Although<strong> beneficial for health, </strong>especially in replacing <strong>saturated fats in the diet</strong>, it is <strong>not</strong> classified as <strong>essential</strong> because the<strong> human body can synthesize it.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: Isovaleric acid</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This is a <strong>branched short-chain saturated fatty acid</strong>, <strong>not </strong>typically classified within the context of <strong>dietary</strong> <strong>essential fatty acids</strong>. It is <strong>more </strong>commonly <strong>known</strong> for its occurrence in certain <strong>types of food fermentation</strong> and <strong>does not</strong> have a role similar to that of<strong> essential unsaturated fatty acids</strong> like <strong>linoleic acid.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Essential fatty acids</strong> are<strong> not synthesized</strong> in the<strong> body</strong> and <strong>need</strong> to be <strong>supplied</strong> in the<strong> diet. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is <strong>because </strong>humans <strong>lack the enzymes </strong>that can introduce <strong>double bond beyond 9<sup>th</sup> Carbon.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">They are <strong>polyunsaturated fatty acid</strong> such as <strong>Linoleic Acid and Linolenic Acid</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Arachidonic Acid</strong> is called as <strong>Semi essential fatty Acid</strong> as it is <strong>synthesized from Linoleic Acid.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">They<strong> lower the risk of Cardiovascular Diseases.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">: DM Vasudevan 9/e: p 253, 254.</span></strong></span></span></p>",
    "correct_choice_id": 35856,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "TreatmentBased"
    ]
  },
  {
    "id": 8984,
    "choices": [
      {
        "id": 35903,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fried rice has high content of TFA</span></span></span></p>"
      },
      {
        "id": 35904,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Partial Hydrogenation increases TFA</span></span></span></p>"
      },
      {
        "id": 35905,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Decreases shelf-life</span></span></span></p>"
      },
      {
        "id": 35906,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&uarr; LDL</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Trans fatty acids (TFAs) have been the subject of much health-related research and public health policy due to their adverse effects on cardiovascular health. Considering the various aspects of TFAs, which of the following statements is FALSE? </span></span></span></p>",
    "unique_key": "Q1951966",
    "question_audio": null,
    "question_video": null,
    "map_id": 30293,
    "difficulty_level": "intermediate",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Decreases shelf-life</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The<strong> false</strong> statement about <strong>trans fatty acids (TFAs)</strong> is that they <strong>decrease the shelf-life</strong> of food products. In reality, one of the reasons <strong>TFAs</strong> became <strong>prevalent</strong> in <strong>processed foods</strong> is because they help to<strong> increase the shelf-life of these products</strong>. <strong>TFAs </strong>are<strong> more resistant</strong> to <strong>oxidation </strong>than their <strong>unsaturated counterparts</strong>, which means they are<strong> less likely</strong> to become<strong> rancid and spoil,</strong> thereby <strong>extending</strong> the<strong> shelf-life of food products.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Fried rice has a high content of TFA</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This can be <strong>true</strong>, especially if the<strong> frying oil </strong>has been<strong> hydrogenated or reused multiple</strong> <strong>times</strong>, which can<strong> lead</strong> to the formation of <strong>TFAs.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Partial Hydrogenation increases TFA</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: <strong>True</strong>. The<strong> partial hydrogenation of vegetable oils</strong> is a major industrial source of <strong>TFAs.</strong> This process converts some <strong>unsaturated bonds to saturated and trans configurations.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: &uarr; LDL</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: <strong>True</strong>.<strong> TFAs</strong> are known to<strong> increase levels of low-density lipoprotein (LDL) cholesterol,</strong> which is often referred to as <strong>&quot;bad&quot; cholesterol</strong> due to its association with an<strong> increased risk of cardiovascular disease.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Trans fatty acids:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is present in<strong> dairy products</strong> and <strong>partially hydrogenated edible oils</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Used </strong>in food industry to <strong>improve the shelf-life</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Present in <strong>high amounts</strong> in processed <strong>foods</strong>, <strong>fast foods,</strong> and <strong>bakery items</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Consumption of <strong>TFA </strong>for <strong>longer duration </strong>might<strong> increase</strong> the <strong>risk</strong> of <strong>atherosclerosis, CAD&nbsp;</strong></span></span></span><strong><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">and Diabetes mellitus</span></span></span></strong></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Exacerbate<strong> essential fatty acid deficiency</strong> by <strong>competing with them.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e p241</span></strong></span></span></p>",
    "correct_choice_id": 35905,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "TreatmentBased"
    ]
  },
  {
    "id": 9074,
    "choices": [
      {
        "id": 36263,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Palmitoleic acid</span></span></span></p>"
      },
      {
        "id": 36264,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Linoleic acid</span></span></span></p>"
      },
      {
        "id": 36265,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Oleic acid</span></span></span></p>"
      },
      {
        "id": 36266,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Stearic acid</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which fatty acid listed below is not synthesized in humans and is considered essential?</span></span></span></p>",
    "unique_key": "Q1761247",
    "question_audio": null,
    "question_video": null,
    "map_id": 30290,
    "difficulty_level": "beginner",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Linoleic acid</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Monounsaturated fatty acids </strong>can be <strong>synthesized </strong>from <strong>saturated fatty acids</strong> by a<strong> &Delta;9 desaturase enzyme system. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is <strong>present</strong> in the <strong>endoplasmic reticulum</strong>. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The reaction requires<strong> NADH and molecular O2 and cytochrome b5</strong>. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Thus, <strong>stearic acid</strong> is<strong> desaturated</strong> to form<strong> oleic acid.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>PUFA </strong>can only be formed <strong>from MUFA</strong> by introduction of <strong>double bonds </strong>only between an <strong>existing double bond</strong> and <strong>carboxyl end of the fatty acid.</strong> But Humans <strong>do not</strong> have enzymes to create <strong>double bond beyond &Delta;9 position.</strong> So, <strong>linoleic</strong> acid <strong>cannot</strong> be <strong>synthesized</strong> from<strong> oleic acid.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">So, <strong>fatty acids </strong>containing <strong>double bonds </strong>beyond <strong>&Delta;9 positions (PUFAs) </strong>need to be obtained in <strong>diet as essential fatty acids</strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Calibri, sans-serif\"><span style=\"font-size:16px\"><strong>Other Options:</strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Palmitoleic acid</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This is a <strong>monounsaturated fatty acid </strong>that humans can <strong>synthesize </strong>via the <strong>desaturation </strong>of <strong>palmitic acid</strong>. Therefore, it is<strong> not </strong>considered <strong>essential</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Oleic acid</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Oleic acid is another <strong>monounsaturated fatty acid </strong>that the human body can <strong>synthesize </strong>through the <strong>desaturation </strong>of <strong>stearic acid</strong>, and it is <strong>not </strong>classified as <strong>essential</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: Stearic acid</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Stearic acid is a <strong>saturated fatty acid </strong>that can be <strong>synthesized de novo </strong>by the <strong>human body</strong>, so it is<strong> not </strong>considered <strong>essential.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Linoleic acid </strong>is an <strong>essential fatty acid </strong>because humans <strong>lack </strong>the <strong>enzymes </strong>necessary to <strong>insert </strong>a <strong>double bond </strong>at the <strong>omega-6 position </strong>of fatty acid chains. As a result, <strong>linoleic acid</strong>, an <strong>omega-6 fatty acid</strong>, must be <strong>obtained </strong>from the <strong>diet</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">: DM Vasudevan 9/e: p187.</span></strong></span></span></p>",
    "correct_choice_id": 36264,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 9205,
    "choices": [
      {
        "id": 36787,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Inhibit the activity of the cystic fibrosis transmembrane conductance regulator protein, resulting in thickened secretions that block airways</span></span></span></p>"
      },
      {
        "id": 36788,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Activate the cyclooxygenase activity of PGH synthase, resulting in increased synthesis of prostaglandins that promote vasodilation</span></span></span></p>"
      },
      {
        "id": 36789,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Inhibits cyclooxygenase but not lipoxygenase, resulting in the flow of arachidonic acid to leukotriene synthesis</span></span></span></p>"
      },
      {
        "id": 36790,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Activate phospholipases, resulting in decreased amounts of dipalmitoyl phosphatidyl choline and alveolar collapse (atelectasis)</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 65-year-old male developed breathing difficulty after intake of aspirin. Aspirin-induced asthma (AIA) is a severe reaction to NSAIDs, results in bronchoconstriction which lasts from 30 minutes to a few hours after ingestion of the medication. Which could be the correct statement that explains about the same:</span></span></span></p>",
    "unique_key": "Q8375410",
    "question_audio": null,
    "question_video": null,
    "map_id": 30291,
    "difficulty_level": "intermediate",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C)</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;Inhibits cyclooxygenase but not lipoxygenase, resulting in the flow of arachidonic acid to leukotriene synthesis</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>NSAIDs </strong>inhibit <strong>cyclooxygenase </strong>but <strong>not </strong>the <strong>lipoxygenase pathway </strong>&rarr; formation of <strong>leukotrienes </strong>&rarr;&nbsp;<strong> bronchoconstriction</strong>. </span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:16px\"><strong>Other Options:</strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>NSAIDs </strong>have <strong>no effect </strong>on the <strong>cystic fibrosis transmembrane </strong>conductance <strong>regulator protein</strong>, which is <strong>defective </strong>in case of <strong>cystic fibrosis</strong>. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Cyclooxygenase </strong>is <strong>inhibited </strong>by <strong>NSAIDs </strong>and is <strong>not activated. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>NSAIDs </strong>have <strong>no </strong>effect on <strong>phospholipases </strong>but <strong>Steroids inhibit phospholipase A2</strong>. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Aspirin </strong>can <strong>block </strong>a pathway in the <strong>body </strong>that usually helps keep <strong>airways open</strong>. When this <strong>pathway is blocked</strong>, <strong>another pathway </strong>that can make the<strong> airways tighten</strong> up becomes <strong>more active</strong>. This can lead to <strong>breathing difficulties</strong> in some people.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e:&nbsp; p 240, 720-721.</span></strong></span></span></p>",
    "correct_choice_id": 36789,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 9237,
    "choices": [
      {
        "id": 36915,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">PUFA</span></span></span></p>"
      },
      {
        "id": 36916,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">MUFA</span></span></span></p>"
      },
      {
        "id": 36917,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">TFA</span></span></span></p>"
      },
      {
        "id": 36918,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">All the above</span></span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Prostaglandins are derived from which type of fatty acids?</span></span></span></p>",
    "unique_key": "Q1971342",
    "question_audio": null,
    "question_video": null,
    "map_id": 30292,
    "difficulty_level": "intermediate",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">PUFA</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Prostaglandins</strong> are derived from <strong>polyunsaturated fatty acids (PUFAs),</strong> specifically <strong>arachidonic acid</strong>, which is a <strong>20-carbon fatty acid</strong> with <strong>four cis double bonds. Arachidonic acid </strong>is released from the <strong>cell membrane phospholipids</strong> by <strong>phospholipase A2</strong> and is then converted into <strong>prostaglandins</strong> and other<strong> eicosanoids</strong> (like<strong> thromboxanes and leukotrienes</strong>) through the<strong> action of cyclooxygenase</strong> <strong>(COX) </strong>enzymes. These molecules play various roles in <strong>inflammation, pain, fever regulation, and blood clotting</strong>, among other <strong>physiological and pathological processes.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Monounsaturated fatty acids (MUFA)</strong> and <strong>c) Trans fatty acids (TFA) </strong>are <strong>not </strong>direct precursors for <strong>prostaglandin synthesis.</strong> While <strong>MUFAs and TFAs </strong>are important<strong> dietary fats</strong>, they <strong>do not </strong>serve as <strong>substrates</strong> for the <strong>cyclooxygenase pathway</strong> that produces <strong>prostaglandins. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The statement that all the above <strong>fatty acids </strong>can serve as <strong>precursors for prostaglandins</strong> is<strong> incorrect,</strong> as <strong>prostaglandins</strong> are specifically <strong>derived</strong> from<strong> polyunsaturated fatty acids</strong> like <strong>arachidonic acid.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Prostaglandins </strong>are <strong>derived</strong> from the<strong> PUFA</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It has <strong>three series </strong>that are<strong> derived</strong> from the following<strong> fatty acids.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>1 series</strong> (1 double bond)&mdash;from <strong>Linoleic acid</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>2 series</strong> (2 double bonds)&mdash;from <strong>Arachidonic acid</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>3 series </strong>(3 double bonds)&mdash;<strong>Eicosapentaenoic</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">All naturally occurring <strong>PGs </strong>belong to the<strong> 2 series.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">: DM Vasudevan 9/e: p 254</span></strong></span></span></p>",
    "correct_choice_id": 36915,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "TreatmentBased"
    ]
  },
  {
    "id": 9227,
    "choices": [
      {
        "id": 36875,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Methylation occurs to produce S-adenosylmethionine</span></span></span></p>"
      },
      {
        "id": 36876,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">GTP hydrolysis accomplishes oxidation of LDL proteins</span></span></span></p>"
      },
      {
        "id": 36877,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Arginine is converted to a neurotransmitter that activates guanyl cyclase</span></span></span></p>"
      },
      {
        "id": 36878,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acetyl-CoA and choline are condensed to form a neurotransmitter</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 65-year-old male with a history of hypertension and hyperlipidemia presents to the emergency department with severe chest pain that started 2 hours ago. The pain is described as pressure-like, located in the center of the chest, and radiates to the left arm. An EKG reveals ST-segment elevations in the anterior leads. The patient is diagnosed with an anterior wall myocardial infarction and is treated with nitroglycerin among other medications. Which of the following best describes the mechanism of action of nitroglycerin in this scenario?</span></span></span></p>",
    "unique_key": "Q9876388",
    "question_audio": null,
    "question_video": null,
    "map_id": 30288,
    "difficulty_level": "beginner",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Arginine is converted to a neurotransmitter that activates guanyl cyclase.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Nitroglycerin </strong>causes release of <strong>nitric oxide (NO)</strong>, which <strong>activates guanyl cyclase</strong> &rarr;produces <strong>cyclic GMP</strong> &rarr;<strong>vasodilation. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>NO</strong> is formed from <strong>one</strong> of the <strong>guanidino nitrogen&rsquo;</strong>s of the <strong>arginine</strong> side chain by the enzyme <strong>nitric oxide synthase. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>NO</strong> has a <strong>short half-life</strong>, reacting with<strong> oxygen</strong> to<strong> form nitrite </strong>and <strong>then nitrates</strong> that are <strong>excreted in urine.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:16px\"><strong>Other Options:</strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><br />\r\n<span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Option A:</strong> <strong>Methylation</strong> to produce<strong> S-adenosylmethionine</strong> is a general <strong>cellular process</strong> involved in various<strong> biochemical reactions</strong>, including <strong>epigenetic regulation</strong> and <strong>polyamine synthesis</strong>, but it is <strong>not </strong>related to the <strong>action of nitroglycerin. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong> GTP hydrolysis </strong>related to the<strong> oxidation of LDL</strong> <strong>proteins</strong> is <strong>not</strong> a mechanism associated with <strong>nitroglycerin.</strong> <strong>LDL oxidation </strong>is <strong>more </strong>related to <strong>atherogenesis. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> The <strong>condensation of Acetyl-CoA</strong> and<strong> choline</strong> to form a <strong>neurotransmitter </strong>refers to the <strong>synthesis of acetylcholine</strong>, which is <strong>not </strong>related to the <strong>mechanism </strong>of <strong>action of nitroglycerin.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Nitroglycerin</strong> works primarily by<strong> releasing nitric oxide (NO)</strong> in the smooth muscle cells of <strong>blood vessels,</strong> which then <strong>activates</strong> <strong>guanylyl cyclase</strong>. This enzyme <strong>increases </strong>the synthesis of <strong>cyclic guanosine monophosphate (cGMP), </strong>leading to <strong>smooth muscle relaxation </strong>and <strong>vasodilation</strong>, particularly in the <strong>venous system </strong>but also in the <strong>coronary arteries</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">: DM Vasudevan 9/e: p 227,655</span></strong></span></span></p>",
    "correct_choice_id": 36877,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "CriteriaBased"
    ]
  },
  {
    "id": 9092,
    "choices": [
      {
        "id": 36335,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Carbon 9</span></span></span></p>"
      },
      {
        "id": 36336,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Carbon 6</span></span></span></p>"
      },
      {
        "id": 36337,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Carbon 5</span></span></span></p>"
      },
      {
        "id": 36338,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Carbon 3</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">What is the furthest point, in terms of carbon atoms from the methyl end, at which human desaturase enzymes are unable to introduce a double bond in a fatty acid?</span></span></span></p>",
    "unique_key": "Q9916331",
    "question_audio": null,
    "question_video": null,
    "map_id": 30286,
    "difficulty_level": "intermediate",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Carbon 9</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Human desaturase enzymes</strong> can introduce <strong>double bonds in fatty acids </strong>up to the <strong>9th carbon </strong>from the<strong> methyl end</strong>. This means humans <strong>cannot synthesize</strong> certain <strong>polyunsaturated fatty acids (PUFAs) </strong>that have <strong>double bonds</strong> beyond the <strong>9th carbon,</strong> such as <strong>omega-3 (&alpha;-linolenic acid) and omega-6 (linoleic acid) fatty acids, </strong>making them <strong>essential nutrients </strong>that must be <strong>obtained</strong> through the <strong>diet.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Carbon 6</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: <strong>Human desaturase </strong>enzymes are capable of introducing <strong>double bonds at carbon atoms closer</strong> to the <strong>methyl end</strong> than <strong>carbon 6</strong>. The <strong>limitation</strong> arises <strong>beyond carbon 9,</strong> making this option<strong> incorrect</strong>. <strong>Essential fatty acids</strong> with <strong>double bonds</strong> past <strong>carbon 9</strong>, like those in <strong>omega-3 and omega-6 families, cannot </strong>be <strong>synthesized </strong>and must be obtained <strong>from the diet.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Carbon 5</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Similar to<strong> carbon 6,</strong> <strong>human desaturase enzymes</strong> can introduce <strong>double bonds</strong> at <strong>positions closer</strong> to the <strong>methyl</strong> <strong>end </strong>than carbon 5. The<strong> restriction </strong>in humans is <strong>beyond carbon 9,</strong> so this option is also<strong> incorrect.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: Carbon 3</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: The human body is capable of introducing<strong> double bonds </strong>at positions nearer to the<strong> methyl end </strong>than<strong> carbon 3.</strong> The critical limitation for <strong>human desaturase enzymes</strong> is beyond <strong>carbon 9</strong>, which necessitates the <strong>dietary </strong>intake of<strong> certain essential</strong> <strong>fatty acids.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Humans </strong>can introduce<strong> double bonds</strong> up to the <strong>9th carbon</strong> from the<strong> methyl end</strong>, but <strong>cannot</strong> synthesize <strong>fatty acids</strong> with <strong>double bonds</strong> beyond this point, such as certain <strong>essential omega-3 and omega-6 fatty acids, </strong>which must be <strong>obtained</strong> through the<strong> diet.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: DM Vasudevan 9/e: p187</span></strong></span></span></p>",
    "correct_choice_id": 36335,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "TreatmentBased"
    ]
  },
  {
    "id": 9052,
    "choices": [
      {
        "id": 36175,
        "text": "<p><span style=\"font-size:12.0pt;\">Familial Chylomicronemia</span></p>"
      },
      {
        "id": 36176,
        "text": "<p><span style=\"font-size:12.0pt;\">Type III Hyperlipoproteinemia</span></p>"
      },
      {
        "id": 36177,
        "text": "<p><span style=\"font-size:12.0pt;\">Abetalipoproteinemia</span></p>"
      },
      {
        "id": 36178,
        "text": "<p><span style=\"font-size:12.0pt;\">Type IIa Hyperlipoproteinemia</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A 25-year-old student has been experiencing yellowish discoloration of the palms for the past seven months, with no changes in sclera or mucous membranes and no history of chemical exposure. His lipid profile shows the below results: Laboratory investigations:&nbsp;</span></p><p style=\"text-align:justify;\">&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/10/8_IvdwEdI.jpg\" alt=\"\" width=\"398\" height=\"134\"></span></p><p style=\"text-align:justify;\">&nbsp;</p><p><span style=\"font-size:12.0pt;\">Total cholesterol: 240 mg/dl (N = &lt; 200 mg/dl)&nbsp;</span></p><p><span style=\"font-size:12.0pt;\">LDL cholesterol: 145 mg/dl&nbsp;(N = &lt; 100 mg/dl)&nbsp;</span></p><p><span style=\"font-size:12.0pt;\">TG: 250 mg/dl&nbsp;(N = 60-150 mg/dl)&nbsp;</span></p><p><span style=\"font-size:12.0pt;\">HDL cholesterol: 45 mg/dl &nbsp;(N = 40-75 mg/dl)&nbsp;</span></p><p><span style=\"font-size:12.0pt;\">Lipoprotein electrophoresis shows a broad beta band.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Given these findings, what is the most likely diagnosis?</span></p>",
    "unique_key": "Q1291107",
    "question_audio": null,
    "question_video": null,
    "map_id": 30308,
    "difficulty_level": "intermediate",
    "subjects_id": [
      1
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B. Type III Hyperlipoproteinemia</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span><br><br>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Type III Hyperlipoproteinemia</strong>, also known as <strong>dysbetalipoproteinemia</strong> or <strong>broad beta disease</strong>, is caused by a defect in <strong>apolipoprotein E (apoE)</strong>, which impairs the clearance of <strong>chylomicron remnants and IDL</strong> from the plasma.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Key features include:</strong></span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\"><strong>Elevated total cholesterol and triglycerides</strong> (typically both increased)</span></li><li><span style=\"font-size:12.0pt;\"><strong>Broad beta band on electrophoresis</strong>, due to accumulation of remnant lipoproteins</span></li><li><span style=\"font-size:12.0pt;\"><strong>Palmar xanthomas</strong> \u2014 yellowish discoloration or deposits in the creases of the palms</span></li><li><span style=\"font-size:12.0pt;\"><strong>Increased risk of premature atherosclerosis</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">This patient\u2019s <strong>lipid pattern</strong>, <strong>broad beta band</strong>, and <strong>palmar discoloration</strong> (xanthomas) are classic for <strong>Type III Hyperlipoproteinemia</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\"><strong>Option A. Familial Chylomicronemia (Type I)</strong> \u2013 Presents with <strong>very high triglycerides</strong>, <strong>creamy plasma</strong>, and <strong>eruptive xanthomas</strong>, usually without a broad beta band.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Option C. Abetalipoproteinemia</strong> \u2013 Features <strong>very low or absent apoB-containing lipoproteins</strong>, leading to <strong>low cholesterol and triglycerides</strong>, <strong>fat malabsorption</strong>, and <strong>acanthocytosis</strong>. Not seen here.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Option D. Type IIa Hyperlipoproteinemia (Familial Hypercholesterolemia)</strong> \u2013 Characterized by <strong>isolated elevated LDL</strong>, <strong>normal triglycerides</strong>, and <strong>tendon xanthomas</strong>. Not compatible with this lipid profile.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span><br><br>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Recognize <strong>Type III Hyperlipoproteinemia</strong> by its unique clinical features:</span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">Combined elevation of cholesterol and triglycerides</span></li><li><span style=\"font-size:12.0pt;\"><strong>Broad beta band</strong> on electrophoresis</span></li><li><span style=\"font-size:12.0pt;\"><strong>Palmar xanthomas</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref</strong>: Vasudevan 9 /ed: p245, 246.</span></p>",
    "correct_choice_id": 36176,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "ImageBased",
      "TreatmentBased"
    ]
  },
  {
    "id": 9063,
    "choices": [
      {
        "id": 36219,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chylomicrons</span></span></span></p>"
      },
      {
        "id": 36220,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">VLDL</span></span></span></p>"
      },
      {
        "id": 36221,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">LDL</span></span></span></p>"
      },
      {
        "id": 36222,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">HDL</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A physician is consulting a patient about his elevated triglyceride levels. The patient is non-diabetic and has no history of alcohol overuse, factors known to influence triglyceride levels. The physician explains that a certain lipoprotein is primarily responsible for transporting triglycerides synthesized by the liver. Which lipoprotein does the liver use to transport these endogenous triglycerides?</span></span></span></p>",
    "unique_key": "Q9333320",
    "question_audio": null,
    "question_video": null,
    "map_id": 30316,
    "difficulty_level": "beginner",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) VLDL</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Very Low-Density Lipoproteins (VLDL) </strong>are produced by the <strong>liver </strong>and are responsible for <strong>transporting endogenous triacylglycerols,</strong> which are synthesized by the liver, <strong>to adipose tissue and muscle</strong>. <strong>VLDL</strong> serves as the <strong>body&#39;s internal transport </strong>mechanism for lipids it has<strong> produced or extracted from the diet and processed.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Chylomicrons</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: These <strong>transport dietary, or exogenous, lipids </strong>from the <strong>intestines to other tissues </strong>in the body after a<strong> meal.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: LDL</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Primarily carries<strong> cholesterol to the body&#39;s cells</strong> rather than triacylglycerol.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: HDL</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Involved in<strong> reverse cholesterol transport,</strong> carrying <strong>cholesterol from the tissues back to the liver</strong>, and is <strong>not </strong>a primary carrier of <strong>triacylglycerol.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/19/screenshot-2024-04-19-110237.png\" style=\"height:490px; width:1000px\" /></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Vasudevan 9 /ed: p 226.</span></strong></span></span></p>",
    "correct_choice_id": 36220,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 9042,
    "choices": [
      {
        "id": 36135,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Facilitated diffusion&nbsp;</span></span></span></p>"
      },
      {
        "id": 36136,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pinocytosis</span></span></span></p>"
      },
      {
        "id": 36137,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Phagocytosis</span></span></span></p>"
      },
      {
        "id": 36138,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Receptor-mediated endocytosis</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In an experiment, a team of scientists incubates liver cells at 0&deg;C and treats them with trypsin to digest surface receptors. The temperature is then increased to 37&deg;C, and radioactive LDL is introduced to the culture. Subsequently, the labelled LDL is found inside the liver cells. What is the process responsible for the internalization of LDL called?</span></span></span></p>",
    "unique_key": "Q9055737",
    "question_audio": null,
    "question_video": null,
    "map_id": 30304,
    "difficulty_level": "intermediate",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Receptor-mediated endocytosis </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The<strong> LDL</strong> is taken up by<strong> peripheral tissues</strong> in the body by<strong> receptor-mediated endocytosis.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>LDL receptors </strong>are<strong> located </strong>in specialized regions called <strong>clathrin coated pits. \u200b\u200bBinding of LDL to the apo-B100 receptor </strong>by <strong>apo B100</strong> &rarr; the<strong> receptor-LDL complex </strong>is internalized by <strong>endocytosis</strong> &rarr; <strong>endosome vesicle fuses</strong> with <strong>lysosomes </strong>&rarr; <strong>receptor</strong> is <strong>recycled and returns</strong> to the <strong>cell surface </strong>and <strong>LDL particle + apoproteins + cholesterol ester</strong> are <strong>hydrolyzed </strong>by <strong>lysosomal hydrolases</strong> &rarr; forms<strong> fatty acids and free cholesterol.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Facilitated diffusion:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Is the transport of<strong> low-permeability molecules</strong> with the aid of a <strong>carrier protein.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Pinocytosis:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Uptake of <strong>small molecules in solution</strong>, is <strong>receptor &ndash;independent.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Phagocytosis:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Process by which <strong>cells</strong> such as<strong> macrophages and neutrophils engulf large particles.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Receptor-mediated endocytosis</strong> is the <strong>specific and efficient</strong> mechanism by which <strong>LDL is internalized by liver cells,</strong> involving the interaction of<strong> LDL with cell surface LDL receptors.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e: p 257-258.</span></strong></span></span></p>",
    "correct_choice_id": 36138,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 9057,
    "choices": [
      {
        "id": 36195,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">RNA alternate splicing</span></span></span></p>"
      },
      {
        "id": 36196,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">RNA editing</span></span></span></p>"
      },
      {
        "id": 36197,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">DNA editing</span></span></span></p>"
      },
      {
        "id": 36198,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">RNA interference</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A molecular biologist is explaining to a group of students the unique process through which Apo B48 is produced in the body. This protein is essential for the formation of chylomicrons, which transport dietary lipids from the intestines to other parts of the body. By what mechanism is Apo B48 generated?</span></span></span></p>",
    "unique_key": "Q7156971",
    "question_audio": null,
    "question_video": null,
    "map_id": 30311,
    "difficulty_level": "intermediate",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">RNA editing</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Apo-B-48</strong> is the major<strong> apoprotein of chylomicrons. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is synthesized only in the<strong> intestinal cells. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Apo-B100 and apo-B48 </strong>are products of the <strong>same gene</strong>, but in the intestine, the <strong>mRNA </strong>undergoes <strong>editing and </strong>so produces the <strong>B48 protein. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is named so because it is only <strong>40% of the size of B100.&nbsp;&nbsp; </strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/19/screenshot-2024-04-19-103140.png\" style=\"height:296px; width:500px\" /></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: RNA alternate splicing</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This process involves the<strong> removal or inclusion </strong>of segments of the <strong>pre-mRNA transcript</strong>, leading to the production of <strong>different mRNA variants </strong>and, consequently<strong>, different proteins from the same gene. </strong>However, it is<strong> not </strong>the mechanism by which <strong>Apo B48 </strong>is produced.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: DNA editing</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: DNA editing refers to<strong> direct changes to the DNA sequence itself</strong>, which is <strong>not </strong>applicable in the <strong>case of Apo B48 production</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: RNA interference</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: RNA interference is a<strong> biological process </strong>in which <strong>RNA molecules inhibit gene expression or translation by neutralizing targeted mRNA molecules. </strong>It<strong> does not </strong>involve the production of <strong>Apo B48</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Apo B48</strong> is generated through<strong> RNA editing, a post-transcriptional modification </strong>that alters the <strong>nucleotide </strong>sequence of the <strong>RNA</strong>, resulting in a <strong>shorter protein variant </strong>crucial for <strong>chylomicron formation in the intestines.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Vasudevan 9 /ed: p226.</span></strong></span></span></p>",
    "correct_choice_id": 36196,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 9038,
    "choices": [
      {
        "id": 36119,
        "text": "<p><span style=\"font-size:12.0pt;\">Increasing the synthesis and secretion of VLDL from liver resulting in high LDL levels in the blood</span></p>"
      },
      {
        "id": 36120,
        "text": "<p><span style=\"font-size:12.0pt;\">Inhibiting the binding of apoB to LDL receptor, thereby blocking the lipoprotein uptake and increasing the blood cholesterol levels</span></p>"
      },
      {
        "id": 36121,
        "text": "<p><span style=\"font-size:12.0pt;\">Decreasing the availability of LDL receptors on the cell surface, resulting in decreased LDL uptake and high blood cholesterol level</span></p>"
      },
      {
        "id": 36122,
        "text": "<p><span style=\"font-size:12.0pt;\">Preventing the cholesterol breakdown into bile acids in the liver</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A 50-year-old man with coronary artery disease (CAD) is being successfully treated with anti-atherogenic medication that targets PCSK9. Following treatment, his lipid profile normalizes, and his cardiac status improves. What is the primary function of PCSK9?</span></p>",
    "unique_key": "Q8805533",
    "question_audio": null,
    "question_video": null,
    "map_id": 30302,
    "difficulty_level": "intermediate",
    "subjects_id": [
      1
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Decreasing the availability of LDL receptors on the cell surface, resulting in decreased LDL uptake and high blood cholesterol level</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) normally binds to LDL receptors and promotes their degradation in lysosomes, which prevents the receptors from being recycled back to the cell surface. This natural function of PCSK9 decreases the number of LDL receptors available on cell surfaces, especially hepatocytes, resulting in reduced LDL clearance from the bloodstream and consequently higher blood cholesterol levels.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Anti-atherogenic medications that target PCSK9 (PCSK9 inhibitors) work by inhibiting this protein, thereby preventing LDL receptor degradation. This leads to:</span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">Increased recycling of LDL receptors back to the cell surface</span></li><li><span style=\"font-size:12.0pt;\">Greater availability of LDL receptors on hepatocytes</span></li><li><span style=\"font-size:12.0pt;\">Enhanced clearance of LDL cholesterol from the bloodstream</span></li><li><span style=\"font-size:12.0pt;\">Reduced blood LDL cholesterol levels</span></li><li><span style=\"font-size:12.0pt;\">Improved cardiovascular outcomes</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options</strong>:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A</strong>: Increasing the synthesis and secretion of VLDL - PCSK9 does not directly affect VLDL synthesis or secretion; its primary role is related to LDL receptor regulation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B</strong>: Inhibiting the binding of apoB to the LDL receptor - PCSK9 does not interfere with apoB binding to LDL receptors; it affects the degradation of LDL receptors themselves.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D</strong>: Preventing the breakdown of cholesterol into bile acids - PCSK9's function is not related to cholesterol metabolism into bile acids; it specifically impacts the recycling and degradation of LDL receptors.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong>&nbsp;</span><br><br>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Understanding that PCSK9 inhibitors work by preventing PCSK9-mediated degradation of LDL receptors, thereby increasing LDL receptor availability, enhancing LDL cholesterol clearance, and lowering blood cholesterol levels in patients with coronary artery disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref</strong>: Harper 30/e:&nbsp; p 271, 275, 278-279.</span></p>",
    "correct_choice_id": 36121,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 9033,
    "choices": [
      {
        "id": 36099,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Type I hyperlipoproteinemia</span></span></span></p>"
      },
      {
        "id": 36100,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Type IV hyperlipoproteinemia</span></span></span></p>"
      },
      {
        "id": 36101,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Type IIb hyperlipoproteinemia</span></span></span></p>"
      },
      {
        "id": 36102,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Type V hyperlipoproteinemia</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In a clinical study examining lipid metabolism disorders, researchers observe participants with markedly elevated plasma levels of chylomicrons and triacylglycerols. Which type of hyperlipoproteinemia is most consistent with these findings?</span></span></span></p>",
    "unique_key": "Q8035906",
    "question_audio": null,
    "question_video": null,
    "map_id": 30300,
    "difficulty_level": "intermediate",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Type I hyperlipoproteinemia</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hyperlipoproteinemia I/Familial lipoprotein lipase deficiency (type I)&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is an<strong> autosomal recessive </strong>condition presents with <strong>fasting chylomicronemia and Hypertriacylglycerolemia</strong> due to <strong>deficiency of LPL </strong>or <strong>abnormal LPL</strong> or <strong>apo C-ll deficiency</strong> causing <strong>inactive LPL.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Slow clearance of chylomicrons</strong> and <strong>VLDL</strong> with <strong>low levels of LDL</strong> and <strong>HDL are noted.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">C/F:<strong> Eruptive xanthoma; hepatomegaly; Pain abdomen,</strong> manifests in <strong>young age </strong>with<strong> less risk</strong> of<strong> coronary disease</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A <strong>chylomicron</strong> band in <strong>fasting plasma</strong> is the<strong> </strong>characteristic finding of the disease.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Familial Endogenous type </strong>- due to <strong>over production of TG </strong>by liver, <strong>elevated VLDL level </strong>&rarr; <strong>Cardiac manifestations.</strong> Associated with<strong> DM, obesity and impaired glucose tolerance.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Elevation</strong> of <strong>both CHL and TG</strong> with <strong>excessive production of apo-B </strong>&rarr; <strong>elevated LDL and VLDL. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>&nbsp;Elevated CM and VLDL. Hypertriglyceridemia </strong>secondary to disorders like <strong>obesity, excessive alcohol intake, renal failure,</strong> <strong>pancreatitis</strong>, etc. are common. Other causes:&nbsp;<strong> hepatic lipase defect, LCAT defect and Lp(a) excess and Wolman&rsquo;s disease</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Type I hyperlipoproteinemia</strong>, also known as <strong>familial lipoprotein lipase deficiency, </strong>is characterized by <strong>markedly elevated plasma</strong> <strong>levels of chylomicrons </strong>due to a <strong>deficiency of lipoprotein lipase</strong> or its <strong>cofactor apolipoprotein C-II. </strong>This leads to an <strong>inability to</strong> <strong>hydrolyze </strong>the <strong>triglycerides</strong> carried by <strong>chylomicrons</strong>, resulting in <strong>high levels of both chylomicrons and triglycerides in the plasma.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Vasudevan 9 /ed: p245, 246.</span></strong></span></span></p>",
    "correct_choice_id": 36099,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "TreatmentBased"
    ]
  },
  {
    "id": 9020,
    "choices": [
      {
        "id": 36047,
        "text": "<p><span style=\"font-size:12.0pt;\">CM &gt; LDL &gt; VLDL &gt; HDL</span></p>"
      },
      {
        "id": 36048,
        "text": "<p><span style=\"font-size:12.0pt;\">CM &gt; VLDL &gt; LDL &gt; HDL</span></p>"
      },
      {
        "id": 36049,
        "text": "<p><span style=\"font-size:12.0pt;\">HDL &gt; VLDL &gt; LDL &gt; CM</span></p>"
      },
      {
        "id": 36050,
        "text": "<p><span style=\"font-size:12.0pt;\">HDL &gt; VLDL &gt; LDL &gt; CM</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt;\">In an electrophoretic separation procedure, a technician observes the migration of lipoproteins from the cathode (-) to the anode (+) sidewhich of the following correctly orders the lipoproteins from cathode to anode?</span></p><p style=\"text-align:justify;\">&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/10/4_03T9YxQ.jpg\" alt=\"\" width=\"400\" height=\"278\"></span></p>",
    "unique_key": "Q4920637",
    "question_audio": null,
    "question_video": null,
    "map_id": 30296,
    "difficulty_level": "difficult",
    "subjects_id": [
      1
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A)&nbsp;CM &gt; LDL &gt; VLDL &gt; HDL</strong></span></p><p><span style=\"font-size:12.0pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\"><strong>Option A:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Plasma lipoproteins can be separated on the basis of their electrophoretic mobility:</span></p><p><span style=\"font-size:12.0pt;\">Those with higher protein content will move faster towards the anode and those with less proteins have low mobility</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Classifcation of Lipoproteins</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Depending on the density (by ultracentrifugation) or on the electrophoretic mobility, the lipoproteins in plasma are classified into five major types&nbsp;</span></p><ol><li><span style=\"font-size:12.0pt;\">Chylomicrons: Contain apoprotein B-48.</span></li><li><span style=\"font-size:12.0pt;\">Very low-density lipoproteins (VLDL) or pre-beta lipoproteins. Main apoprotein is B-100.</span></li><li><span style=\"font-size:12.0pt;\">Intermediate density lipoproteins (IDL) or broad-beta lipoproteins</span></li><li><span style=\"font-size:12.0pt;\">Low-density lipoproteins or beta lipoproteins. Major apoprotein in LDL is B-100.</span></li><li><span style=\"font-size:12.0pt;\">High-density lipoproteins or alpha lipoproteins. Major apoprotein in HDL is apo A.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Separation by Ultracentrifugation</strong></span></p><p><span style=\"font-size:12.0pt;\">The lipoproteins are characterized on the basis of their density. Fat is less dense than water; so fat floats on water. Lipoproteins with high lipid content will have a low density and so float on centrifugation. Those with high protein content will sediment easily and have a high density.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Separation by Electrophoresis</strong></span></p><p><span style=\"font-size:12.0pt;\">As a general rule, those with higher protein content will move faster towards the anode and those with fewer proteins have minimum mobility.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Note : pattern of electrophoresis and ultracentrifugation are different as shown in the diagram.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Electrophoresis&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Standard order from Cathode (-) to Anode (+):</strong></span></p><p><span style=\"font-size:12.0pt;\"><strong>CM &gt;LDL&gt;VLDL&gt;HDL&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ultracentrifugation: sequence is&nbsp;</strong></span></p><p><span style=\"font-size:12.0pt;\">CM &gt; VLDL &gt; LDL &gt; HDL</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Picture3_cTaOOJy.png\" width=\"2696\" height=\"2068\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Comparison of electrophoretic and ultracentrifugation patterns of lipoproteins.</span></p><p><span style=\"font-size:12.0pt;\">(VLDL: very low-density lipoproteins; IDL: intermediate density lipoproteins; LDL: low-density lipoproteins; HDL: high-density lipoproteins; FFA: free fatty acid)</span></p><p><span style=\"font-size:12.0pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Lipoprotein electrophoresis separates particles based on their <strong>protein content and charge.</strong> Understanding the typical migration pattern helps diagnose dyslipidemias and distinguish between different lipoprotein abnormalities.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref</strong>: Lippincott 7/e: 228.</span></p>",
    "correct_choice_id": 36047,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ImageBased",
      "TreatmentBased"
    ]
  },
  {
    "id": 9027,
    "choices": [
      {
        "id": 36075,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fatty acids</span></span></span></p>"
      },
      {
        "id": 36076,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glucagon</span></span></span></p>"
      },
      {
        "id": 36077,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glycerol</span></span></span></p>"
      },
      {
        "id": 36078,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chylomicrons</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Three hours after a healthy middle-aged man eats a meal that includes carbohydrates, proteins, and fats, a blood sample is drawn to assess his lipid profile. Considering normal digestive physiology and the timing of the sample in relation to his meal, which component in his blood is likely to be elevated at this point?</span></span></span></p>",
    "unique_key": "Q6091017",
    "question_audio": null,
    "question_video": null,
    "map_id": 30299,
    "difficulty_level": "intermediate",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chylomicrons</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">After a <strong>well-balanced meal</strong> , the <strong>products of digestion</strong> such as <strong>glucose, amino acids, triacylglycerols</strong> are packaged as <strong>chylomicrons</strong> from the<strong> intestine and VLDL</strong> from the<strong> liver enter the bloodstream </strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Fatty acids</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Fatty acids in the <strong>blood </strong>usually <strong>increase during fasting </strong>when<strong> fat stores </strong>are mobilized for <strong>energy, </strong>not postprandially.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Glucagon</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Glucagon levels typically <strong>rise during fasting </strong>to<strong> promote glucose production</strong> and release by the <strong>liver, not</strong> after a <strong>meal </strong>when<strong> insulin is the predominant hormone.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Glycerol</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: <strong>Glycerol</strong> levels in the <strong>blood</strong> typically <strong>increase during triglyceride breakdown</strong>, which occurs <strong>during fasting </strong>or <strong>exercise,</strong> <strong>not postprandially.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>postprandial rise in chylomicron levels</strong> in response to a <strong>well-balanced meal</strong>, reflecting the <strong>normal physiological process </strong>of <strong>dietary fat transport.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e:&nbsp; p 257-259.</span></strong></span></span></p>",
    "correct_choice_id": 36078,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "TreatmentBased"
    ]
  },
  {
    "id": 9026,
    "choices": [
      {
        "id": 36071,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Familial type III hyperlipoproteinemia</span></span></span></p>"
      },
      {
        "id": 36072,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Abetalipoproteinemia</span></span></span></p>"
      },
      {
        "id": 36073,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">LDL receptor mutation</span></span></span></p>"
      },
      {
        "id": 36074,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Familial LPL deficiency (type l)</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 50-year-old male with a familial history of increased cholesterol levels presents with an isolated elevation in LDL. His father and brother had similar lipid abnormalities. Given the isolated increase in LDL and family history, what is the most likely diagnosis?</span></span></span></p>",
    "unique_key": "Q3494015",
    "question_audio": null,
    "question_video": null,
    "map_id": 30298,
    "difficulty_level": "intermediate",
    "subjects_id": [
      1
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">LDL receptor mutation</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Lipoproteinemia</strong> are categorized by <strong>Frederickson&#39;s Classification </strong></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Familial hypercholesterolemia (FH) results in</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> severe <strong>hypercholesterolemia </strong>associated with<strong> premature atherosclerosis. </strong></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>defect is in the gene</strong> for the<strong> LDL receptor or mutation </strong>in the ligand region of<strong> apo B100</strong> &rarr; so, <strong>LDL</strong> is <strong>not</strong> cleared from the<strong> </strong><strong>blood.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Familial type llI hyperlipoproteinemia:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> due to the <strong>abnormality</strong> in <strong>apoE</strong> , remnant <strong>clearance</strong> by the<strong> liver is defective</strong> resulting <strong>in increased levels of chylomicron and VLDL remnants.&nbsp;</strong>It can cause <strong>hypercholesterolemia, atherosclerosis, and xanthomas.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Abetalipoproteinemia:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>&nbsp;Defective</strong> loading of <strong>apo B</strong> with lipid &rarr; <strong>absence of formation of chylomicrons, VLDL or LDL</strong>,<strong> low</strong> <strong>blood acylglycerols</strong> with accumulation of it in the<strong> intestine and liver.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: Familial LPL deficiency (type l):</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>&nbsp;Due to deficiency </strong>of <strong>LPL or abnormal LPL or apo C-ll deficiency</strong> &rarr;&nbsp; <strong>Hypertriacylglycerolemia</strong> with slow clearance of chylomicrons and VLDL, <strong>low levels of LDL and HDL. </strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective</span></u></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>LDL receptor </strong>gene mutation is characterized by <strong>isolated elevated LDL cholesterol levels </strong>and a <strong>family history of hypercholesterolemia</strong> and early <strong>cardiovascular disease.</strong></span></span></span><br />\r\n&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e:&nbsp; p 275,276.</span></strong></span></span></p>",
    "correct_choice_id": 36073,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "TreatmentBased"
    ]
  },
  {
    "id": 9008,
    "choices": [
      {
        "id": 35999,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Familial Chylomicronemia</span></span></span></p>"
      },
      {
        "id": 36000,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Familial Hypercholesterolemia</span></span></span></p>"
      },
      {
        "id": 36001,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Abetalipoproteinemia</span></span></span></p>"
      },
      {
        "id": 36002,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;Broad Beta Disease</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Based on the clinical presentation (as shown in image), which of the following is the most probable diagnosis? </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/10/1_BiC30gi.jpg\" style=\"height:190px; width:284px\" /></span></span></span></p>",
    "unique_key": "Q1136238",
    "question_audio": null,
    "question_video": null,
    "map_id": 30295,
    "difficulty_level": "intermediate",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Familial Hypercholesterolemia</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>deposition of lipids</strong> in<strong> subcutaneous tissue</strong> leads to <strong>xanthomas.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Xanthelasma </strong>are<strong> lipid deposits under the periorbital skin </strong>and contain mainly <strong>cholesterol.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Tendinous xanthoma </strong>are found <strong>over the tendons.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Deposits of lipids </strong>in <strong>cornea</strong> lead to<strong> corneal arcus</strong>; indicating <strong>hypercholesterolemia</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Familial Chylomicronemia:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">C/F- <strong>Hepatomegaly, eruptive xanthoma and abdominal pain.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Abetalipoproteinemia:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Low levels of serum triglycerides,</strong> <strong>cholesterol and phospholipids</strong>. C/F-<strong> Blindness </strong>due to <strong>degenerative changes</strong> in <strong>retina</strong> and <strong>spiny projections </strong>in<strong> erythrocytes (acanthocytes).</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: Broad Beta Disease:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>&nbsp;Palmar xanthoma</strong> and <strong>increased risk for vascular disease.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Familial Hypercholesterolemia</strong> is characterized by <strong>high LDL cholesterol levels </strong>and the presence of <strong>xanthomas</strong>, which are deposits of <strong>cholesterol in the skin and tendons</strong>, due to a<strong> genetic defect in LDL receptors.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Vasudevan 9 /ed: P245, 246.</span></strong></span></span></p>",
    "correct_choice_id": 36000,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "ImageBased",
      "TreatmentBased"
    ]
  },
  {
    "id": 9022,
    "choices": [
      {
        "id": 36055,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chylomicrons</span></span></span></p>"
      },
      {
        "id": 36056,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">HDL</span></span></span></p>"
      },
      {
        "id": 36057,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">LDL</span></span></span></p>"
      },
      {
        "id": 36058,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">VLDL</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 36-year-old man who consumes a fat-free, high-carbohydrate diet finds that he continues to gain weight. Considering the dietary influence on lipoprotein metabolism, which apoprotein is most likely to be elevated in his blood?</span></span></span></p>",
    "unique_key": "Q3754305",
    "question_audio": null,
    "question_video": null,
    "map_id": 30297,
    "difficulty_level": "difficult",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">VLDL</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Excess Carbohydrates </strong>in the <strong>body</strong> are converted to<strong> Acetyl CoA. </strong>These are then <strong>converted to Fatty acid</strong>, which <strong>gets</strong> <strong>esterified</strong> to form<strong> Endogenous TGs. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>VLDL </strong>is the<strong> carrier of endogenous TGs</strong>. So,<strong> blood VLDL</strong> level is <strong>raised.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Chylomicrons:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Carry <strong>TAG </strong>from<strong> gut</strong> to <strong>muscle and adipose tissue</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: HDL:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Carry<strong> cholesterol</strong> from <strong>peripheral tissues to liver</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: LDL:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Carry<strong> cholesterol </strong>from <strong>liver to peripheral tissues</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A <strong>fat-free, high-carbohydrate diet</strong> can lead to <strong>increased synthesis of VLDL</strong> (Very Low-Density Lipoprotein) in the<strong> liver.</strong> <strong>VLDL</strong> is responsible for <strong>transporting endogenously synthesized triglycerides</strong>, which the<strong> body produces</strong> from <strong>excess carbohydrates,</strong> to <strong>adipose tissue</strong> for <strong>storage</strong>. This could contribute to <strong>ongoing obesity </strong>despite the <strong>absence of dietary fat.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e: p 255-257.</span></strong></span></span></p>",
    "correct_choice_id": 36058,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 9048,
    "choices": [
      {
        "id": 36159,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chylomicrons</span></span></span></p>"
      },
      {
        "id": 36160,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">VLDL</span></span></span></p>"
      },
      {
        "id": 36161,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">HDL</span></span></span></p>"
      },
      {
        "id": 36162,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">LDL</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient with coronary artery disease (CAD), currently undergoing treatment, is advised to implement lifestyle modifications and monitor his lipid profile quarterly. Among the lipoproteins evaluated, which one is characterized by the lowest lipid-to-protein ratio?</span></span></span></p>",
    "unique_key": "Q2490427",
    "question_audio": null,
    "question_video": null,
    "map_id": 30306,
    "difficulty_level": "intermediate",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C)</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> HDL</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>High-density lipoprotein (HDL) </strong>is known for having the <strong>highest protein </strong>content relative to its <strong>lipid content </strong>among the <strong>various lipoproteins, </strong>resulting in the <strong>lowest lipid-to-protein ratio</strong>. This <strong>high protein </strong>content contributes to <strong>HDL&#39;s </strong>denser nature compared to other lipoproteins and its role in <strong>reverse cholesterol transport</strong>, where it <strong>facilitates </strong>the removal of <strong>excess cholesterol from cells </strong>and <strong>atheromatous plaques </strong>in the <strong>arteries</strong>, transporting it back to the <strong>liver for excretion or recycling</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Calibri, sans-serif\"><span style=\"font-size:16px\"><strong><u>Other Options:</u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Chylomicrons</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: These are the <strong>largest lipoproteins </strong>with the <strong>highest lipid content, </strong>primarily <strong>triglycerides</strong>, thus having a <strong>high lipid-to-protein ratio.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: VLDL (Very Low-Density Lipoprotein)</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: VLDL particles are <strong>rich in triglycerides </strong>and have a <strong>higher lipid-to-protein ratio </strong>compared to <strong>HDL </strong>but<strong> lower than chylomicrons.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: LDL (Low-Density Lipoprotein)</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: LDL carries mostly<strong> cholesterol </strong>and has a <strong>lower lipid-to-protein ratio </strong>than <strong>VLDL </strong>and <strong>chylomicrons but higher than HDL</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/18/screenshot-2024-04-18-182641.png\" style=\"height:410px; width:1000px\" /></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Among<strong> different HDL particles</strong>, <strong>percentage of lipids </strong>seen will be:&nbsp;&nbsp; </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">HDL<sub>1</sub>&nbsp;: 65%</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">HDL2&nbsp; : 67%</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">HDL3&nbsp; : 43%</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pre&beta;-HDL : 30</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e: p 478-479, 484.</span></strong></span></span></p>",
    "correct_choice_id": 36161,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "TreatmentBased"
    ]
  },
  {
    "id": 9036,
    "choices": [
      {
        "id": 36111,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">245 mg/dl</span></span></span></p>"
      },
      {
        "id": 36112,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">135 mg/dl</span></span></span></p>"
      },
      {
        "id": 36113,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">85 mg/dl</span></span></span></p>"
      },
      {
        "id": 36114,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">45 mg/dl</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 45-year-old woman undergoes routine health screening, including a lipid profile, while fasting. Her results show a total cholesterol of 300 mg/dL, HDL cholesterol of 25 mg/dL, and triglycerides of 150 mg/dL. Utilizing the Friedewald equation to assess her cardiovascular risk, what is the LDL cholesterol level in this patient?</span></span></span></p>",
    "unique_key": "Q2855174",
    "question_audio": null,
    "question_video": null,
    "map_id": 30301,
    "difficulty_level": "intermediate",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">245 mg/dl</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>total blood cholesterol</strong> in the <strong>fasting state </strong>is <strong>equal</strong> to the <strong>sum </strong>of the <strong>cholesterol in LDL + cholesterol in HDL +</strong> <strong>cholesterol in VLDLs. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This<strong> last term </strong>is calculated by <strong>dividing the triacylglycerol value by 5 </strong>because<strong> cholesterol </strong>accounts for about <strong>1/5 </strong>of the <strong>volume of VLDL in fasted blood</strong>.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><strong><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">300 = LDL cholesterol + 25+150/5</span></span></span></strong></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">LDL cholesterol = 300-55= 245 mg/dl.</span></strong></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The<strong> Friedewald equation</strong>, used to estimate the <strong>level of LDL cholesterol</strong>, is<strong> LDL = Total Cholesterol - HDL - (Triglycerides / 5).</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: DM Vasudevan, 9/e: p241, 242, Lippincott 7/e: p 244</span></strong></span></span></p>",
    "correct_choice_id": 36111,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 9040,
    "choices": [
      {
        "id": 36127,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">APOE3&nbsp; </span></span></span></p>"
      },
      {
        "id": 36128,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">APOE1 </span></span></span></p>"
      },
      {
        "id": 36129,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">APOE4 </span></span></span></p>"
      },
      {
        "id": 36130,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">APOE2</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 52-year-old man presents with a two-year history of gradually declining cognitive function. PET imaging reveals widespread amyloid deposition, notably in the striatum. Considering the role of apolipoproteins in Alzheimer&#39;s disease pathology, which apolipoprotein variant is most closely associated with this condition?</span></span></span></p>",
    "unique_key": "Q4112074",
    "question_audio": null,
    "question_video": null,
    "map_id": 30303,
    "difficulty_level": "intermediate",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">APOE4 </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><u><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Familial AD and Apo-E4 gene:</span></strong></u> <span style=\"font-family:&quot;Calibri&quot;,sans-serif\">There is an <strong>association between patients </strong>possessing the <strong>apo E4 allele </strong>and the<strong> incidence</strong> of<strong> Alzheimer disease. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Apparently,<strong> apo E4 binds </strong>more <strong>avidly to &beta;-amyloid</strong> found in<strong> neuritic plaques. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Genes</strong> identified with <strong>AD </strong>are that <strong>coding for APP, presenilin-1 (chromosome 14), presenilin-2 (chromosome 1) or AD3</strong> <strong>(chromosome 14) or AD4 (chromosome 1), and Apo-E4 gene (chromosome 19). </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>presence of Apo-E4 gene</strong> is the major <strong>risk factor for AD. </strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: APOE3</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This is the <strong>most common allele of APOE</strong> and is considered <strong>neutral </strong>in terms of<strong> Alzheimer&#39;s risk.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: APOE1</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This is<strong> not </strong>a commonly <strong>recognized allele </strong>in the context of <strong>Alzheimer&#39;s disease risk.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: APOE2</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This <strong>allele</strong> is considered to have a<strong> protective effect against Alzheimer&#39;s disease, </strong>associated with a <strong>lower risk </strong>of <strong>developing the condition.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>APOE4 </strong>is a <strong>genetic risk factor </strong>for <strong>Alzheimer&#39;s disease, </strong>associated with <strong>increased amyloid deposition</strong> in the<strong> brain</strong> and an <strong>elevated</strong> <strong>risk </strong>of developing the <strong>disease</strong>, particularly at an <strong>earlier age.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e: p 46, 275.</span></strong></span></span></p>",
    "correct_choice_id": 36129,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "TreatmentBased"
    ]
  },
  {
    "id": 9046,
    "choices": [
      {
        "id": 36151,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Elevated LDL</span></span></span></p>"
      },
      {
        "id": 36152,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Elevated HDL</span></span></span></p>"
      },
      {
        "id": 36153,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Elevated lipoprotein lipase </span></span></span></p>"
      },
      {
        "id": 36154,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Elevated chylomicrons</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 32-year-old man with a sedentary lifestyle presents with abdominal pain. An ultrasound reveals hepatomegaly, and his lipid profile, characterized by a creamy layer over clear plasma 24 hours after collection, indicates elevated triglycerides and cholesterol levels. He is diagnosed with Type I hyperlipoproteinemia. Which of the following is a hallmark feature of this condition?</span></span></span></p>",
    "unique_key": "Q5674627",
    "question_audio": null,
    "question_video": null,
    "map_id": 30305,
    "difficulty_level": "beginner",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Elevated chylomicrons</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hyperlipoproteinemia I/Familial lipoprotein lipase deficiency (type I)&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is an <strong>autosomal recessive condition </strong>presents with <strong>fasting chylomicronemia and Hypertriacylglycerolemia </strong>due to <strong>deficiency </strong>of<strong> LPL or abnormal LPL or apo C-ll deficiency</strong> causing <strong>inactive LPL</strong>.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Slow clearance </strong>of <strong>chylomicrons and VLDL </strong>with<strong> low levels of LDL and HDL</strong> are noted.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">C/F:<strong> Eruptive xanthoma</strong>;<strong> hepatomegaly; Pain abdomen</strong>, manifests in <strong>young age</strong> with<strong> less risk</strong> of<strong> coronary disease.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A<strong> chylomicron</strong> band in <strong>fasting plasma </strong>is the characteristic finding of the disease.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Calibri, sans-serif\"><span style=\"font-size:16px\"><strong><u>Other Options:</u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Elevated LDL:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Seen in<strong> type IIA and IIB </strong>and <strong>low levels </strong>in <strong>type I Hyperlipoproteinemia.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Elevated HDL:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Low levels of HDL </strong>in <strong>type I </strong>due to<strong> slow clearance</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Elevated lipoprotein lipase:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In <strong>type I Hyperlipoproteinemia, lipoprotein lipase </strong>is <strong>deficient </strong>and <strong>not elevated </strong>as given in the option.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Identify<strong> Type I hyperlipoproteinemia </strong>by the presence of <strong>elevated chylomicrons</strong>, leading to <strong>high plasma triglyceride levels </strong>and the characteristic appearance of a <strong>lipid profile sample </strong>after<strong> standing</strong>, <strong>indicative </strong>of this condition&#39;s impact on <strong>lipid metabolism.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e: p 275.</span></strong></span></span></p>",
    "correct_choice_id": 36154,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 9050,
    "choices": [
      {
        "id": 36167,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Xanthelasma palpebrarum</span></span></span></p>"
      },
      {
        "id": 36168,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Xanthoma</span></span></span></p>"
      },
      {
        "id": 36169,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Arcus senilis</span></span></span></p>"
      },
      {
        "id": 36170,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tendinous xanthoma</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 50-year-old woman reports having yellowish, soft lesions at the inner corners of the upper eyelids on both eyes for the past three years. Recently, she has noticed an increase in their size. Based on the described location and appearance of the lesions, what is the most likely diagnosis?</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/10/7_4tAV0dx.jpg\" style=\"height:183px; width:270px\" /></span></span></span></p>",
    "unique_key": "Q5635507",
    "question_audio": null,
    "question_video": null,
    "map_id": 30307,
    "difficulty_level": "beginner",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Xanthelasma palpebrarum</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The diagnosis of the patient is <strong>Familial hypercholesterolemia.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In this there is defect is in <strong>LDL receptor or mutation </strong>in the ligand region of <strong>apo B100 </strong>&rarr; so, <strong>LDL </strong>is <strong>not cleared </strong>from the<strong> </strong><strong>blood deposition of lipids </strong>in <strong>subcutaneous tissue </strong>&rarr; leads to <strong>xanthomas</strong>, seen over <strong>tendons </strong>known as <strong>Tendinous xanthoma</strong>.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Xanthelasma are lipid deposits under the periorbital skin.</span></strong></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Xanthoma</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: While xanthomas are also<strong> lipid deposits </strong>in the <strong>skin</strong>, they can <strong>occur </strong>in various<strong> parts of the body</strong>, <strong>not </strong>specifically on the <strong>eyelids</strong>. <strong>Xanthelasma </strong>is a <strong>type of xanthoma </strong>that specifically occurs on the <strong>eyelids.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Arcus senilis</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This is a <strong>gray or white arc </strong>visible <strong>above and below</strong> the outer part of the <strong>cornea, not </strong>on the <strong>eyelids</strong>, and it&#39;s typically associated with <strong>aging or high cholesterol.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: Tendinous xanthoma</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: These are <strong>lipid deposits </strong>found in <strong>tendons</strong>, particularly the <strong>Achilles tendon</strong>, <strong>not </strong>on the <strong>eyelids</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Xanthelasma palpebrarum </strong>is <strong>soft, yellowish plaques </strong>on the eyelids, indicative of<strong> lipid deposition in the skin</strong>, which may suggest underlying <strong>hyperlipidemia </strong>but can also occur in individuals with <strong>normal lipid profiles.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Vasudevan 9 /ed: P245, 246.</span></strong></span></span></p>",
    "correct_choice_id": 36167,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "ImageBased"
    ]
  },
  {
    "id": 9054,
    "choices": [
      {
        "id": 36183,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">VLDL</span></span></span></p>"
      },
      {
        "id": 36184,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chylomicron</span></span></span></p>"
      },
      {
        "id": 36185,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">HDL</span></span></span></p>"
      },
      {
        "id": 36186,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">LDL</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which human plasma lipoprotein has the highest percentage of triacylglycerol (TAG) by weight?</span></span></span></p>",
    "unique_key": "Q4844476",
    "question_audio": null,
    "question_video": null,
    "map_id": 30309,
    "difficulty_level": "beginner",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chylomicron</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Chylomicrons </strong>are the <strong>lipoprotein particles </strong>that contain the <strong>highest </strong>percentage of<strong> triacylglycerol (TAG) </strong>by weight. They are responsible for <strong>transporting dietary lipids</strong>, predominantly <strong>triglycerides</strong>, from the<strong> intestines to other parts </strong>of the <strong>body </strong>for <strong>metabolism or storage</strong>. Due to their <strong>high TAG content</strong>, <strong>chylomicrons </strong>are the <strong>least dense </strong>of the <strong>lipoproteins</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:16px\"><strong><u>Other Options:</u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: VLDL</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: <strong>Very Low-Density Lipoproteins </strong>(VLDL) carry <strong>endogenously </strong>synthesized <strong>triglycerides </strong>from the <strong>liver to peripheral tissues </strong>but have a <strong>lower </strong>percentage of<strong> triglycerides </strong>compared <strong>to chylomicrons</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: HDL</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:<strong> High-Density Lipoproteins </strong>(HDL) are involved in <strong>reverse cholesterol </strong>transport and contain the <strong>least </strong>amount of <strong>triglycerides </strong>among the options listed.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: LDL</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: <strong>Low-Density Lipoproteins </strong>(LDL) primarily carry <strong>cholesterol </strong>and have a <strong>lower percentage of triglycerides </strong>compared to <strong>VLDL and chylomicrons.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">HDL &ndash;<strong> High protein , Phospholipid</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">LDL &ndash; <strong>High CHL , CHL Esters</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">CM- <strong>High TAG (80%)</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">VLDL -<strong> TAG (50%) </strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/ed, pg 254</span></strong></span></span></p>",
    "correct_choice_id": 36184,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 9055,
    "choices": [
      {
        "id": 36187,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Very low density lipoproteins (VLDLs)</span></span></span></p>"
      },
      {
        "id": 36188,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Low-density lipoproteins (LDLs)</span></span></span></p>"
      },
      {
        "id": 36189,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">High-density lipoproteins (HDLs)</span></span></span></p>"
      },
      {
        "id": 36190,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Albumin</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which lipoprotein is predominantly involved in delivering cholesterol to the tissues?</span></span></span></p>",
    "unique_key": "Q4183207",
    "question_audio": null,
    "question_video": null,
    "map_id": 30310,
    "difficulty_level": "intermediate",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Low-density lipoproteins (LDLs)&nbsp;</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The<strong> uptake of exogenous cholesterol </strong>by <strong>cells </strong>results in a marked suppression of <strong>endogenous cholesterol synthesis</strong>. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Low-density human lipoprotein not </strong>only contains the greatest ratio of <strong>bound cholesterol to protein </strong>but also has the <strong>greatest potency </strong>in<strong> suppressing endogenous cholesterogenesis. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>LDLs </strong>normally suppress <strong>cholesterol synthesis </strong>by binding to a <strong>specific membrane receptor </strong>that mediates <strong>inhibition </strong>of <strong>hydroxymethylglutaryl (HMG) coenzyme A reductase.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:16px\"><strong><u>Other Options:</u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Transport of TAG </strong>from <strong>liver to muscle and adipose tissue</strong>. <strong>Cholesterol</strong> composition <strong>20 %</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Transports Cholesterol </strong>from <strong>peripheral tissues to liver</strong>.<strong> Cholesterol</strong> <strong>10-30%</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Transports FFA </strong>from <strong>adipose Tissue to muscle and liver</strong>. Free fatty acids are<strong> seen in circulation</strong>, <strong>weakly bound to albumin</strong>. <strong>Cholesterol 0%</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Low-density lipoproteins (LDLs) </strong>are recognized as the primary carriers of <strong>cholesterol in the bloodstream, delivering cholesterol </strong>to various tissues for use in <strong>cell membranes and other functions. LDLs </strong>bind to <strong>specific LDL receptors </strong>on cell surfaces, <strong>facilitating </strong>the <strong>uptake </strong>of <strong>cholesterol into cells</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Vasudevan 9/ed: p225.</span></strong></span></span></p>",
    "correct_choice_id": 36188,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 9058,
    "choices": [
      {
        "id": 36199,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">LPL deficiency </span></span></span></p>"
      },
      {
        "id": 36200,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tangier disease</span></span></span></p>"
      },
      {
        "id": 36201,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Familial hypercholesterolemia</span></span></span></p>"
      },
      {
        "id": 36202,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Abetalipoproteinemia</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A clinician is treating a patient presenting with tendon xanthomas, elevated LDL levels, and high serum cholesterol. The patient has been prescribed lovastatin, a cholesterol-lowering medication. Based on these clinical features, what is the most likely diagnosis? </span></span></span></p>",
    "unique_key": "Q1076854",
    "question_audio": null,
    "question_video": null,
    "map_id": 30312,
    "difficulty_level": "beginner",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Familial hypercholesterolemia</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The clinical &amp; lab features are suggestive of <strong>Familial hypercholesterolemia</strong>.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>defect </strong>is in the<strong> </strong><strong>gene for the LDL receptor or mutation </strong>in the ligand region of <strong>apo B100 </strong>&rarr; so <strong>LDL is not cleared </strong>from the<strong> </strong><strong>blood</strong>.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">C/F:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> The <strong>deposition of lipids </strong>in <strong>subcutaneous tissue </strong>leads to <strong>xanthomas</strong>, seen <strong>over tendons </strong>known as <strong>Tendinous xanthoma</strong>.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Xanthelasma </strong>are <strong>lipid </strong>deposits under the <strong>periorbital skin.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Deposits of <strong>lipids in cornea </strong>lead to<strong> corneal arcus</strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: LPL deficiency</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Lipoprotein lipase (LPL) deficiency leads to<strong> elevated chylomicrons</strong>, causing <strong>high triglycerides </strong>but <strong>not </strong>typically resulting in <strong>high LDL or tendon xanthomas</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Tangier disease</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Characterized by <strong>very low levels of high-density lipoprotein (HDL) </strong>and can lead to the <strong>deposition </strong>of <strong>cholesterol </strong>in tissues, but it <strong>does not </strong>typically present with <strong>elevated LDL levels </strong>and<strong> tendon xanthomas.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: Abetalipoproteinemia</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: A <strong>rare </strong>condition characterized by the <strong>absence of apolipoprotein B</strong>-containing <strong>lipoproteins</strong>, leading to <strong>fat malabsorption </strong>and <strong>neurological </strong>symptoms<strong>, not high LDL or cholesterol levels</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The clinical presentation and appropriate treatment for<strong> familial hypercholesterolemia, </strong>includes <strong>high LDL cholesterol, tendon xanthomas</strong>, and the<strong> use of statin </strong>medications like <strong>lovastatin to lower cholesterol levels</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Vasudevan 9 /ed: p245, 246.</span></strong></span></span></p>",
    "correct_choice_id": 36201,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 9060,
    "choices": [
      {
        "id": 36207,
        "text": "<p><span style=\"font-size:12.0pt;\">Broad beta disease</span></p>"
      },
      {
        "id": 36208,
        "text": "<p><span style=\"font-size:12.0pt;\">Abetalipoproteinemia</span></p>"
      },
      {
        "id": 36209,
        "text": "<p><span style=\"font-size:12.0pt;\">Familial Hyper Chylomicronemia</span></p>"
      },
      {
        "id": 36210,
        "text": "<p><span style=\"font-size:12.0pt;\">Familial Hypercholesterolemia</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt;\">A 50-year-old man with abdominal pain is found to have hepatomegaly via ultrasound. On examination, he exhibits skin findings as shown in the image, with a blood sample that appears creamy and shows elevated triglycerides levels. Based on the clinical presentation and laboratory findings, what is the most likely diagnosis?</span></p><p style=\"text-align:justify;\">&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img class=\"image_resized\" style=\"aspect-ratio:242/128;width:57.43%;\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/10/11_XE3FVIl.jpg\" alt=\"\" width=\"242\" height=\"128\"></span></p>",
    "unique_key": "Q3354613",
    "question_audio": null,
    "question_video": null,
    "map_id": 30313,
    "difficulty_level": "intermediate",
    "subjects_id": [
      1
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C. Familial Hyper Chylomicronemia</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span><br><br>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Familial&nbsp;</strong>Hyper<strong> Chylomicronemia Syndrome</strong> (also known as <strong>Type I Hyperlipoproteinemia</strong>) is a <strong>rare autosomal recessive disorder</strong> caused by <strong>lipoprotein lipase (LPL) deficiency</strong> or dysfunction, or by <strong>apo C-II deficiency</strong>, which is a necessary cofactor for LPL activation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Key clinical features:</strong></span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\"><strong>Eruptive xanthomas</strong> (small, yellow papules, especially on the buttocks or extensor surfaces)</span></li><li><span style=\"font-size:12.0pt;\"><strong>Hepatomegaly</strong></span></li><li><span style=\"font-size:12.0pt;\"><strong>Recurrent abdominal pain</strong> (may be related to pancreatitis)</span></li><li><span style=\"font-size:12.0pt;\"><strong>Milky or creamy plasma</strong> appearance</span></li><li><span style=\"font-size:12.0pt;\"><strong>Very high serum triglyceride levels</strong>, often &gt;1000 mg/dL</span></li></ul><p><span style=\"font-size:12.0pt;\">Although this condition typically presents in <strong>childhood or adolescence</strong>, adult presentations can occur, especially if the diagnosis is delayed or partial enzyme activity exists.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\"><strong>Option A: Broad Beta Disease (Type III Hyperlipoproteinemia)</strong> \u2013 Associated with <strong>palmar xanthomas</strong> and elevated <strong>remnants</strong>. Presents with <strong>increased cardiovascular risk</strong>.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Option B: Abetalipoproteinemia</strong> \u2013 Features <strong>very low serum triglycerides and cholesterol</strong>, <strong>acanthocytosis</strong>, <strong>fat malabsorption</strong>, and <strong>retinal degeneration</strong>. Plasma is not creamy.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Option D: Familial Hypercholesterolemia (Type IIa)</strong> \u2013 Caused by <strong>LDL receptor mutations</strong>, presents with <strong>tendinous xanthomas</strong>, <strong>corneal arcus</strong>, and <strong>very high LDL cholesterol</strong> levels. Triglycerides are usually normal.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:12.0pt;\">Recognize <strong>Familial Chylomicronemia Syndrome</strong> by:</span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\"><strong>Eruptive xanthomas</strong></span></li><li><span style=\"font-size:12.0pt;\"><strong>Creamy plasma with markedly elevated triglycerides</strong></span></li></ul><p><span style=\"font-size:12.0pt;\">It reflects a defect in <strong>chylomicron clearance</strong>, due to <strong>LPL enzyme deficiency or its apo C-II cofactor</strong>, resulting in accumulation of triglyceride-rich lipoproteins in plasma.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Ref: Harper 30/e: p 275.</span></p>",
    "correct_choice_id": 36209,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "ImageBased"
    ]
  },
  {
    "id": 9061,
    "choices": [
      {
        "id": 36211,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">130</span></p>"
      },
      {
        "id": 36212,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">100</span></p>"
      },
      {
        "id": 36213,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">75</span></p>"
      },
      {
        "id": 36214,
        "text": "<p><span style=\"font-size:12pt;\">50</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt;\">A physician is advising a patient on target LDL cholesterol levels for optimal cardiovascular health. what is the recommended upper limit for LDL cholesterol in mg/dl?</span></p>",
    "unique_key": "Q9059763",
    "question_audio": null,
    "question_video": null,
    "map_id": 30314,
    "difficulty_level": "intermediate",
    "subjects_id": [
      1
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B. 100</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">For <strong>optimal cardiovascular health,</strong> particularly in <strong>primary prevention</strong> (patients without existing cardiovascular disease), the <strong>recommended upper limit for LDL cholesterol is typically \u2264100 mg/dL.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Key guidelines (such as those from the <strong>American Heart Association</strong> and <strong>NCEP ATP III</strong>) suggest:</span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\"><strong>&lt;100 mg/dL:</strong> Optimal LDL level</span></li><li><span style=\"font-size:12.0pt;\"><strong>100\u2013129 mg/dL:</strong> Near or above optimal</span></li><li><span style=\"font-size:12.0pt;\"><strong>130\u2013159 mg/dL:</strong> Borderline high</span></li><li><span style=\"font-size:12.0pt;\"><strong>160\u2013189 mg/dL:</strong> High</span></li><li><span style=\"font-size:12.0pt;\"><strong>\u2265190 mg/dL:</strong> Very high</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\"><strong>Option A. 130 mg/dL:</strong> This is considered <strong>borderline high</strong> for LDL, not the optimal upper limit.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Option C. 75 mg/dL:</strong> it\u2019s <strong>below the general upper limit</strong> for most patients.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Option D. 50 mg/dL:</strong> Not a standard upper limit; <strong>too low</strong> for general recommendation.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objectives:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">Understand that <strong>&lt;100 mg/dL</strong> is the widely recommended <strong>upper limit</strong> for LDL cholesterol in general cardiovascular prevention.</span></li></ul>",
    "correct_choice_id": 36212,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "TreatmentBased"
    ]
  },
  {
    "id": 9062,
    "choices": [
      {
        "id": 36215,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Atherosclerosis</span></span></span></p>"
      },
      {
        "id": 36216,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cholestasis</span></span></span></p>"
      },
      {
        "id": 36217,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">MI</span></span></span></p>"
      },
      {
        "id": 36218,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hepatitis</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">During a clinical discussion on the diagnostic significance of various lipoproteins, a medical instructor inquires about the clinical condition associated with elevated levels of Lipoprotein X. Which condition is indicated by the presence of Lipoprotein X?</span></span></span></p>",
    "unique_key": "Q8656979",
    "question_audio": null,
    "question_video": null,
    "map_id": 30315,
    "difficulty_level": "intermediate",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cholestasis</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In <strong>cholestasis</strong>,<strong> free cholesterol </strong>combines with <strong>phospholipids </strong>and secreted into<strong> plasma </strong>as a constituent of a <strong>lamellar</strong> <strong>particle called LP- X</strong> &rarr; gets <strong>deposited in skinfolds</strong> &rarr; <strong>producing lesions</strong> resembling those in <strong>FDBL. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Plantar and eruptive xanthomas</strong> are also<strong> seen </strong>in<strong> patients </strong>with<strong> cholestasis.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Calibri, sans-serif\"><span style=\"font-size:16px\"><strong><u>Other Options:</u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Atherosclerosis</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: While atherosclerosis involves <strong>lipid accumulation,</strong> <strong>Lipoprotein X</strong> is <strong>not</strong> a <strong>specific </strong>indicator for this condition. Traditional lipoproteins like <strong>LDL and HDL</strong> are <strong>more</strong> closely related to <strong>atherosclerotic risk.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Myocardial Infarction (MI)</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: <strong>Lipoprotein X</strong> is <strong>not</strong> a biomarker for <strong>MI</strong>.<strong> Cardiac troponins</strong> and other markers like <strong>CK-MB </strong>are used to diagnose <strong>myocardial infarction.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: Hepatitis</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Hepatitis refers to <strong>inflammation of the liver</strong>, which can be <strong>due to viral infections</strong> or other causes. <strong>Elevated</strong> <strong>Lipoprotein X</strong> is<strong> not</strong> a specific marker for<strong> hepatitis</strong>, although<strong> liver function tests </strong>may <strong>show abnormalities</strong> in this condition.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Lipoprotein X</strong> is an <strong>abnormal lipoprotein</strong> that is often present in the<strong> plasma of patients with cholestasis,</strong> a condition characterized by<strong> impaired bile flow.</strong> The <strong>accumulation of lipids </strong>that are<strong> normally excreted in bile</strong> leads to the formation of this <strong>atypical</strong> <strong>lipoprotein</strong>. Its <strong>detection </strong>can serve as an<strong> indicator of cholestatic liver disease.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Vasudevan 9 /ed: p 229.</span></strong></span></span></p>",
    "correct_choice_id": 36216,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "TreatmentBased"
    ]
  },
  {
    "id": 9053,
    "choices": [
      {
        "id": 36179,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Apo B-100</span></span></span></p>"
      },
      {
        "id": 36180,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Apo B-48</span></span></span></p>"
      },
      {
        "id": 36181,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Apo A-II</span></span></span></p>"
      },
      {
        "id": 36182,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Apo A-I</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Among the listed apolipoproteins, which one serves as an activator for Lecithin Cholesterol Acyltransferase (LCAT), an enzyme critical in the process of cholesterol esterification within high-density lipoprotein (HDL) particles?</span></span></span></p>",
    "unique_key": "Q6897969",
    "question_audio": null,
    "question_video": null,
    "map_id": 30323,
    "difficulty_level": "intermediate",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Apo A-I</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Apo A-I </strong>is the <strong>primary protein </strong>component of <strong>HDL </strong>particles and serves as an <strong>activator </strong>for <strong>LCAT</strong>. LCAT plays a crucial role in the <strong>esterification of free cholesterol </strong>on the surface of <strong>HDL particles</strong>, facilitating the <strong>maturation of HDL </strong>and its role in <strong>reverse cholesterol transport </strong>from <strong>peripheral tissues </strong>back to the <strong>liver for excretion</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:16px\"><strong><u>Other Options:</u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Apo B-100</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This <strong>apolipoprotein </strong>is the primary protein component of <strong>low-density lipoprotein (LDL) </strong>and<strong> very low-density lipoprotein (VLDL), not </strong>associated with <strong>activating LCAT</strong>. Its primary role is in the <strong>structural integrity </strong>of these particles and in mediating their <strong>interaction with LDL receptors.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Apo B-48</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Apo B-48 is found in <strong>chylomicrons and chylomicron remnants</strong>. It is essential for the<strong> assembly and secretion </strong>of these <strong>lipoproteins </strong>in the <strong>intestines </strong>but <strong>does not </strong>play a role in <strong>activating LCAT</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Apo A-II</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Although Apo A-II is also a<strong> component of HDL,</strong> unlike Apo A-I, it is <strong>not </strong>known to <strong>activate LCAT</strong>. Its precise function is <strong>not </strong>as well understood as that of <strong>Apo A-I</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>INHIBITOR</strong> OF ENZYMES: <strong>CI</strong> inhibits <strong>CETP</strong>, <strong>A-II, C-III</strong> inhibits <strong>LPL </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>ACTIVATOR</strong> OF ENZYMES:<strong> </strong>&nbsp;<strong>A-I</strong> activates <strong>LCAT</strong>, <strong>C-I, II</strong> activates<strong> LPL</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/19/screenshot-2024-04-19-101017.png\" style=\"height:435px; width:1000px\" /></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/ed, pg -272.</span></strong></span></span></p>",
    "correct_choice_id": 36182,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "TreatmentBased"
    ]
  },
  {
    "id": 9014,
    "choices": [
      {
        "id": 36023,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hypo alpha lipoproteinemia</span></span></span></p>"
      },
      {
        "id": 36024,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tangier Disease</span></span></span></p>"
      },
      {
        "id": 36025,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Familial alpha Lp-deficiency</span></span></span></p>"
      },
      {
        "id": 36026,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hyper alpha lipoproteinemia</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 45-year-old man with established coronary artery disease returns with new complaints of numbness in his hands and feet. On examination, below finding is observed. His lipid panel reveals HDL cholesterol levels are markedly low. What is the most likely diagnosis?</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/10/2_T4chRaU.jpg\" style=\"height:157px; width:255px\" /></span></span></span></p>",
    "unique_key": "Q1064617",
    "question_audio": null,
    "question_video": null,
    "map_id": 30324,
    "difficulty_level": "intermediate",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Tangier Disease</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Defects in ABCA1</strong>, an <strong>ATP-binding cassette (ABC) </strong>protein involved in<strong> transferring cellular cholesterol to HDL. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">So<strong>, plasma HDL is low </strong>and <strong>alpha band </strong>is<strong> absent</strong> in<strong> electrophoresis. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Cholesterol esters </strong>are accumulated in<strong> tissues. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">C/F: <strong>Large orange yellow tonsils</strong>,<strong> muscle atrophy</strong>,<strong> recurrent peripheral neuropathies </strong>and <strong>atherosclerosis. </strong>These are the hallmark features. </span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Hypo alpha lipoproteinemia:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Here serum<strong> HDL is decreased </strong>&rarr;<strong> High risk for coronary artery diseases.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Familial alpha Lp-deficiency:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Have <strong>&darr;&darr;HDL and A-l, Normal- Cholesterol and TAG </strong>&rarr; <strong>Increased risk of CAD.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: Hyper alpha lipoproteinemia:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Increased HDL</strong> and is a<strong> rare </strong>condition apparently<strong> beneficial to health.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Tangier disease</strong> by its classic presentation of<strong> orange-yellow tonsillar hypertrophy, neuropathy, and low HDL levels.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Lippincott 7/e: P 236</span></strong></span></span></p>",
    "correct_choice_id": 36024,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "ImageBased",
      "TreatmentBased"
    ]
  },
  {
    "id": 9016,
    "choices": [
      {
        "id": 36031,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A and R both are right but R is not the correct explanation of A</span></span></span></p>"
      },
      {
        "id": 36032,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A is wrong but R is a right statement</span></span></span></p>"
      },
      {
        "id": 36033,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A and R both are wrong </span></span></span></p>"
      },
      {
        "id": 36034,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A as well as R is right, and R is a correct explanation of A</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Assertion (A):</span></u></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Lecithin cholesterol acyl transferase (LCAT) deficiency leads to accumulation of nascent/discoidal HDL particles in the blood.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong><u>Reasoning (R):</u>&nbsp;</strong>LCAT is responsible for efflux of cholesterol from the membrane to&nbsp;&nbsp;&nbsp; the lipoprotein of low cholesterol HDL<sub>3</sub>, discoidal HDL or pre-beta HDL.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">What is the relationship between her condition and the role of LCAT?</span></span></span></p>",
    "unique_key": "Q6533816",
    "question_audio": null,
    "question_video": null,
    "map_id": 30322,
    "difficulty_level": "intermediate",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A as well as R is right, and R is a correct explanation of A</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>free cholesterol </strong>derived from <strong>peripheral tissue cells</strong> are taken up by <strong>HDL. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>apo A-l </strong>of HDL activates <strong>LCAT </strong>(lecithin cholesterol acyl transferase) in the plasma and<strong> LCAT binds to HDL disc. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>cholesterol from the cell</strong> is transferred to<strong> HDL</strong> by a <strong>cholesterol efflux regulator protein </strong>which is an <strong>ABC protein.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/18/screenshot-2024-04-18-174018.png\" style=\"height:359px; width:500px\" /></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>LCAT</strong> is an enzyme that <strong>esterifies cholesterol</strong> on <strong>high-density lipoprotein (HDL) </strong>particles, <strong>transforming</strong> them from their <strong>nascent,</strong> <strong>discoidal form into spherical mature HDL.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper&rsquo;s Illustrated Biochemistry, 30 /e, p 258-259.</span></strong></span></span></p>",
    "correct_choice_id": 36034,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 9031,
    "choices": [
      {
        "id": 36091,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">A and R both are wrong</span></p>"
      },
      {
        "id": 36092,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">A as well as R are right and R is a correct explanation of A</span></p>"
      },
      {
        "id": 36093,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">A is wrong but R is a right statement</span></p>"
      },
      {
        "id": 36094,
        "text": "<p><span style=\"font-size:12pt;\">A and R both are right but R is not the correct explanation of A</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt;\">What is the relationship between this finding and the function of LCAT?</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Assertion (A): Excess cholesterol in the cell is esterified into cholesterol ester and is stored up there.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Reasoning (R): LCAT converts free cholesterol to the cholesterol ester and plays a major role in reverse cholesterol transport.</span></p>",
    "unique_key": "Q5855937",
    "question_audio": null,
    "question_video": null,
    "map_id": 30325,
    "difficulty_level": "difficult",
    "subjects_id": [
      1
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D. A and R both are right but R is not the correct explanation of A</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\"><strong>Assertion (A)</strong> is <strong>correct</strong> \u2014 <strong>excess intracellular cholesterol</strong> is esterified and stored in the <strong>cholesterol pool</strong> within cells. This esterification allows for non-toxic storage of cholesterol in lipid droplets.</span></li><li><span style=\"font-size:12.0pt;\">However, the <strong>enzyme responsible for this process is ACAT (Acyl-CoA:cholesterol acyltransferase)</strong>, which is <strong>intracellular</strong>, not LCAT.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Reason (R)</strong> is also <strong>correct</strong> \u2014 <strong>LCAT (Lecithin:cholesterol acyltransferase)</strong> is a <strong>plasma enzyme</strong> bound to <strong>HDL</strong>, and it converts <strong>free cholesterol</strong> (acquired from peripheral tissues) into <strong>cholesterol esters</strong> as part of <strong>reverse cholesterol transport</strong>, allowing HDL to carry cholesterol back to the liver.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Why R is not the correct explanation of A:</strong></span></p><p><span style=\"font-size:12.0pt;\">LCAT esterifies <strong>plasma cholesterol</strong> during transport on <strong>HDL</strong>, not cholesterol in the <strong>intracellular cholesterol pool</strong>, which is the focus of A. The <strong>esterification of cholesterol for storage inside cells</strong> is performed by <strong>ACAT</strong>, not LCAT.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:12.0pt;\">Differentiate between the roles of <strong>LCAT</strong> and <strong>ACAT</strong>:</span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\"><strong>LCAT</strong>: Acts in <strong>plasma</strong>, facilitates <strong>reverse cholesterol transport</strong>, esterifies <strong>free cholesterol on HDL</strong>.</span></li><li><span style=\"font-size:12.0pt;\"><strong>ACAT</strong>: Acts <strong>inside cells</strong>, esterifies <strong>intracellular cholesterol for storage</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref</strong>: Harper 30/e page 259.</span></p>",
    "correct_choice_id": 36094,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "TreatmentBased"
    ]
  },
  {
    "id": 9182,
    "choices": [
      {
        "id": 36695,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Thiamine</span></span></span></p>"
      },
      {
        "id": 36696,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Guanidinoacetate</span></span></span></p>"
      },
      {
        "id": 36697,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dietary Choline</span></span></span></p>"
      },
      {
        "id": 36698,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dimethyl propionate</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 50-year-old obese man presents to his family physician with a recent diagnosis of nonalcoholic fatty liver disease (NAFLD). He is seeking advice on dietary modifications and supplements that could help prevent the progression of his liver condition. The physician reviews his diet and nutritional intake to identify any deficiencies that could be contributing to his fatty liver?</span></span></span></p>",
    "unique_key": "Q2951088",
    "question_audio": null,
    "question_video": null,
    "map_id": 30334,
    "difficulty_level": "intermediate",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dietary Choline</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Choline </strong>is essential for the <strong>synthesis of phosphatidylcholine, </strong>a key component of <strong>very-low-density lipoprotein (VLDL), </strong>which is necessary for the <strong>transport of fats out of the liver</strong>. A <strong>deficiency </strong>in <strong>choline </strong>can contribute to <strong>fat accumulation in the liver. </strong>Thus, <strong>adequate dietary </strong>intake of <strong>choline </strong>can help <strong>prevent </strong>and possibly <strong>ameliorate fatty liver</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Calibri, sans-serif\"><span style=\"font-size:16px\"><strong>Other Options:</strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Thiamine</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: While thiamine is important for general metabolism, there&#39;s <strong>no direct evidence </strong>that <strong>thiamine supplementation </strong>alone would <strong>prevent fatty liver</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Guanidinoacetate</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This is a <strong>precursor to creatine </strong>and does <strong>not </strong>have a direct role in the <strong>prevention of fatty liver.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: Dimethyl propionate</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This is <strong>not </strong>a recognized <strong>treatment or preventive measure for fatty liver</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Lipotropic factors </strong>can <strong>reverse </strong>the effects of<strong> fatty liver</strong>. It includes <strong>Betaine, B12, Choline, Methionine, Inositol, Lecithin, Folic acid, Glycine, Serine.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e, p 261</span></strong></span></span></p>",
    "correct_choice_id": 36697,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "TreatmentBased"
    ]
  },
  {
    "id": 9069,
    "choices": [
      {
        "id": 36243,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">CPS&ndash;I</span></span></span></p>"
      },
      {
        "id": 36244,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hormone sensitive lipase</span></span></span></p>"
      },
      {
        "id": 36245,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glycogen Phosphorylase</span></span></span></p>"
      },
      {
        "id": 36246,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acetyl CoA carboxylase</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A research team studying metabolic responses to nutrient deprivation measures enzymatic activities in subjects after a 24-hour fast. They aim to determine which enzyme associated with lipid metabolism shows decreased activity in this energy-conserving state. Which enzyme is the research team least likely to find elevated in the fasting state?</span></span></span></p>",
    "unique_key": "Q4108234",
    "question_audio": null,
    "question_video": null,
    "map_id": 30329,
    "difficulty_level": "intermediate",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D)&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acetyl CoA carboxylase</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Phosphorylation inactivates acetyl CoA carboxylase. </strong>Thus, <strong>AMP activated kinase </strong>(AMPK) <strong>phosphorylates acetyl CoA carboxylase </strong>and <strong>inactivates </strong>it</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>ATP inhibits AMPK</strong>, hence <strong>fatty acid synthesis </strong>is <strong>increased </strong>in a <strong>well-fed state</strong>.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Fatty acid synthesis decreases </strong>in <strong>fasting state</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>This </strong>enzyme is <strong>inhibited </strong>by <strong>palmitoyl CoA</strong>, the <strong>end </strong>product of <strong>fatty acid synthesis</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Dephosphorylation of Acetyl CoA carboxylase </strong>is effected by <strong>protein phosphatase 1</strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Calibri, sans-serif\"><span style=\"font-size:16px\"><strong><u>Other Options:</u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: CPS&ndash;I</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:<strong> Carbamoyl phosphate synthetase I</strong> is an enzyme in the <strong>urea cycle, </strong>which may have <strong>increased </strong>activity during<strong> fasting</strong> due to the breakdown of<strong> amino acids for gluconeogenesis</strong>, resulting in <strong>excess nitrogen</strong> that needs to be<strong> excreted as urea.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Hormone-sensitive lipase</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This enzyme is responsible for<strong> breaking down stored triglycerides </strong>in adipose tissue into <strong>free</strong> <strong>fatty acids and glycerol</strong>, which is <strong>upregulated</strong> during <strong>fasting to provide energy.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Glycogen Phosphorylase</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This enzyme <strong>breaks down glycogen</strong> into <strong>glucose-1-phosphate</strong>, which is then converted to <strong>glucose-6-phosphate for gluconeogenesis</strong> or <strong>energy production,</strong> and is thus <strong>upregulated</strong> during <strong>fasting.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>During fasting</strong>, the body <strong>downregulates </strong>enzymes involved in <strong>synthesizing storage </strong>compounds, such as <strong>acetyl CoA carboxylase, </strong>while <strong>upregulating enzymes</strong> that <strong>facilitate</strong> the mobilization of<strong> stored nutrients, </strong>like<strong> hormone-sensitive lipase</strong> and <strong>glycogen phosphorylase.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e:&nbsp; p 238</span></strong></span></span></p>",
    "correct_choice_id": 36246,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "TreatmentBased"
    ]
  },
  {
    "id": 9102,
    "choices": [
      {
        "id": 36375,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is synthesized from lysine and methionine in liver and kidney</span></span></span></p>"
      },
      {
        "id": 36376,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is chemically Beta-hydroxy Gamma-Trimethyl amino butyrate</span></span></span></p>"
      },
      {
        "id": 36377,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is a transporter for short chain fatty acids</span></span></span></p>"
      },
      {
        "id": 36378,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Vitamin B12 is essential for its synthesis</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In a pediatric clinic, a teenage girl presents with complaints of fatigue and muscle weakness. After conducting lab tests, the diagnosis points towards a carnitine deficiency. The attending physician explains to the girl and her parents about carnitine&#39;s role and its characteristics. Which of the following statements about carnitine is correct?</span></span></span></p>",
    "unique_key": "Q4190379",
    "question_audio": null,
    "question_video": null,
    "map_id": 30330,
    "difficulty_level": "difficult",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) It is synthesized from lysine and methionine in the liver and kidney. </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Options A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Long-chain acyl-CoA</strong> (or FFA) <strong>cannot</strong> penetrate the <strong>inner membrane of mitochondria, </strong>So has to be<strong> carried by carnitine</strong> <strong>transporter</strong> <strong>(option C).</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Carnitine</strong> is synthesized in the<strong> liver and kidneys </strong>from <strong>lysine and methionine.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Vitamin C (ascorbic acid)</strong> is essential for the<strong> synthesis of carnitine</strong> <strong>(option D).</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">During <strong>growth or pregnancy,</strong> the requirement of<strong> carnitine </strong>might<strong> exceed its natural production</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. It is chemically Beta-hydroxy Gamma-Trimethyl amino butyrate</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This statement is a <strong>correct</strong> description of the<strong> chemical</strong> <strong>structure of carnitine</strong>, indicating that this option could also be considered<strong> correct.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. It is a transporter for short chain fatty acids</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: <strong>Carnitine</strong> primarily<strong> facilitates</strong> the transport of <strong>long-chain fatty acids</strong> into <strong>mitochondria for oxidation</strong>,<strong> not</strong> short-chain fatty acids.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Vitamin B12 is essential for its synthesis</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: While <strong>vitamin B12 </strong>is essential for many <strong>metabolic processes</strong>, it is <strong>not</strong> directly involved in the <strong>synthesis of carnitine</strong>. The <strong>synthesis of carnitine</strong> requires <strong>lysine, methionine, and other cofactors like vitamin C,</strong> but <strong>not vitamin B12.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Carnitine, synthesized from lysine and methionine in the liver and kidneys</strong>, is essential for the<strong> transport of long-chain fatty acids</strong> into <strong>mitochondria for &beta;-oxidation</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper30/e pg 224, Vasudevan 9/ed:p202</span></strong></span></span></p>",
    "correct_choice_id": 36375,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "TreatmentBased"
    ]
  },
  {
    "id": 9097,
    "choices": [
      {
        "id": 36355,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glucose-6-phosphate dehydrogenase</span></span></span></p>"
      },
      {
        "id": 36356,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">6-phosphogluconate dehydrogenase</span></span></span></p>"
      },
      {
        "id": 36357,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cytoplasmic malate dehydrogenase</span></span></span></p>"
      },
      {
        "id": 36358,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Malic enzyme</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sources of NADPH for fatty acid synthesis include all the following reactions, except:</span></span></span></p>",
    "unique_key": "Q2807703",
    "question_audio": null,
    "question_video": null,
    "map_id": 30328,
    "difficulty_level": "difficult",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cytoplasmic malate dehydrogenase</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This <strong>enzyme converts oxaloacetate to malate</strong> &amp;<strong> utilizes one NADH</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The<strong> co-enzyme </strong>utilized for <strong>de novo synthesis of fatty acid</strong> is <strong>NADPH. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>sources </strong>of&nbsp; <strong>NADPH for fatty acid synthesis </strong>are:</span></span></span>\r\n\t<ul>\r\n\t\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Pentose Phosphate Pathway</strong> (<strong>Glucose-6-phosphate dehydrogenase, 6-phosphogluconate dehydrogenase).</strong></span></span></span></li>\r\n\t\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Malic enzyme</strong> (Converts<strong> Malate to Pyruvate</strong>)</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Glucose-6-phosphate dehydrogenase</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This enzyme is the <strong>first in the pentose phosphate pathway </strong>and is a<strong> major source </strong>of <strong>NADPH for fatty acid synthesis</strong> by oxidizing<strong> glucose-6-phosphate to 6-phosphogluconolactone.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: 6-phosphogluconate dehydrogenase</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Also part of the<strong> pentose phosphate pathway,</strong> this enzyme further contributes to <strong>NADPH production </strong>by oxidizing<strong> 6-phosphogluconate to ribulose-5-phosphate.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: Malic enzyme</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This enzyme catalyzes the<strong> decarboxylation of malate to pyruvate,</strong> producing <strong>NADPH </strong>in the process, and serves as an <strong>additional source of NADPH for fatty acid synthesis.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Cytoplasmic malate dehydrogenase </strong>is<strong> not</strong> a source of<strong> NADPH for fatty acid synthesis,</strong> unlike <strong>glucose-6-phosphate dehydrogenase</strong>, <strong>6-phosphogluconate dehydrogenase</strong>, and the <strong>malic enzyme,</strong> which all contribute to<strong> NADPH production</strong> in the<strong> cytoplasm </strong>for <strong>biosynthetic </strong>processes such as<strong> fatty acid synthesis.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">: DM Vasudevan 9/e: p 159.</span></strong></span></span></p>",
    "correct_choice_id": 36357,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 9064,
    "choices": [
      {
        "id": 36223,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A and R both are right but R is not the correct explanation of A</span></span></span></p>"
      },
      {
        "id": 36224,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A is wrong but R is a right statement</span></span></span></p>"
      },
      {
        "id": 36225,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A as well as R are right, and R is a correct explanation of A</span></span></span></p>"
      },
      {
        "id": 36226,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A and R both are wrong</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Assertion (A):</span></u></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> In well-fed state, activity of acetyl CoA carboxylase activity is increased.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><br />\r\n<span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Reasoning (R):</span></u></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Citrate produced from acetyl CoA in well-fed state acts as an allosteric activator of acetyl CoA carboxylase:</span></span></span></p>",
    "unique_key": "Q6060131",
    "question_audio": null,
    "question_video": null,
    "map_id": 30327,
    "difficulty_level": "intermediate",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A as well as R are right, and R is a Correct explanation of A</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Acetyl-CoA carboxylase</strong> is an <strong>allosteric enzyme</strong> and is activated by <strong>citrate, </strong>which <strong>increases </strong>in concentration in a <strong>well-fed state </strong>and is also an <strong>indicator of a plentiful supply of acetyl-CoA.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Citrate </strong>favours <strong>conversion </strong>of the enzyme from an <strong>inactive dimer to an active polymeric form</strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/10/picture22_WBxHtRE.jpg\" style=\"height:339px; width:602px\" /></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Inactivation </strong>is by <strong>phosphorylation </strong>of the enzyme and by<strong> long-chain acyl-CoA </strong>molecules such as <strong>palmitoyl CoA </strong>using <strong>feedback inhibition </strong>and <strong>inhibition </strong>of <strong>citrate transport from mitochondria to cytosol</strong>.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Acetyl CoA carboxylase </strong>is an enzyme crucial in <strong>fatty acid synthesis. </strong>In a <strong>well-fed state, </strong>the abundance of <strong>acetyl CoA </strong>leads to the production of <strong>citrate</strong>, which can be transported <strong>out </strong>of the <strong>mitochondria into the cytosol</strong>. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Citrate </strong>serves as an <strong>allosteric activator of acetyl CoA carboxylase</strong>, <strong>increasing </strong>its <strong>activity. </strong>This<strong> upregulation </strong>is consistent with the <strong>body&#39;s shift toward anabolic processes</strong>, like <strong>fatty acid synthesis</strong>, when there is a <strong>surplus of energy</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e: p 237-238</span></strong></span></span></p>",
    "correct_choice_id": 36225,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 9077,
    "choices": [
      {
        "id": 36275,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fatty acid synthesis</span></span></span></p>"
      },
      {
        "id": 36276,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ketone synthesis</span></span></span></p>"
      },
      {
        "id": 36277,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Gluconeogenesis</span></span></span></p>"
      },
      {
        "id": 36278,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glycolysis</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Identify the metabolic pathway that specifically utilizes NADPH as a reducing agent?</span></span></span></p>",
    "unique_key": "Q4609977",
    "question_audio": null,
    "question_video": null,
    "map_id": 30331,
    "difficulty_level": "intermediate",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;Ans. A) Fatty acid synthesis</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>NADPH</strong> provides the <strong>reducing equivalents</strong> necessary for the <strong>biosynthesis of fatty acids. </strong>It is used in the <strong>reductive reactions</strong> of the <strong>fatty acid synthesis</strong> pathway, such as the<strong> conversion</strong> of<strong> acetoacetyl-ACP to malonyl-ACP</strong>, and is a<strong> critical factor</strong> in the <strong>synthesis </strong>of <strong>new fatty acid molecules.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:16px\"><strong>Other Options:</strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Ketone synthesis</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This process takes place <strong>predominantly</strong> in the <strong>mitochondria of liver cells</strong> during periods of <strong>carbohydrate</strong> scarcity and <strong>does not </strong>primarily use<strong> NADPH.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Gluconeogenesis</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This is the pathway by which <strong>glucose is synthesized</strong> from <strong>non-carbohydrate precursors</strong>, and it<strong> does not</strong> typically involve <strong>NADPH.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: Glycolysis</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This is the <strong>metabolic pathway</strong> that <strong>breaks down glucose to pyruvate, </strong>generating <strong>ATP and NADH, not</strong> utilizing <strong>NADPH.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fatty acid synthesis require Cofactors like:&nbsp;NADPH, ATP, Mn<sup>2+</sup> , HCO<sub>3</sub><sup>-</sup> , Biotin</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/ed ,p 232</span></strong></span></span></p>",
    "correct_choice_id": 36275,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "TreatmentBased"
    ]
  },
  {
    "id": 9081,
    "choices": [
      {
        "id": 36291,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">ATP</span></span></span></p>"
      },
      {
        "id": 36292,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">NADPH</span></span></span></p>"
      },
      {
        "id": 36293,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">FADH<sub>2</sub></span></span></span></p>"
      },
      {
        "id": 36294,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">HCO<sub>3</sub><sup>-</sup></span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Identify which of the following is not utilized in the synthesis of fatty acids:</span></span></span></p>",
    "unique_key": "Q2847135",
    "question_audio": null,
    "question_video": null,
    "map_id": 30332,
    "difficulty_level": "intermediate",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">FADH<sub>2</sub></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>FADH2 </strong>is a <strong>reduced form</strong> of<strong> flavin adenine dinucleotide </strong>that is primarily involved as an<strong> electron carrier</strong> in the<strong> mitochondrial electron</strong> <strong>transport chain</strong> to produce<strong> ATP. </strong>It is <strong>not</strong> used as a <strong>direct substrate or cofactor </strong>in the <strong>biosynthetic pathway of fatty acids.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:16px\"><strong>Other Options:</strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: ATP</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: ATP provides the <strong>energy</strong> necessary for the activation of <strong>acetyl-CoA to malonyl-CoA</strong> in the <strong>first step</strong> of<strong> fatty acid</strong> <strong>synthesis.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: NADPH</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: <strong>NADPH</strong> is a <strong>reducing agent</strong> that <strong>donates electrons </strong>in the<strong> reductive biosynthetic </strong>steps of <strong>fatty acid synthesis.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: HCO3- (bicarbonate)</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Bicarbonate serves as a source of the<strong> carboxyl group </strong>in the <strong>conversion</strong> of<strong> acetyl-CoA to malonyl-CoA</strong> by <strong>acetyl-CoA carboxylase</strong> during <strong>fatty acid synthesis.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Two major enzyme complexes</strong> are involved in the <strong>synthesis of fatty acids. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>first</strong> is <strong>acetyl-CoA carboxylase</strong>, which <strong>synthesizes malonyl-CoA </strong>by&nbsp; the&nbsp; steps shown<strong> below</strong> for the <strong>synthesis of</strong> <strong>palmitate:</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>7 acetyl-CoA</strong> + 7 <strong>HCO<sub>3</sub></strong><sup>- </sup>+ 7 <strong>ATP</strong> </span><em><span style=\"font-family:&quot;Cambria Math&quot;,serif\">&rarr;</span></em></span></span><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;<strong>7 malonyl-CoA + 7 ADP + 7 P<sub>i</sub></strong> </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Using the <strong>malonyl-CoA, palmitate</strong> is then <strong>synthesized</strong> by <strong>seven cycles</strong> of the <strong>fatty acid synthetase complex, </strong>whose <strong>stoichiometry</strong> is summarized <strong>below:</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">acetyl-CoA + 7 malonyl-CoA + 14 NADPH </span></strong><em><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Cambria Math&quot;,serif\">&rarr;</span></em></span></span><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;<strong>palmitate + 7 CO<sub>2</sub> +14 NAD<sup>+ </sup>+ 8 CoA + 6 H<sub>2</sub>O</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">As can be seen from the equations above, the <strong>necessary amount of malonyl-CoA </strong>is<strong> synthesized.</strong> <strong>Palmitate</strong> is subsequently <strong>synthesized from malonyl-CoA </strong>and <strong>one initial acetyl-CoA.</strong> Thus, <strong>acetyl-CoA, NADPH, ATP, and HCO<sub>3</sub><sup>- </sup>are all necessary in this process.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref:</span></u></strong><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"> DM Vasudevan 9/e: p 156-160</span></strong></span></span></p>",
    "correct_choice_id": 36293,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 9085,
    "choices": [
      {
        "id": 36307,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Endoplasmic reticulum</span></span></span></p>"
      },
      {
        "id": 36308,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Golgi body</span></span></span></p>"
      },
      {
        "id": 36309,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lysosomes</span></span></span></p>"
      },
      {
        "id": 36310,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ribosomes</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In a laboratory studying cellular lipid metabolism, scientists are investigating the enzymatic pathways responsible for fatty acid modification. A particular focus is on understanding where in the cell long-chain fatty acids undergo elongation to produce extended lipid species. Which organelle is central to this process?</span></span></span></p>",
    "unique_key": "Q3625979",
    "question_audio": null,
    "question_video": null,
    "map_id": 30333,
    "difficulty_level": "intermediate",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Endoplasmic reticulum</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The<strong> endoplasmic reticulum</strong> is the key <strong>organelle </strong>involved in the <strong>elongation of long-chain fatty acids</strong>. This<strong> process</strong> is crucial for the <strong>synthesis of various complex lipids</strong> that are <strong>integral to cellular membranes</strong> and<strong> signaling pathways.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:16px\"><strong>Other Options:</strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Golgi body</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: The Golgi apparatus is primarily involved in the <strong>modification, sorting, and packaging of proteins</strong> and <strong>lipids for</strong> <strong>secretion or use within the cell</strong>. It is<strong> not directly</strong> involved in the <strong>elongation of fatty acids.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Lysosomes</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Lysosomes are <strong>organelles</strong> that contain <strong>digestive enzymes</strong> used for<strong> breaking down </strong>various <strong>biomolecules</strong>, <strong>cellular debris, and foreign pathogens.</strong> They are <strong>not </strong>involved in the <strong>synthesis or elongation of fatty acids.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: Ribosomes</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Ribosomes are the <strong>cellular structures</strong> responsible for <strong>protein synthesis,</strong> <strong>translating mRNA </strong>into <strong>polypeptide</strong> <strong>chains</strong>. They <strong>do not</strong> participate in<strong> fatty acid elongation or lipid metabolism directly.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>Microsomal system (microsomal fatty acid elongase system)</strong> <strong>elongates saturated or unsaturated fatty acyl CoA </strong>by addition of <strong>two-carbon units</strong> successively. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Donor</strong> of <strong>2 carbon</strong> <strong>acetyl groups: Malonyl CoA. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><strong><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">NADPH </span></span></span></strong><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is needed for the </span></span></span><strong><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">reaction. </span></span></span></strong></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This system can<strong> elongate FA having 10C units</strong> onwards<strong> up to</strong> the length of <strong>22 or 24C.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">: DM Vasudevan 9/e: p 186</span></strong></span></span></p>",
    "correct_choice_id": 36307,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 9094,
    "choices": [
      {
        "id": 36343,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">TRUE</span></span></span></p>"
      },
      {
        "id": 36344,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">FALSE</span></span></span></p>"
      },
      {
        "id": 36345,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">True/False </span></span></span></p>"
      },
      {
        "id": 36346,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">None of the above</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fatty acid synthesis occurs outside the mitochondria. Is this statement true or false?</span></span></span></p>",
    "unique_key": "Q8275486",
    "question_audio": null,
    "question_video": null,
    "map_id": 30326,
    "difficulty_level": "beginner",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">TRUE </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Fatty acid synthesis</strong> is indeed an <strong>extra-mitochondrial process, primarily </strong>occurring in the<strong> cytoplasm </strong>of cells. The cytoplasm houses the necessary enzymes for the<strong> de novo synthesis of fatty acids</strong>, <strong>distinguishing</strong> this <strong>pathway from mitochondrial processes </strong>like <strong>fatty</strong> <strong>acid oxidation.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Fatty acids</strong> are <strong>synthesized </strong>mainly by a <strong>de novo synthetic pathway</strong> operating in <strong>cytoplasm</strong>. So, it is referred to as an <strong>extramitochondrial or cytoplasmic fatty acid synthase system.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">: DM Vasudevan 9/e: p 156</span></strong></span></span></p>",
    "correct_choice_id": 36343,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "TreatmentBased"
    ]
  },
  {
    "id": 9214,
    "choices": [
      {
        "id": 36823,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Coenzyme A</span></span></span></p>"
      },
      {
        "id": 36824,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Beta-carotene</span></span></span></p>"
      },
      {
        "id": 36825,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Beta-hydroxybutyrate</span></span></span></p>"
      },
      {
        "id": 36826,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Apoprotein</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 35-year-old man has been observing a fast as part of a cultural festival for several days. Despite significantly reduced food intake, he surprisingly reports feeling mentally alert and does not experience any dizziness or significant discomfort typically associated with low blood sugar levels. Intrigued by this adaptation, he visits a healthcare provider for a routine check-up. The provider explains how the body adapts to prolonged fasting by utilizing alternative energy sources to maintain brain function and overall metabolism:</span></span></span></p>",
    "unique_key": "Q3294753",
    "question_audio": null,
    "question_video": null,
    "map_id": 30033,
    "difficulty_level": "beginner",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. C)</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Beta-hydroxybutyrate.</strong> </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Ketone bodies</strong> include <strong>acetoacetate, beta-hydroxybutyrate and acetone,</strong> which are produced by the <strong>liver in the fasting</strong> state by<strong> beta-oxidation of fatty acids.</strong>&nbsp; </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Then these <strong>ketone bodies </strong>are released <strong>into</strong> the<strong> bloodstream</strong> &rarr;used as <strong>alternative energy</strong> sources for<strong> muscle, kidney,</strong> <strong>and brain</strong>.&nbsp; </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">But the<strong> brain</strong> specifically requires a <strong>small amount of circulating glucose</strong> to function and the<strong> amount required</strong> is <strong>reduced</strong> when<strong> ketone body </strong>sources are available.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:16px\"><strong>Other Options:</strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Coenzyme A:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> It is found in <strong>mitochondria</strong> and<strong> carries acetyl groups</strong> into the <strong>TCA cycle.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Beta-carotene:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> It is a<strong> vitamin </strong>with <strong>antioxidant properties.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: Apoprotein:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> It is<strong> one</strong> of the <strong>proteins</strong> that<strong> hold lipoproteins together.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">During <strong>prolonged fasting</strong>, the <strong>body shifts to ketosis</strong>, a <strong>metabolic state</strong> where it uses<strong> ketone bodies</strong> as an <strong>alternative energy source.</strong> <strong>Beta-hydroxybutyrate</strong> is one of the <strong>primary ketone bodies</strong> produced by the <strong>liver from fatty acids</strong> in the <strong>absence </strong>of sufficient <strong>glucose.</strong> The <strong>brain can utilize beta-hydroxybutyrate</strong> efficiently in place of <strong>glucose,</strong> allowing for <strong>sustained</strong> <strong>cognitive function</strong> and <strong>energy levels</strong> despite <strong>low blood glucose.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e: p 148-149.</span></strong></span></span></p>",
    "correct_choice_id": 36825,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "TreatmentBased"
    ]
  },
  {
    "id": 6409,
    "choices": [
      {
        "id": 25605,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Gluconeogenesis</span></span></span></p>"
      },
      {
        "id": 25606,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Free fatty acid breakdown</span></span></span></p>"
      },
      {
        "id": 25607,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glycogenolysis</span></span></span></p>"
      },
      {
        "id": 25608,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Triglyceride breakdown</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 10-year-old girl presents to the emergency department with severe polyuria and polydipsia. Laboratory tests reveal the presence of ketones in her urine. Considering the metabolic conditions, which is the most likely source of these ketones?</span></span></span></p>",
    "unique_key": "Q2131992",
    "question_audio": null,
    "question_video": null,
    "map_id": 30029,
    "difficulty_level": "beginner",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Free fatty acid breakdown &nbsp;&nbsp; &nbsp;&nbsp;</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\">&nbsp;<strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>presenting features </strong>are suggestive of <strong>type 1 diabetes.&nbsp; </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The primary source of<strong> ketones is free fatty acid breakdown.&nbsp; </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Ketone body formation </strong>occurs as follows:<strong> Insulin deficiency</strong> &rarr; <strong>activated lipolysis</strong> &rarr; <strong>increased plasma free fatty acids</strong>&nbsp; &rarr; <strong>increased hepatic fatty acids</strong> &rarr; accelerated<strong> ketogenesis </strong>&rarr; <strong>ketosis</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Calibri, sans-serif\"><span style=\"font-size:16px\"><strong><u>other options:</u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Gluconeogenesis:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> While <strong>gluconeogenesis</strong> involves the production of <strong>glucose</strong> from <strong>non-carbohydrate sources,</strong> it<strong> does not</strong> directly lead to<strong> ketone production.</strong> It is a<strong> glucose-</strong>generating process that occurs in the<strong> liver and kidneys.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Glycogenolysis:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This process involves the <strong>breakdown of glycogen stored </strong>in the <strong>liver</strong> and<strong> muscle</strong> into <strong>glucose. </strong>Glycogenolysis<strong> does not</strong> directly result in <strong>ketone production</strong>; instead, it provides an <strong>immediate source of glucose.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Triglyceride breakdown:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Triglyceride breakdown in <strong>adipose tissue </strong>leads to the release of<strong> glycerol and free fatty acids</strong>. While the<strong> breakdown of triglycerides </strong>initiates the <strong>release of fatty acids</strong>, it is the<strong> subsequent &beta;-oxidation</strong> of these<strong> fatty acids</strong> in the <strong>liver </strong>that leads <strong>directly to ketone production</strong>. Therefore, <strong>&quot;free fatty acid breakdown&quot;</strong> is a<strong> more specific</strong> answer in the context of<strong> ketone production.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Ketone bodies</strong> are produced primarily in the<strong> live</strong>r through the process of <strong>ketogenesis,</strong> which occurs when there is an<strong> increased breakdown of free fatty acids</strong>. This situation typically arises in states of<strong> decreased carbohydrate </strong>availability or<strong> impaired glucose utilization,</strong> leading the <strong>body to switch to fat </strong>as an <strong>alternative energy source</strong>. In this patient&#39;s case, the <strong>presence</strong> of <strong>ketones in the urine</strong> suggests that her<strong> body is utilizing fatty acids for energy,</strong> which results in the production of <strong>ketones </strong>as a <strong>byproduct of fatty acid metabolism in the liver.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e: p 231-233</span></strong></span></span></p>",
    "correct_choice_id": 25606,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 6441,
    "choices": [
      {
        "id": 25733,
        "text": "<p><span style=\"font-size:12.0pt;\">Diabetic ketoacidosis</span></p>"
      },
      {
        "id": 25734,
        "text": "<p><span style=\"font-size:12.0pt;\">Uncontrolled diabetes</span></p>"
      },
      {
        "id": 25735,
        "text": "<p><span style=\"font-size:12.0pt;\">Lactic acidosis</span></p>"
      },
      {
        "id": 25736,
        "text": "<p><span style=\"font-size:12.0pt;\">Diabetes insipidus</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt;\">A 45-year-old woman was brought to the hospital in a disoriented, confused state by her husband. She is a known case of type 1 diabetes for the last 25 years. O/E \u2013she had signs of dehydration, Low BP and acidosis with faintly fruity odour. The diagnosis is:</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/04/picture3_QNkydRl.jpg\" alt=\"\" width=\"700\" height=\"391\"></span></p>",
    "unique_key": "Q1797932",
    "question_audio": null,
    "question_video": null,
    "map_id": 30030,
    "difficulty_level": "beginner",
    "subjects_id": [
      1
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Diabetic ketoacidosis&nbsp;</strong></span></p><p><span style=\"font-size:12.0pt;\"><strong>&nbsp;</strong></span></p><p><span style=\"font-size:12.0pt;\"><strong>Option A:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">This patient presents with classic signs and symptoms of diabetic ketoacidosis (DKA): altered mental status, dehydration, hypotension, metabolic acidosis, and the characteristic fruity odor of acetone on her breath.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Treatment:&nbsp;</span></p><p><span style=\"font-size:12.0pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\">The patient Should be rehydrated with normal saline given intravenously (IV) and insulin IV.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Blood glucose, ketone bodies and electrolytes should be measured periodically.&nbsp;</span></p><p><span style=\"font-size:12.0pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\"><strong><u>Explanation</u></strong>:</span></p><p><span style=\"font-size:12.0pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Uncontrolled diabetes</strong>: While the patient does have diabetes, the specific presentation with acidosis, ketonemia, and the clinical context suggest DKA rather than just uncontrolled diabetes.</span></p><p><span style=\"font-size:12.0pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Lactic acidosis</strong>: Lactic acidosis presents with acidosis but is typically associated with severe hypoperfusion or hypoxia, and the ketone levels would not be elevated as they are in this case.</span></p><p><span style=\"font-size:12.0pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Diabetes insipidus</strong>: Diabetes insipidus is characterized by polyuria and polydipsia due to a deficiency of antidiuretic hormone (ADH) or kidney's response to ADH, but it does not cause hyperglycemia, acidosis, or ketonemia.</span></p><p><span style=\"font-size:12.0pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\"><strong><u>Educational Objective:</u></strong></span></p><p><span style=\"font-size:12.0pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\">Diabetic ketoacidosis is an acute, potentially life-threatening complication of diabetes characterized by hyperglycemia, ketosis, and metabolic acidosis. Clinical presentation typically includes dehydration, Kussmaul breathing, fruity breath odor (acetone), altered mental status, and hypotension.&nbsp;</span></p><p><span style=\"font-size:12.0pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\"><strong>Ref</strong>: Harper 30/e: p 231.</span></p>",
    "correct_choice_id": 25733,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "ImageBased"
    ]
  },
  {
    "id": 9195,
    "choices": [
      {
        "id": 36747,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ketonemia</span></span></span></p>"
      },
      {
        "id": 36748,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ketonuria</span></span></span></p>"
      },
      {
        "id": 36749,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Smell of acetone</span></span></span></p>"
      },
      {
        "id": 36750,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">All the above</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 29-year-old woman embarks on a ketogenic diet as part of a weight loss plan. After a few weeks, she notices some symptoms and decides to consult her family physician. The healthcare provider explains the physiological state her body is in due to the high-fat, low-carbohydrate diet and discusses the signs and implications of this metabolic state:</span></span></span></p>",
    "unique_key": "Q9281871",
    "question_audio": null,
    "question_video": null,
    "map_id": 30031,
    "difficulty_level": "beginner",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) All the above</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Normally the <strong>rate of synthesis </strong>of <strong>ketone bodies </strong>by the <strong>liver </strong>is <strong>well </strong>balanced by their metabolism by <strong>extrahepatic tissues </strong>&rarr; causes <strong>blood level of ketone bodies </strong>&lt;&lt; <strong>1 mg/dL </strong>and only <strong>traces </strong>are <strong>excreted in urine</strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/11/10.jpg\" style=\"height:472px; width:602px\" /></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">When the <strong>rate of synthesis </strong>exceeds the <strong>ability of utilization </strong>&rarr;&nbsp;accumulation of <strong>ketone bodies in blood </strong>(<strong>Ketonemia</strong>), <strong>excretion </strong>in <strong>urine </strong>(<strong>ketonuria</strong>) and smell of <strong>acetone </strong>in <strong>breath. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>All these three </strong>constitute together to form <strong>ketosis</strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:16px\"><strong>Other Options:</strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Ketonemia</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This term refers to the<strong> presence of ketone bodies </strong>in the <strong>blood</strong>. It is one of the <strong>hallmark signs of ketosis</strong>, indicating that the body is <strong>using ketones </strong>as an <strong>alternative energy </strong>source due to <strong>low glucose availability or utilization.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Ketonuria</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Ketonuria denotes the <strong>excretion </strong>of <strong>ketone bodies </strong>in the <strong>urine</strong>. It&#39;s a <strong>direct </strong>result of <strong>ketonemia; </strong>when <strong>ketone </strong>levels in the <strong>blood rise</strong>, the <strong>kidneys filter </strong>some of these <strong>ketones out</strong>, which then <strong>appear </strong>in the <strong>urine</strong>. It&#39;s often used as a <strong>diagnostic indicator for ketosis.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Smell of acetone</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: <strong>Acetone, </strong>one of the <strong>three </strong>primary <strong>ketone bodies </strong>(alongside <strong>acetoacetate and beta-hydroxybutyrate</strong>), can be <strong>exhaled </strong>in the <strong>breath </strong>when in <strong>ketosis</strong>, leading to a <strong>distinct fruity or nail polish </strong>remover-like <strong>smell</strong>. This is a common <strong>anecdotal </strong>marker of being in a<strong> state of ketosis,</strong> especially <strong>noted</strong> among<strong> individuals</strong> following a <strong>ketogenic diet.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Ketosis </strong>is characterized by <strong>elevated levels of ketone bodies</strong>, which can manifest as <strong>ketonemia </strong>(presence of ketones in the blood), <strong>ketonuria </strong>(presence of ketones in the urine), and a <strong>distinctive acetone smell </strong>in the breath. Understanding these manifestations provides insights into the <strong>body&#39;s metabolic state </strong>during <strong>carbohydrate restriction</strong>, <strong>fasting, or uncontrolled diabetes</strong>, highlighting the <strong>body&#39;s adaptive mechanisms </strong>to <strong>alternative energy sources</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">: DM Vasudevan 9/e: p 213</span></strong></span></span></p>",
    "correct_choice_id": 36750,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 9218,
    "choices": [
      {
        "id": 36839,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Brain</span></span></span></p>"
      },
      {
        "id": 36840,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Skeletal muscle </span></span></span></p>"
      },
      {
        "id": 36841,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">RBCs</span></span></span></p>"
      },
      {
        "id": 36842,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cardiac muscle</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is unable to utilize ketone bodies as an energy source?</span></span></span></p>",
    "unique_key": "Q1305671",
    "question_audio": null,
    "question_video": null,
    "map_id": 30028,
    "difficulty_level": "beginner",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">RBCs</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Red blood cells (RBCs) </strong>are <strong>unable </strong>to utilize <strong>ketone bodies </strong>due to the <strong>absence of mitochondria</strong>, where <strong>ketone bodies </strong>are converted into <strong>acetyl-CoA </strong>and then enter the <strong>citric acid cycle </strong>for <strong>energy production</strong>. <strong>RBCs </strong>rely solely on <strong>glycolysis </strong>for their <strong>energy needs</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:16px\"><strong>Other Options:</strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Brain</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: The brain can u<strong>tilize ketone bodies </strong>as an <strong>alternative energy source </strong>during prolonged <strong>fasting </strong>or <strong>carbohydrate restriction</strong>, after an <strong>adaptation period</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Skeletal muscle</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Skeletal muscles can use <strong>ketone bodies </strong>for <strong>energy</strong>, especially during <strong>prolonged periods of fasting </strong>or <strong>intense exercise </strong>when <strong>glucose </strong>availability is <strong>limited</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: Cardiac muscle</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: The heart can <strong>efficiently </strong>use <strong>ketone bodies </strong>as a <strong>fuel source</strong>, particularly in conditions where <strong>fatty acid oxidation </strong>is <strong>compromised </strong>or in the context of <strong>increased energy demand.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The<strong> ketone bodies </strong>are formed in the <strong>liver by mitochondrial enzyme thiolase </strong>and are utilized by <strong>extrahepatic tissues</strong> such as <strong>heart muscle</strong>, <strong>renal cortex, skeletal muscle,</strong> and <strong>brain</strong>, which prefer the<strong> ketone bodies </strong>as <strong>alternate sources </strong>of <strong>energy</strong>, if <strong>glucose </strong>is <strong>not </strong>available.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Ketone bodies </strong>are <strong>not </strong>utilised by<strong> RBCs </strong>due to the <strong>absence of mitochondria</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/ed ,pg 227 </span></span></strong><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\"> </span></strong></span></span></p>",
    "correct_choice_id": 36841,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 9231,
    "choices": [
      {
        "id": 36891,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">HMG CoA Synthase</span></span></span></p>"
      },
      {
        "id": 36892,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">HMG CoA lyase</span></span></span></p>"
      },
      {
        "id": 36893,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">HMG CoA reductase</span></span></span></p>"
      },
      {
        "id": 36894,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">HMG CoA carboxylase</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which enzyme is common to the synthesis pathways of both ketone bodies and cholesterol? </span></span></span></p>",
    "unique_key": "Q6433752",
    "question_audio": null,
    "question_video": null,
    "map_id": 30032,
    "difficulty_level": "intermediate",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">HMG CoA Synthase</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>HMG CoA Synthase </strong>is the enzyme involved in the <strong>synthesis of both ketone bodies </strong>and <strong>cholesterol</strong>. It <strong>catalyzes </strong>the condensation of <strong>acetoacetyl-CoA </strong>with <strong>another </strong>molecule of <strong>acetyl-CoA to form 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA), </strong>which is a <strong>crucial step </strong>in <strong>both pathways</strong>. In the <strong>liver</strong>, the presence of <strong>HMG CoA Synthase </strong>in the <strong>mitochondria </strong>facilitates the production of <strong>ketone bodies, </strong>whereas in the<strong> cytoplasm</strong>, it <strong>participates </strong>in the early steps of <strong>cholesterol biosynthesis.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:16px\"><strong>Other Options:</strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>HMG CoA Lyase </strong>is involved in the <strong>ketogenesis pathway</strong>, specifically in the breakdown of <strong>HMG-CoA to acetoacetate </strong>and <strong>acetyl-CoA</strong>, but it <strong>does not </strong>play a role in <strong>cholesterol synthesis. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong> HMG CoA Reductase </strong>is a key enzyme in the <strong>cholesterol synthesis pathway, </strong>catalyzing the <strong>conversion of HMG-CoA </strong>to <strong>mevalonate</strong>. This enzyme is the <strong>target of statin drugs</strong>, which are <strong>used </strong>to <strong>lower cholesterol levels. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>HMG CoA Carboxylase </strong>is involved in <strong>fatty acid synthesis</strong>, converting <strong>acetyl-CoA to malonyl-CoA, </strong>and is <strong>not </strong>directly involved in the <strong>synthesis of ketone bodies or cholesterol</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Acetyl CoA </strong>combines <strong>with acetoacetyl CoA </strong>&rarr; <strong>HMG CoA </strong>by the enzyme<strong> HMG CoA synthase</strong>. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mitochondrial HMG CoA&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is used for <strong>ketogenesis,</strong> and <strong>cytosoli</strong>c fraction is used for <strong>cholesterol synthesis</strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e p 170</span></strong></span></span></p>",
    "correct_choice_id": 36891,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "InvestigationBased"
    ]
  },
  {
    "id": 9151,
    "choices": [
      {
        "id": 36571,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Carnitine deficiency</span></span></span></p>"
      },
      {
        "id": 36572,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fatty acid synthase deficiency</span></span></span></p>"
      },
      {
        "id": 36573,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tay-Sachs disease</span></span></span></p>"
      },
      {
        "id": 36574,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Biotin deficiency</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A neurologist is assessing a teenage girl who has been experiencing fatigue severe enough to prevent her participation in physical education classes. She presents with muscle weakness in her limbs. Lab tests indicate high serum levels of triacylglycerols esterified with long-chain fatty acids (LCFAs) and hypoglycemia. A muscle biopsy shows an abundance of lipid vacuoles. What condition do these clinical findings suggest?</span></span></span></p>",
    "unique_key": "Q7254428",
    "question_audio": null,
    "question_video": null,
    "map_id": 30269,
    "difficulty_level": "intermediate",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Carnitine deficiency</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Carnitine deficiency </strong>is seen in <strong>preterm infants</strong>, where <strong>impaired fatty acid oxidation </strong>is noticed &rarr; so <strong>more glucose </strong>is utilized &rarr; episodes of <strong>hypoglycemia</strong>. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Primary carnitine deficiency: </span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Classical presentation is<strong> hypoketotic hypoglycemic encephalopathy</strong>, <strong>hepatomegaly</strong>, <strong>elevated transaminases and ammonia, cardiomyopathy, pericardial effusion</strong>, <strong>muscle weakness</strong>, <strong>recurrent </strong>episodes of <strong>vomiting </strong>and <strong>diarrhea </strong>and <strong>infections </strong>and <strong>hypochromic anemia</strong>. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The above symptoms are <strong>triggered by fasting or viral infections.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Secondary carnitine deficiency</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: c/f<strong>-Hypoketotic hypoglycemia </strong>in <strong>infancy, cardiac and skeletal muscle disease </strong>later in life<strong>, seizures, apnea and developmental delay</strong>. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The causes for <strong>secondary carnitine deficiency </strong>includes <strong>organic acidurias, respiratory chain and mitochondrial defects</strong>, <strong>renal Fanconi syndrome </strong>and <strong>drug induced </strong>(<strong>valproic acid, zidovudine</strong>).</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Affects the <strong>de novo synthesis </strong>of <strong>fatty acids </strong>occurs in the <strong>cytoplasm </strong>with the help of a <strong>dimeric multi-enzyme complex </strong>termed <strong>Fatty acid synthase</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Deficiency of hexosaminidase A </strong>leads to accumulation of <strong>Ganglioside (GM2). C/F</strong>-<strong>Mental retardation, Cherry red spot in the macula </strong>with Progressive deterioration and <strong>death by 3&ndash;4 years.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;Biotin deficiency includes <strong>dermatitis, atrophic glossitis, hyperesthesia, muscle pain, anorexia </strong>and <strong>hallucinations</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The clinical manifestations of <strong>carnitine deficiency</strong>, including <strong>muscle weakness, elevated serum triacylglycerols </strong>with <strong>LCFAs, hypoglycemia</strong>, and <strong>lipid accumulation in muscle cells</strong>, which reflect the <strong>impaired transport </strong>of <strong>fatty acids </strong>into mitochondria for <strong>&beta;-oxidation</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e:p 224,231.</span></strong></span></span></p>",
    "correct_choice_id": 36571,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 9174,
    "choices": [
      {
        "id": 36663,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Takes place in mitochondria</span></span></span></p>"
      },
      {
        "id": 36664,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Produce dicarboxylic acids</span></span></span></p>"
      },
      {
        "id": 36665,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">NADPH and cytochrome P-450 play a role</span></span></span></p>"
      },
      {
        "id": 36666,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Involves methyl group at omega end</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Identify an incorrect statement about omega-oxidation of fatty acids:</span></span></span></p>",
    "unique_key": "Q3352508",
    "question_audio": null,
    "question_video": null,
    "map_id": 30280,
    "difficulty_level": "intermediate",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. A)</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Takes place in mitochondria</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is a minor pathway taking place in <strong>microsomes (Endoplasmic reticulum), </strong>with the help of <strong>hydroxylase </strong>enzymes such as <strong>NADPH and cytochrome P-450. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>CH3 </strong>group is converted to<strong> CH2OH and oxidized </strong>with the help of <strong>NAD+ to a COOH </strong>group to produce <strong>dicarboxylic acids. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>&omega;-oxidation </strong>becomes important when <strong>&beta;-oxidation is defective </strong>and <strong>dicarboxylic acids </strong>(<strong>6C </strong>and <strong>8C </strong>acids) are <strong>excreted </strong>in urine resulting in <strong>dicarboxylic aciduria. </strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Calibri, sans-serif\"><span style=\"font-size:16px\"><strong><u>Other Options:</u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Produce dicarboxylic acids</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: <strong>True</strong>, <strong>omega-oxidation </strong>can result in the production of <strong>dicarboxylic acids </strong>when the <strong>omega carbon of fatty acids </strong>is <strong>oxidized</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: NADPH and cytochrome P-450 play a role</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: <strong>True</strong>, <strong>omega-oxidation </strong>involves the <strong>cytochrome P-450 enzyme </strong>system, which <strong>utilizes NADPH </strong>as a <strong>cofactor</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: Involves methyl group at omega end</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: <strong>True</strong>, <strong>omega-oxidation </strong>involves the <strong>oxidation </strong>of the <strong>methyl group </strong>at the <strong>omega (last carbon) </strong>end of fatty acids.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Omega-oxidation of fatty acids </strong>takes place primarily in the <strong>endoplasmic reticulum </strong>of cells, <strong>not in mitochondria</strong>. This pathway serves as an <strong>alternative to the &beta;-oxidation of fatty acids</strong>, which occurs in <strong>mitochondria and peroxisomes.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">: DM Vasudevan 9/e: p 205</span></strong></span></span></p>",
    "correct_choice_id": 36663,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "TreatmentBased"
    ]
  },
  {
    "id": 9159,
    "choices": [
      {
        "id": 36603,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Accumulation of phytanic acid</span></span></span></p>"
      },
      {
        "id": 36604,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Formation of dicarboxylic acid</span></span></span></p>"
      },
      {
        "id": 36605,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Formation of propionyl CoA</span></span></span></p>"
      },
      {
        "id": 36606,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Formation of acetyl CoA</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 45-year-old man presents to the clinic with progressive difficulty in night vision and a recent history of unsteady gait. He reports no significant medical history except for a strict vegetarian diet for many years. Physical examination reveals mild hepatomegaly and decreased ankle reflexes. Laboratory tests show elevated plasma levels of a specific fatty acid. The patient&rsquo;s condition is suspected to be due to a metabolic disorder affecting fatty acid catabolism:</span></span></span></p>",
    "unique_key": "Q7459435",
    "question_audio": null,
    "question_video": null,
    "map_id": 30273,
    "difficulty_level": "intermediate",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. A)</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Accumulation of phytanic acid </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Alpha oxidation </strong>is removal of <strong>1C </strong>at a time from <strong>COOH end&nbsp; </strong>and its takes place in <strong>peroxisomes</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Eg: <strong>Phytanic acid </strong>(require prior <strong>&alpha;-oxidation to proceed to &szlig;-oxidation</strong>).</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">So, <strong>defective or lack of alpha oxidation </strong>of <strong>phytanic acid </strong>leads to <strong>its accumulation. </strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Formation of dicarboxylic acid</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Dicarboxylic acids accumulate as a result of <strong>&omega;-oxidation, </strong>which typically occurs when <strong>&beta;-oxidation is impaired, not </strong>&alpha;-oxidation.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Formation of propionyl CoA</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Propionyl CoA is a product of the<strong> &beta;-oxidation </strong>of <strong>odd-chain fatty acids</strong>, <strong>not </strong>related to <strong>&alpha;-oxidation defects</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: Formation of acetyl CoA</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: <strong>Acetyl CoA </strong>is a product of <strong>&beta;-oxidation of fatty acids</strong>. <strong>Lack </strong>of <strong>&alpha;-oxidation </strong>does <strong>not </strong>directly lead to the formation of <strong>acetyl CoA.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Lack </strong>of <strong>&alpha;-oxidation of fatty acids </strong>leads to the accumulation of <strong>phytanic acid</strong>, a <strong>branched-chain fatty acid </strong>derived mainly from <strong>dietary sources</strong>, particularly <strong>ruminant fats</strong>. Humans <strong>lack </strong>the enzymes to introduce a <strong>double bond </strong>in <strong>phytanic acid</strong>, making <strong>&alpha;-oxidation </strong>necessary for <strong>its catabolism</strong>. <strong>Deficiencies </strong>in this pathway, such as in <strong>Refsum disease</strong>, lead to the accumulation of <strong>phytanic acid</strong>, which is <strong>toxic </strong>to cells and can cause symptoms like <strong>night blindness, ataxia, and peripheral neuropathy.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/ed ,pg 231</span></strong></span></span></p>",
    "correct_choice_id": 36603,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "Factual"
    ]
  },
  {
    "id": 9147,
    "choices": [
      {
        "id": 36555,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">H2O2 </span></span></span></p>"
      },
      {
        "id": 36556,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acetyl CoA</span></span></span></p>"
      },
      {
        "id": 36557,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Different enzymes are found in different site</span></span></span></p>"
      },
      {
        "id": 36558,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">NADH is required</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">What is this difference in the production of byproducts between beta-oxidation in peroxisomes and that in mitochondria?</span></span></span></p>",
    "unique_key": "Q6533901",
    "question_audio": null,
    "question_video": null,
    "map_id": 30267,
    "difficulty_level": "intermediate",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">H2O2</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Beta-oxidation </strong>in <strong>peroxisomes </strong>differs from <strong>mitochondrial beta-oxidation </strong>in that it produces <strong>hydrogen peroxide (H2O2) </strong>as a <strong>byproduct</strong>. <strong>Peroxisomal oxidation </strong>involves enzymes that transfer <strong>electrons directly to oxygen</strong>, forming <strong>H2O2</strong>. This <strong>byproduct </strong>is then <strong>broken </strong>down by <strong>catalase</strong>, which is <strong>abundant </strong>in <strong>peroxisomes</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Acetyl CoA</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:<strong> Both peroxisomal and mitochondrial beta-oxidation </strong>generate <strong>acetyl CoA</strong>, so this is <strong>not </strong>a distinguishing feature.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Different enzymes are found in different sites</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: While it&#39;s <strong>true that different enzymes catalyze </strong>the steps of <strong>beta-oxidation in peroxisomes and mitochondria</strong>, this option does <strong>not </strong>refer to a <strong>unique byproduct </strong>of the <strong>reaction</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: NADH is required</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: NADH is a product of <strong>mitochondrial beta-oxidation </strong>where it is later <strong>used in the electron transport chain </strong>to generate <strong>ATP</strong>. <strong>Peroxisomal oxidation </strong>does <strong>not </strong>contribute directly to the <strong>electron </strong>transport chain and therefore the role of <strong>NADH </strong>in <strong>peroxisomal beta-oxidation </strong>is <strong>not </strong>a key distinguishing feature in the context of byproduct production.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A <strong>modified beta-oxidation pathway </strong>takes place in <strong>peroxisomes for fatty Acids </strong>&gt; <strong>C20, C22 (VLCFs)</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Oxidation </strong>in the <strong>Peroxisomes </strong>&rarr; produces <strong>Acetyl CoA and H2O2 </strong>(instead of FADH2)</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>No ATP </strong>is generated.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Further oxidation </strong>of<strong> Acetyl CoA and Octanoyl CoA </strong>takes place in the <strong>mitochondria</strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e page 226</span></strong></span></span></p>",
    "correct_choice_id": 36555,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 9101,
    "choices": [
      {
        "id": 36371,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Short chain fatty acids</span></span></span></p>"
      },
      {
        "id": 36372,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Long chain fatty acids</span></span></span></p>"
      },
      {
        "id": 36373,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Medium chain fatty acids</span></span></span></p>"
      },
      {
        "id": 36374,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Very long chain fatty acids</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In a pediatric clinic, a physician evaluates a 7-month-old male infant presented by his mother with concerns about hypotonia, hepatomegaly, and delayed developmental milestones. Suspecting Zellweger syndrome, a peroxisomal disorder, the physician considers the metabolic abnormalities associated with this condition. Which type of fatty acids is known to accumulate in patients with Zellweger syndrome?</span></span></span></p>",
    "unique_key": "Q7342559",
    "question_audio": null,
    "question_video": null,
    "map_id": 30265,
    "difficulty_level": "intermediate",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Very long chain fatty acids</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>&nbsp;&nbsp;&nbsp;</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Zellweger syndrome&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is also known as <strong>Cerebrohepatorenal syndrome</strong> which is due to <strong>defective oxidation</strong> of <strong>very long</strong> <strong>chain fatty acids (VLCFA).</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Due to <strong>mutations </strong>in <strong>peroxins genes</strong> , <strong>entry</strong> of enzymes into the <strong>peroxisomes </strong>are denied causing<strong> insufficient oxidation</strong> of <strong>VLCFA</strong> leading to <strong>its accumulation in CNS</strong> causing <strong>neurological impairment and death in childhood.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It usually<strong> presents at birth </strong>with profound <strong>neurologic impairment </strong>and the <strong>victims</strong> often <strong>dying within a year.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:16px\"><strong>Other Options:</strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> They <strong>do not</strong> require <strong>carnitine</strong> for transport across the<strong> inner mitochondrial membrane</strong> and so are <strong>easily oxidized.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: </span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Long chain fatty acid</strong> accumulation is due to deficiency of <strong>long chain acyl CoA dehydrogenase </strong>resulting in <strong>Nonketotic</strong> <strong>hypoglycaemia</strong> with<strong> low carnitine</strong> and<strong> increased acyl carnitine </strong>in plasma.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>MCAD</strong> accumulation occurs due to <strong>deficiency of medium chain acyl CoA dehydrogenase </strong>results in <strong>acidosis,</strong> <strong>hyperammonemia, hypoglycaemia</strong> and<strong> fatty liver.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Zellweger syndrome</strong> is a<strong> peroxisomal</strong> disorder characterized by the <strong>absence or malfunction of peroxisomes</strong> in the cells. One of the key functions of<strong> peroxisomes is the &beta;-oxidation of very long chain fatty acids (VLCFAs).</strong><strong> </strong>In <strong>Zellweger syndrome</strong>, the<strong> inability to</strong> <strong>metabolize VLCFAs</strong> leads to their<strong> accumulation in tissues and blood,</strong> contributing to the<strong> clinical manifestations of the disorder.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e: p 241,614</span></strong></span></span></p>",
    "correct_choice_id": 36374,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 9157,
    "choices": [
      {
        "id": 36595,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Jamaican Vomiting Sickness</span></span></span></p>"
      },
      {
        "id": 36596,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Zellweger syndrome</span></span></span></p>"
      },
      {
        "id": 36597,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Carnitine deficiency</span></span></span></p>"
      },
      {
        "id": 36598,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Propionyl CoA carboxylase deficiency</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 62-year-old man from Africa with a history of diabetes presents with severe vomiting, epigastric pain, and confusion. He has been using local herbal remedies to manage his blood sugar for the last 8 months and is concerned about possible overconsumption. On examination, he is comatose, dehydrated, and shows signs of tachycardia and tachypnea. Laboratory tests reveal hypoglycemia at 53 mg/dl and a significant electrolyte imbalance. His urine is positive for a high amount of dicarboxylic acid? </span></span></span></p>",
    "unique_key": "Q5826771",
    "question_audio": null,
    "question_video": null,
    "map_id": 30272,
    "difficulty_level": "beginner",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Jamaican Vomiting Sickness</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Ackee fruit </strong>that grows in<strong> Jamaica and West Africa </strong>contain a<strong> toxin</strong> called <strong>Hypoglycin,</strong> which is an <strong>inhibitor of fatty acyl</strong> <strong>CoA dehydrogenase.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It causes <strong>severe Hypoglycemia</strong> if <strong>ingested</strong> as it<strong> inhibits beta oxidation of fatty acids.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Characterized by <strong>sudden </strong>onset of <strong>vomiting 2&ndash;6 hrs after ingestion</strong>, followed by <strong>convulsion, coma and death.&nbsp; </strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:16px\"><strong>Other Options:</strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;<strong>Defective</strong> oxidation of<strong> VLCFA</strong> &rarr; accumulation of <strong>VLCFA in CNS </strong>&rarr; causes <strong>neurological impairment and death </strong>in childhood.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;Option C:&nbsp; Carnitine deficiency&nbsp;I&nbsp;&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is reported in <strong>preterm infants </strong>with <strong>impaired fatty acid oxidation </strong>&rarr; <strong>more glucose </strong>is utilized &rarr; <strong>hypoglycemia</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: </span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Characterized by <strong>propionic acidemia, ketoacidosis</strong>, and <strong>mental abnormalities.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Jamaican Vomiting Sickness</strong>, which is <strong>caused </strong>by the ingestion of <strong>unripe ackee fruit </strong>containing <strong>hypoglycin A</strong>, a<strong> toxin </strong>that<strong> inhibits </strong>fatty acid oxidation. The resulting <strong>buildup </strong>of <strong>dicarboxylic acids </strong>in the <strong>urine </strong>and <strong>hypoglycemia </strong>due to <strong>impaired gluconeogenesis </strong>are indicative of this <strong>diagnosis</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">: DM Vasudevan 9/e: p 219</span></strong></span></span></p>",
    "correct_choice_id": 36595,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 8957,
    "choices": [
      {
        "id": 35795,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Propionic acidemia </span></span></span></p>"
      },
      {
        "id": 35796,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">LCACDH deficiency </span></span></span></p>"
      },
      {
        "id": 35797,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glutaric aciduria</span></span></span></p>"
      },
      {
        "id": 35798,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">MCAD deficiency</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 4-day-old male infant, previously healthy, is brought to the emergency department by his mother due to sudden onset of dyspnea followed by loss of consciousness. The infant was born via normal vaginal delivery and had been well until this episode. Tragically, within an hour of arrival, the infant passed away.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/10/3_9N1ABtU.jpg\" style=\"height:205px; width:291px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Laboratory investigations revealed the following critical findings:</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Blood sugar: 25 mg/dL, indicating profound hypoglycemia.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Elevated levels of medium-chain acylcarnitines.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Significant presence of dicarboxylic acids in the urine.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Based on the clinical presentation and laboratory findings, which of the following is the most probable diagnosis?</span></span></span></p>",
    "unique_key": "Q4721738",
    "question_audio": null,
    "question_video": null,
    "map_id": 30283,
    "difficulty_level": "intermediate",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">MCAD Deficiency </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>MCAD deficiency </strong>is a disorder of <strong>fatty acid oxidation</strong> that <strong>prevents the body </strong>from<strong> converting certain fats into energy</strong>, particularly <strong>during fasting</strong>. This can lead to episodes of <strong>low blood sugar (hypoglycemia), weakness, and lethargy</strong>. The critical findings in this case&mdash;<strong>profound hypoglycemia,</strong> <strong>elevated</strong> levels of <strong>medium-chain acylcarnitines</strong>, and the <strong>presence of dicarboxylic acids</strong> in the <strong>urine</strong>&mdash;are hallmark indicators of <strong>MCAD deficiency. </strong>These s<strong>ubstances accumulate</strong> due to the <strong>inability </strong>to break down <strong>medium-chain fatty acids</strong>, leading to the <strong>clinical presentation observed</strong> in this<strong> infant.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A:</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Propionic Acidemia -&nbsp;</strong>Characterized by the <strong>accumulation of propionic acid, </strong>this condition typically presents with a <strong>metabolic acidosis </strong>rather than the specific <strong>metabolic derangements</strong> seen in this case.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: LCACDH Deficiency -&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This condition affects the<strong> metabolism of long-chain fatty acids. </strong>The <strong>laboratory findings </strong>in this <strong>infant,</strong> however, are<strong> indicative of a disorder </strong>involving<strong> medium-chain fatty acids.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C:</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Glutaric Aciduria -&nbsp;</strong>This <strong>metabolic disorder</strong> leads to the accumulation of <strong>glutaric acid </strong>and typically presents with <strong>macrocephaly and neurological signs,</strong> which were<strong> not </strong>reported in this case.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>MCAD deficiency</strong> - Key diagnostic markers include <strong>hypoglycemia, elevated medium-chain acylcarnitines, and dicarboxylic aciduria.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">: DM Vasudevan 9/e: p 204.</span></strong></span></span></p>",
    "correct_choice_id": 35798,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "ImageBased"
    ]
  },
  {
    "id": 9171,
    "choices": [
      {
        "id": 36651,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A and R both are right but R is not the correct explanation of A</span></span></span></p>"
      },
      {
        "id": 36652,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A is wrong but R is a right statement</span></span></span></p>"
      },
      {
        "id": 36653,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A as well as R are right and R is a correct explanation of A</span></span></span></p>"
      },
      {
        "id": 36654,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A and R both are wrong</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Assertion (A):</span></u></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Hypoglycaemia is common in preterm neonates.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Reasoning (R):</span></u></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Carnitine deficiency is seen in preterm infants, who have impaired fatty acid oxidation causing more glucose utilization.</span></span></span></p>",
    "unique_key": "Q2278776",
    "question_audio": null,
    "question_video": null,
    "map_id": 30279,
    "difficulty_level": "intermediate",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><strong><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) A as well as R are right and R is a correct explanation of A</span></span></span></strong></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Hypoglycemia </strong>is indeed common in <strong>preterm neonates </strong>(Assertion A), partly because of their <strong>immature hepatic glycogen stores </strong>and the <strong>higher brain-to-body </strong>mass ratio leading to a <strong>rapid glucose consumption</strong>.<strong> Carnitine deficiency </strong>(Reasoning R) is also more frequent in <strong>preterm infants </strong>due to <strong>inadequate stores </strong>and <strong>less maternal transfer</strong>, which leads to <strong>impaired fatty acid oxidation</strong>, a process that <strong>normally </strong>helps to <strong>conserve glucose</strong>. Thus, with <strong>compromised fatty acid oxidation, more glucose is utilized</strong>, contributing to the risk of<strong> hypoglycemia.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Carnitine deficiency </strong>is noted in <strong>preterm infants</strong>, in whom <strong>impaired fatty acid oxidation </strong>are seen. So <strong>more glucose </strong>is utilized, resulting in <strong>recurrent episodes of hypoglycaemia</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">: DM Vasudevan 9/e: p 202</span></strong></span></span></p>",
    "correct_choice_id": 36653,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 9144,
    "choices": [
      {
        "id": 36543,
        "text": "<p><span style=\"font-size:12.0pt;\">Carnitine palmitoyl transferase I</span></p>"
      },
      {
        "id": 36544,
        "text": "<p><span style=\"font-size:12.0pt;\">Acyl Co- dehydrogenase</span></p>"
      },
      {
        "id": 36545,
        "text": "<p><span style=\"font-size:12.0pt;\">Carnitine palmitoyl transferase II</span></p>"
      },
      {
        "id": 36546,
        "text": "<p><span style=\"font-size:12.0pt;\">Carnitine acylcarnitine translocase</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt;\">Based on the diagram provided, which enzyme is not involved in shuttling fatty acids into the mitochondrial matrix for \u03b2-oxidation?</span></p><p style=\"text-align:justify;\">&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Your%20paragraph%20text%20(1).png\" width=\"1080\" height=\"634\"></p>",
    "unique_key": "Q8317698",
    "question_audio": null,
    "question_video": null,
    "map_id": 30266,
    "difficulty_level": "difficult",
    "subjects_id": [
      1
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans: B. Acyl Co-A dehydrogenase</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The diagram shows the carnitine shuttle system, which is responsible for transporting long-chain fatty acids from the cytosol into the mitochondrial matrix, where \u03b2-oxidation occurs.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Acyl Co-A Dehydrogenase</strong></span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">Location: Mitochondrial matrix</span></li><li><span style=\"font-size:12.0pt;\">Function: Catalyzes the first step of \u03b2-oxidation, dehydrogenating Acyl-CoA to form a trans double bond between the \u03b1 and \u03b2 carbons.</span></li><li><span style=\"font-size:12.0pt;\">Involved in shuttle?&nbsp; No \u2013 it acts after the fatty acid has already entered the matrix.</span></li></ul><p>&nbsp;</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Carnitine Palmitoyl Transferase I (CPT I)</strong></span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">Location: Outer mitochondrial membrane</span></li><li><span style=\"font-size:12.0pt;\">Function: Converts Acyl-CoA to Acyl-carnitine by transferring the fatty acid to carnitine.</span></li><li><span style=\"font-size:12.0pt;\">Involved in shuttle? Yes</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Carnitine Palmitoyl Transferase II (CPT II)</strong></span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">Location: Inner mitochondrial membrane (matrix side)</span></li><li><span style=\"font-size:12.0pt;\">Function: Converts Acyl-carnitine back to Acyl-CoA and carnitine, allowing the fatty acid to enter \u03b2-oxidation.</span></li><li><span style=\"font-size:12.0pt;\">Involved in shuttle? Yes</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Carnitine Acylcarnitine Translocase</strong></span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">Location: Inner mitochondrial membrane</span></li><li><span style=\"font-size:12.0pt;\">Function: Transports Acyl-carnitine into the mitochondrial matrix while moving free carnitine back to the cytosol in a counter-transport manner.</span></li><li><span style=\"font-size:12.0pt;\">Involved in shuttle? Yes</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Your%20paragraph%20text%20(2)_2MKFtfT.png\" width=\"1080\" height=\"1080\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Role of carnitine in the transport of long-chain fatty acids through the inner mitochondrial membrane.</strong></span></p><p><br><span style=\"font-size:12.0pt;\">Long-chain acyl-CoA formed by acyl-CoA synthetase enters the intermembrane space. For transport across the inner membrane, acyl groups must be transferred from CoA to carnitine by carnitine palmitoyl transferase-I. The acylcarnitine formed is then carried into the matrix by a translocase enzyme in exchange for a free carnitine and acyl-CoA is reformed by carnitine palmitoyltransferase-II.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Understand the carnitine shuttle system, which is essential for the mitochondrial import of long-chain fatty acids. Key enzymes involved include CPT I, CPT II, and the translocase. Acyl-CoA dehydrogenase is not involved in transport\u2014it functions after the fatty acid enters the matrix, initiating \u03b2-oxidation.</span></p><p><span style=\"font-size:12.0pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\"><strong>Ref</strong>: Vasudevan 9/ ed: p151, Harper 30/e: p 224</span></p>",
    "correct_choice_id": 36544,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "ImageBased",
      "TreatmentBased"
    ]
  },
  {
    "id": 9155,
    "choices": [
      {
        "id": 36587,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Infantile Refsum&rsquo;s disease</span></span></span></p>"
      },
      {
        "id": 36588,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Zellweger syndrome</span></span></span></p>"
      },
      {
        "id": 36589,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Carnitine deficiency</span></span></span></p>"
      },
      {
        "id": 36590,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Propionyl CoA carboxylase deficiency</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 3-year-old girl child brought by her parents with complaints of difficulty in swallowing food, impaired vision at night and hearing impairment for the past 5 months seems to be worsening. O/E: </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/11/4.jpg\" style=\"height:276px; width:173px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">EYES: Bilateral nystagmus</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">FEET: 4th phalange was short in both feet</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">SKIN: dry</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Electroretinogram: Retinal pigmentation in both fundi.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lab reports: elevated VLCFA and phytanic acid.&nbsp; </span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">What is the most probable diagnosis?</span></span></span></p>",
    "unique_key": "Q4251544",
    "question_audio": null,
    "question_video": null,
    "map_id": 30271,
    "difficulty_level": "intermediate",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Infantile Refsum&rsquo;s disease</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The constellation of symptoms such as <strong>difficulty swallowing, vision and hearing impairment, specific skeletal abnormalities, dry skin, and distinctive retinal pigmentation</strong>, coupled with lab findings of <strong>elevated VLCFAs and phytanic acid</strong>, points to <strong>Infantile Refsum&rsquo;s disease. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This is a <strong>peroxisomal disorder </strong>characterized by <strong>impaired peroxisomal biogenesis </strong>and function, leading to the <strong>accumulation </strong>of <strong>phytanic acid and VLCFAs. </strong>The clinical manifestations are <strong>less severe and present later </strong>than in <strong>Zellweger syndrome</strong>, and the disease typically allows for a <strong>longer lifespan.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong>Other Options:</strong></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Zellweger syndrome:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Defective </strong>oxidation of <strong>VLCFA </strong>&rarr;<strong> accumulation </strong>of VLCFA in <strong>CNS </strong>&rarr; causes<strong> neurological impairment and death </strong>in childhood.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Carnitine deficiency&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is reported in <strong>preterm infants with impaired fatty acid oxidation </strong>&rarr; <strong>more glucose </strong>is utilized &rarr; <strong>hypoglycemia</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: Propionyl CoA carboxylase deficiency:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">characterized by <strong>propionic acidemia, ketoacidosis, and mental abnormalities.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Difficulty swallowing, night blindness, hearing loss, bilateral nystagmus, brachydactyly, dry skin, retinal pigmentation, and elevated VLCFAs </strong>and <strong>phytanic acid </strong>is diagnosed with <strong>Infantile Refsum&rsquo;s disease, </strong>a<strong> peroxisomal disorder.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">: DM Vasudevan 9/e: p 205</span></strong></span></span></p>",
    "correct_choice_id": 36587,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "ImageBased",
      "TreatmentBased"
    ]
  },
  {
    "id": 9164,
    "choices": [
      {
        "id": 36623,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acyl-CoA dehydrogenase</span></span></span></p>"
      },
      {
        "id": 36624,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acyl-CoA synthetase</span></span></span></p>"
      },
      {
        "id": 36625,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/22/screenshot-2024-04-22-153833.png\" style=\"height:12px; width:9px\" />&nbsp;<span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">2-Enoyl-CoA hydratase</span></span></span></p>"
      },
      {
        "id": 36626,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">L (+)-3-Hydroxyacyl-CoA dehydrogenase</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 26-year-old male long-distance runner presents to his primary care physician with complaints of muscle cramps and fatigue during exercise. He follows a strict low-carbohydrate, high-fat diet and is concerned about his energy levels. Intrigued by the metabolic processes that provide energy during prolonged exercise, he asks about the step in fatty acid oxidation that requires an input of energy. The physician, recognizing this as an important aspect of fatty acid metabolism that could impact the patient&rsquo;s symptoms, decides to review the biochemical pathway:</span></span></span></p>",
    "unique_key": "Q5182004",
    "question_audio": null,
    "question_video": null,
    "map_id": 30276,
    "difficulty_level": "intermediate",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acyl-CoA synthetase</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>first step of fatty acid oxidation</strong> requires activation of the <strong>fatty acid to an acyl-CoA. </strong>This reaction is catalyzed by the <strong>enzyme acyl-CoA synthetase</strong> and requires <strong>ATP </strong>which hydrolyses to <strong>AMP ~ two high energy phosphates.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/11/6.jpg\" style=\"height:191px; width:602px\" /></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In subsequent reactions,<strong> two carbons </strong>are removed at a time from the <strong>carboxyl end </strong>to form <strong>acetyl-CoA</strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: </span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>fatty acyl CoA </strong>is <strong>dehydrogenated </strong>to a<strong> transenoyl CoA </strong>by the <strong>enzyme Acyl-CoA dehydrogenase </strong>with <strong>FAD </strong>accepting the hydrogen atoms.&nbsp; <strong>FADH2 </strong>when oxidised in <strong>electron transport chain </strong>will produce <strong>1.5 ATP </strong>molecules</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Enoyl CoA hydratase</strong> catalyzes the step which forms a <strong>beta-hydroxy fatty acyl CoA.</strong> The <strong>L isomer</strong> alone is formed during the <strong>hydration</strong> of the <strong>trans-double bond.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: </span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>beta-hydroxy fatty acyl CoA</strong> is again<strong> oxidized</strong> to form <strong>beta-keto fatty acyl CoA </strong>producing a<strong> NADH</strong>. which <strong>further </strong>gets<strong> </strong>oxidized in <strong>electron transport chain</strong> generating <strong>2.5 ATPs</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Acyl-CoA synthetase</strong> is the enzyme responsible for <strong>catalyzing </strong>the initial step in<strong> fatty acid oxidation </strong>where a<strong> fatty acid</strong> is activated to form <strong>acyl-CoA</strong>. This reaction requires the <strong>hydrolysis of ATP to AMP </strong>and <strong>pyrophosphate (PPi)</strong>, making it the <strong>only step in fatty acid</strong> <strong>oxidation</strong> that requires an <strong>input of energy.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><u>Ref</u>: DM Vasudevan 9/e: p 203</span></strong></span></span></p>",
    "correct_choice_id": 36624,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 9166,
    "choices": [
      {
        "id": 36631,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acyl carrier protein</span></span></span></p>"
      },
      {
        "id": 36632,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Carnitine</span></span></span></p>"
      },
      {
        "id": 36633,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">LCAT</span></span></span></p>"
      },
      {
        "id": 36634,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">CETP</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 55-year-old man with a history of congestive heart failure is undergoing a cardiac rehabilitation program. His cardiologist explains the importance of fatty acid metabolism in cardiac muscle for energy production. She details how fatty acids are transported into the mitochondria for &beta;-oxidation, a process especially vital in cardiac tissue, which primarily uses fatty acid oxidation to meet its energy needs. Given the heart&#39;s reliance on fatty acids for energy, the cardiologist emphasizes one particular molecule&#39;s role in transporting fatty acids across the inner mitochondrial membrane:</span></span></span></p>",
    "unique_key": "Q6822254",
    "question_audio": null,
    "question_video": null,
    "map_id": 30277,
    "difficulty_level": "intermediate",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Carnitine</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Fatty acids</strong> are activated in the <strong>cytoplasm</strong>; but <strong>beta-oxidation </strong>takes place in <strong>mitochondria. </strong>So,<strong> transport of fatty acids</strong> across the<strong> mitochondrial membrane</strong> is essential. </span></span></span></li>\r\n\t<li><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The<strong> LCFA CoA cannot </strong>pass through the<strong> inner mitochondrial membrane </strong>and requires a <strong>transporter, carnitine</strong> for transfer of<strong> fatty acids (see fig.).</strong></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/11/7.jpg\" style=\"height:625px; width:602px\" /></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Acyl carrier protein:&nbsp; </span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Forms a part of <strong>fatty acid synthase complex</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;&copy; LCAT:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Lecithin-cholesterol acyl transferase. </strong>Involved in <strong>HDL metabolism</strong>.<strong> Apo Al of HDL</strong> activates<strong> LCAT.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option&nbsp; D: CETP:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> The<strong> cholesterol ester</strong> from <strong>HDL </strong>is transferred to <strong>VLDL, IDL and LDL</strong> by a <strong>Cholesterol Ester Transfer Protein.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Carnitine</strong> is crucial for the transport of<strong> long-chain fatty acids</strong> across the <strong>inner mitochondrial membrane </strong>in <strong>cardiac muscle.</strong> It forms a <strong>complex with fatty acids </strong>to facilitate their <strong>translocation into the mitochondria,</strong> where <strong>&beta;-oxidation</strong> occurs to generate <strong>ATP for energy.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">: DM Vasudevan 9/e: p 202</span></strong></span></span></p>",
    "correct_choice_id": 36632,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 9184,
    "choices": [
      {
        "id": 36703,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increased hydrolysis of fat from adipocytes</span></span></span></p>"
      },
      {
        "id": 36704,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Decreased synthesis of fatty acids</span></span></span></p>"
      },
      {
        "id": 36705,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Decreased [NADH]/[NAD+) ratio</span></span></span></p>"
      },
      {
        "id": 36706,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Impaired beta oxidation of fatty acids</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 55-year-old man with a history of chronic alcohol abuse presents to the emergency department with severe abdominal pain. An ultrasound of the abdomen reveals fatty liver. The emergency medicine physician begins to explain to the medical students present that chronic alcohol consumption can lead to hepatic steatosis and outlines the pathophysiological mechanisms behind this condition:</span></span></p>",
    "unique_key": "Q7800091",
    "question_audio": null,
    "question_video": null,
    "map_id": 30282,
    "difficulty_level": "intermediate",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Impaired beta oxidation of fatty acids. </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In <strong>alcoholic liver disease</strong>, the metabolism of <strong>alcohol</strong> significantly <strong>increases the NADH/NAD+ ratio</strong> in <strong>hepatocytes</strong>, which in turn <strong>impairs </strong>the <strong>beta oxidation of fatty acids.</strong> This occurs because the <strong>excess NADH inhibits</strong> the<strong> citric acid cycle</strong>, leading to an accumulation of <strong>acetyl-CoA and fatty acids</strong> within the <strong>liver</strong>. This <strong>impaired fatty acid oxidation</strong>, along with <strong>increased lipogenesis </strong>and <strong>decreased VLDL secretion</strong>, contributes to the development of <strong>fatty liver, or hepatic steatosis, </strong>in <strong>chronic alcoholics.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Increased hydrolysis of fat from adipocytes</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: While alcohol can <strong>increase lipolysis</strong>, the key issue in <strong>alcoholic fatty liver disease </strong>is the <strong>impairment </strong>of <strong>fatty acid oxidation</strong>, rather than an increase in the hydrolysis of fat from adipocytes.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Decreased synthesis of fatty acids</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: <strong>Alcohol consumption </strong>typically leads to an <strong>increase</strong>, <strong>not </strong>a <strong>decrease</strong>, in the <strong>synthesis </strong>of <strong>fatty acids </strong>in the<strong> liver</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Decreased [NADH]/[NAD+] ratio</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: <strong>Alcohol metabolism </strong>actually <strong>increases </strong>the <strong>[NADH]/[NAD+] ratio</strong>, which is <strong>one factor </strong>contributing to <strong>impaired fatty acid oxidation.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Increased </strong>level of <strong>acetyl CoA </strong>causes <strong>increased fatty acid synthesis.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Impaired beta oxidation of fatty acids </strong>leads to <strong>increased TAG </strong>in the <strong>liver </strong>resulting in <strong>fatty liver and steatosis.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Lippincott 7/e: p317.</span></strong></span></span></p>",
    "correct_choice_id": 36706,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 9149,
    "choices": [
      {
        "id": 36563,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Decreased ability to convert acetyl coenzyme A to glucose</span></span></span></p>"
      },
      {
        "id": 36564,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Decreased acetyl CoA production</span></span></span></p>"
      },
      {
        "id": 36565,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increased conversion of acetyl coenzyme A to acetoacetate</span></span></span></p>"
      },
      {
        "id": 36566,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increased production of ATP and nicotinamide adenine dinucleotide</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A pediatrician is evaluating a 7-month-old boy who was admitted with a seizure, gastrointestinal symptoms, and decreased appetite. Laboratory tests show severe hypoglycemia, normal blood carnitine levels, absence of ketones in the urine, and the presence of various dicarboxylic acids. These findings suggest a diagnosis of medium-chain acyl-coenzyme A dehydrogenase (MCAD) deficiency. Considering the biochemistry of MCAD deficiency, what is the underlying cause of fasting hypoglycemia in this condition?</span></span></span></p>",
    "unique_key": "Q7744626",
    "question_audio": null,
    "question_video": null,
    "map_id": 30268,
    "difficulty_level": "intermediate",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Decreased acetyl CoA production</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>MCAD deficiency </strong>impairs the body&#39;s ability to <strong>break down medium-chain fatty acids </strong>due to a <strong>lack of functional MCAD enzyme</strong>. This <strong>impedes </strong>the production of <strong>acetyl CoA </strong>from these <strong>fatty acids </strong>during <strong>fasting</strong>, when the <strong>body normally </strong>relies on <strong>fat oxidation </strong>for <strong>energy</strong>. <strong>Acetyl CoA </strong>is crucial for maintaining <strong>blood glucose levels via gluconeogenesis </strong>during periods <strong>without food</strong>. In <strong>MCAD deficiency</strong>, the <strong>reduced </strong>availability of <strong>acetyl CoA limits gluconeogenesis, </strong>leading to <strong>fasting hypoglycemia</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>&nbsp;Other Options:</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Decreased ability to convert acetyl coenzyme A to glucose</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: <strong>Acetyl CoA cannot </strong>be converted to <strong>glucose in humans </strong>due to the <strong>irreversibility </strong>of the <strong>pyruvate dehydrogenase </strong>reaction, which is <strong>not </strong>specific to <strong>MCAD </strong>deficiency.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Increased conversion of acetyl coenzyme A to acetoacetate</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: <strong>MCAD deficiency </strong>would actually lead to a <strong>decreased production of ketone bodies </strong>like <strong>acetoacetate </strong>because there is <strong>less acetyl CoA </strong>available from <strong>fatty acid oxidation</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: Increased production of ATP and NAD</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: <strong>MCAD deficiency </strong>would result in <strong>decreased </strong>production of <strong>ATP </strong>and <strong>NADH </strong>from <strong>medium-chain fatty acid oxidation </strong>because the <strong>fatty acids </strong>are <strong>not </strong>being properly <strong>metabolized</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>MCAD deficiency </strong>leads to <strong>decreased acetyl CoA </strong>production from <strong>medium-chain fatty acids</strong>, which <strong>impairs gluconeogenesis </strong>and <strong>energy </strong>production during <strong>fasting</strong>, resulting in <strong>hypoglycemia</strong>. The <strong>disease </strong>also leads to an <strong>accumulation of fatty acid</strong> metabolites, such as <strong>dicarboxylic acids</strong>, in the <strong>blood and urine</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">: DM Vasudevan 9/e: p204.</span></strong></span></span></p>",
    "correct_choice_id": 36564,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "TreatmentBased"
    ]
  },
  {
    "id": 9153,
    "choices": [
      {
        "id": 36579,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Zellweger syndrome</span></span></span></p>"
      },
      {
        "id": 36580,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Infantile Refsum&rsquo;s Disease</span></span></span></p>"
      },
      {
        "id": 36581,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Refsum&rsquo;s Disease</span></span></span></p>"
      },
      {
        "id": 36582,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Organic Acidurias</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A neonate in the NICU presents with seizures, poor muscle tone, feeding difficulties, distinct facial features, bilateral cataracts, and ultrasound findings of renal cysts. Blood work indicates elevated very long-chain fatty acids (VLCFAs), reduced levels of plasmalogen, and increased levels of cholestenoic acid. Based on these clinical findings, what is the most likely diagnosis?</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/11/3.jpg\" style=\"height:216px; width:218px\" /></span></span></span></span></p>",
    "unique_key": "Q1981460",
    "question_audio": null,
    "question_video": null,
    "map_id": 30270,
    "difficulty_level": "beginner",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Zellweger syndrome</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Zellweger syndrome </strong>is due to <strong>defective oxidation of very long chain fatty acids (VLCFA). </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Peroxisomes </strong>are <strong>empty or peroxisomal enzymes </strong>are <strong>not </strong>transported correctly into <strong>peroxisomes </strong>&rarr; leads to <strong>insufficient </strong>oxidation of <strong>VLCFA </strong>&rarr;<strong> accumulation </strong>of <strong>VLCFA </strong>in <strong>CNS </strong>&rarr; <strong>neurological impairment and death </strong>in childhood.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Zellweger syndrome, adrenoleukodystrophy and infantile Refsum&rsquo;s disease </strong>are together classified as <strong>Peroxisomal biogenesis disorders</strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:16px\"><strong>Other Options:</strong></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Infantile Refsum&#39;s Disease:&nbsp; </span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is also a <strong>peroxisomal disorder </strong>&rarr; <strong>phytanic acid</strong> accumulation along with <strong>VLCFA </strong>&amp; <strong>Children do not survive long.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option&nbsp; C. Refsum&#39;s Disease:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Due to <strong>lack of alpha-hydroxylase </strong>&rarr; <strong>alpha oxidation </strong>does <strong>not </strong>occur &rarr; <strong>phytanic acid </strong>accumulates in the tissues &rarr; <strong>C/F: severe neurological symptoms</strong>, <strong>polyneuropathy</strong>, <strong>retinitis pigmentosa</strong>, <strong>nerve deafness and cerebellar ataxia</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Organic Acidurias:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;<strong>Disorders </strong>of metabolism of <strong>fatty acids, branched&nbsp;</strong></span></span></span><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Chain, aromatic amino acids and citric acid cycle </strong>&rarr; accumulation of <strong>organic acids </strong>in body tissues and their <strong>excretion in urine </strong>&rarr; <strong>acidosis, vomiting, convulsions and coma</strong>. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Zellweger syndrome</strong>, a <strong>peroxisomal biogenesis disorder</strong>, is characterized by the <strong>absence </strong>of functional <strong>peroxisomes</strong>, which leads to the <strong>accumulation of VLCFAs </strong>and <strong>defects </strong>in <strong>plasmalogen </strong>synthesis necessary for <strong>normal cell membrane function</strong>. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The clinical presentation, including distinctive <strong>facial features, cataracts, and renal cysts</strong>, along with the <strong>specific biochemical abnormalities</strong>, strongly suggests <strong>Zellweger syndrome.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">: DM Vasudevan 9/e: p209, 254</span></strong></span></span></p>",
    "correct_choice_id": 36579,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "Factual",
      "ImageBased"
    ]
  },
  {
    "id": 9161,
    "choices": [
      {
        "id": 36611,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">106 ATP</span></span></span></p>"
      },
      {
        "id": 36612,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">142 ATP</span></span></span></p>"
      },
      {
        "id": 36613,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">129 ATP</span></span></span></p>"
      },
      {
        "id": 36614,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">139 ATP</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 28-year-old biochemistry researcher is analyzing energy yield from various metabolic pathways. He is particularly interested in the total ATP production from the complete oxidation of palmitic acid, a common saturated fatty acid. In his experimental setup, he meticulously accounts for all the steps involved in &beta;-oxidation, the citric acid cycle, and the electron transport chain, ensuring accurate calculations of ATP yield:</span></span></span></p>",
    "unique_key": "Q6626828",
    "question_audio": null,
    "question_video": null,
    "map_id": 30274,
    "difficulty_level": "beginner",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">106 ATP&nbsp;&nbsp; </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Oxidation </strong>of <strong>C16</strong> fatty acid palmitate: A total of <strong>8 molecules of acetyl-CoA </strong>is formed.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Each gives rise to <strong>10 molecules of ATP </strong>on oxidation in <strong>TCA cycle</strong>, making <strong>80 </strong>molecules. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Two </strong>must be <strong>subtracted </strong>for the <strong>initial activation </strong>of the <strong>fatty acid</strong>, yielding a net gain of <strong>106 mol of ATP </strong>per mole of <strong>palmitate.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/11/5.jpg\" style=\"height:371px; width:602px\" /></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>total ATP </strong>yield in <strong>palmitic acid</strong> oxidation is <strong>106 ATP</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/ed ,pg 225</span></strong></span></span></p>",
    "correct_choice_id": 36611,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 9162,
    "choices": [
      {
        "id": 36615,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mitochondria</span></span></span></p>"
      },
      {
        "id": 36616,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lysosomes</span></span></span></p>"
      },
      {
        "id": 36617,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Peroxisomes</span></span></span></p>"
      },
      {
        "id": 36618,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Nucleus</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 3-month-old infant presents to the pediatrician with hypotonia, hepatomegaly, and developmental delays. The mother reports that the baby has had difficulty feeding and exhibits poor responsiveness to stimuli. Physical examination notes a high forehead, hypertelorism, and epicanthic folds. The physician, suspecting a genetic disorder affecting cellular organelles, orders a series of diagnostic tests, including metabolic screening and imaging:</span></span></span></p>",
    "unique_key": "Q3506656",
    "question_audio": null,
    "question_video": null,
    "map_id": 30275,
    "difficulty_level": "beginner",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Peroxisomes</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Here the <strong>peroxisomes </strong>are <strong>empty or peroxisomal enzymes </strong>are <strong>not </strong>transported correctly into <strong>peroxisomes </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Zellweger syndrome, adrenoleukodystrophy </strong>and <strong>infantile Refsum&rsquo;s disease </strong>are together classified as <strong>Peroxisomal biogenesis disorders</strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Mitochondria:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Disorders </strong>associated -<strong>Mitochondrial myopathies</strong>,<strong> Charcot-Marie-Tooth disease.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Lysosomes:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Disorders</strong> associated &ndash;<strong> </strong><strong>Inclusion cell (I-cell) disease, sphingolipidoses</strong>, <strong>Mucopolysaccharidosis</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: Nucleus:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Autoimmune disorders</strong>, <strong>DNA repair defects</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Zellweger syndrome </strong>is a <strong>rare </strong>congenital disorder caused by a <strong>defect</strong> in <strong>peroxisome biogenesis, </strong>leading to various clinical symptoms such as <strong>hypotonia, hepatomegaly, developmental delays</strong>, and <strong>distinct craniofacial </strong>features.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">: DM Vasudevan 9/e: p 209, 254</span></strong></span></span></p>",
    "correct_choice_id": 36617,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 9170,
    "choices": [
      {
        "id": 36647,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Accumulation of very long chain fatty acid</span></span></span></p>"
      },
      {
        "id": 36648,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Accumulation of medium chain fatty acid</span></span></span></p>"
      },
      {
        "id": 36649,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increased plasmalogen</span></span></span></p>"
      },
      {
        "id": 36650,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Decreased pipecolic acid</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 7-year-old boy is brought to a pediatric neurologist by his parents, who are concerned about recent changes in his behavior and academic performance. Over the past six months, he has exhibited signs of hyperactivity, vision problems, and hearing loss. His teachers have noted a significant decline in his attention span and comprehension skills. The neurologist, suspecting a genetic disorder affecting the metabolism of fatty acids, orders a comprehensive lipid panel including very long-chain fatty acid (VLCFA) levels:</span></span></span></p>",
    "unique_key": "Q7866694",
    "question_audio": null,
    "question_video": null,
    "map_id": 30278,
    "difficulty_level": "beginner",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Accumulation of very long chain fatty acid</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Adrenoleukodystrophy (ALD) </strong>is a <strong>genetic disorder </strong>characterized by the accumulation of <strong>very long-chain fatty acids (VLCFAs) </strong>in the body due to a <strong>defect </strong>in the <strong>peroxisomal transporter protein </strong>that imports <strong>VLCFAs </strong>into <strong>peroxisomes </strong>for degradation. This <strong>accumulation </strong>is especially <strong>damaging to the myelin sheath of nerve cells</strong>, leading to <strong>progressive neurological symptoms.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Accumulation of medium chain fatty acid</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: ALD <strong>does not </strong>typically involve the accumulation of <strong>medium-chain fatty acids</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Increased plasmalogen</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Plasmalogens are a type of <strong>phospholipid</strong>; their levels are <strong>not directly </strong>related to <strong>ALD</strong>, which is primarily concerned with the <strong>metabolism of VLCFAs</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: Decreased pipecolic acid</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Pipecolic acid is associated with<strong> peroxisomal disorders </strong>like <strong>Zellweger syndrome</strong>, <strong>not </strong>specifically with <strong>ALD</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Deficient oxidation </strong>of <strong>VLCFA </strong>by <strong>peroxisomal enzyme systems </strong>&rarr; <strong>VLCFAs </strong>are accumulated &rarr; <strong>myelin sheaths </strong>are <strong>destroyed </strong>&rarr; <strong>adrenoleukodystrophy</strong>. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">: DM Vasudevan 9/e: p 205</span></strong></span></span></p>",
    "correct_choice_id": 36647,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 9176,
    "choices": [
      {
        "id": 36671,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Citric acid cycle</span></span></span></p>"
      },
      {
        "id": 36672,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fatty acid oxidation</span></span></span></p>"
      },
      {
        "id": 36673,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glycolysis</span></span></span></p>"
      },
      {
        "id": 36674,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pentose phosphate pathway</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following metabolic pathways generates the most ATP?</span></span></span></p>",
    "unique_key": "Q9938939",
    "question_audio": null,
    "question_video": null,
    "map_id": 30281,
    "difficulty_level": "beginner",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fatty acid oxidation</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Fatty acid oxidation </strong>of <strong>palmitate </strong>results in a total of <strong>106 ATP</strong>.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A total of <strong>7 rounds of beta-oxidation </strong>yield <strong>28 ATPs</strong>.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A total of <strong>8 </strong>mol of <strong>acetyl-CoA </strong>is formed. Each gives rise to <strong>10 mol of ATP </strong>on oxidation in <strong>TCA cycle</strong>, making <strong>80 mol. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Two </strong>must be subtracted for the <strong>initial activation of the fatty acid</strong>, yielding a <strong>net gain </strong>of <strong>108-2 </strong>= <strong>106 mol of ATP </strong>per mole of <strong>palmitate</strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The citric acid cycle produces a net of 10 ATP per turn of the cycle</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glycolysis produces a net of 7 ATP molecules per glucose under aerobic conditions.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The pentose phosphate pathway does not generate any ATP but instead forms NADPH and ribose 5-phosphate</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective </span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fatty acid oxidation, specifically &beta;-oxidation of fatty acids, generates the most AT, because the breakdown of fatty acids yields numerous molecules of acetyl-CoA, NADH, and FADH2, all of which enter the citric acid cycle and electron transport chain to produce ATP. Fatty acids are a dense form of energy storage, and their oxidation releases a significant amount of energy.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">: DM Vasudevan 9/e: p 204.</span></strong></span></span></p>",
    "correct_choice_id": 36672,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "TreatmentBased"
    ]
  },
  {
    "id": 9011,
    "choices": [
      {
        "id": 36011,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Type 2 diabetes</span></span></span></p>"
      },
      {
        "id": 36012,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hypertension </span></span></span></p>"
      },
      {
        "id": 36013,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Familial hypercholesterolemia&nbsp; </span></span></span></p>"
      },
      {
        "id": 36014,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hyperuricemia&nbsp;</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 70-year-old male was prescribed a medication which inhibits the activity of the enzyme HMG-CoA reductase.&nbsp; What is the most likely diagnosis?</span></span></span></p>",
    "unique_key": "Q5119443",
    "question_audio": null,
    "question_video": null,
    "map_id": 30319,
    "difficulty_level": "beginner",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;<strong>Ans. C)</strong>&nbsp;<strong>Familial hypercholesterolemia</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Statins</strong> are a class of drugs that <strong>inhibit the activity of the enzyme HMG-CoA reductase</strong> which is the<strong> rate limiting enzyme</strong> in <strong>cholesterol synthesis. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Their <strong>function </strong>causes<strong> reduction in LDL, total cholesterol and triglycerides</strong> in patients with<strong> familial hypercholesterolemia.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Type 2 diabetes:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Oral hypoglycemic agents</strong>-<strong>sulfonylurea and biguanides (Metformin), glitazones etc., Insulin injections.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Hypertension:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Anti-hypertensives</strong> &ndash;<strong>calcium channel blockers</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: Hyperuricemia:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>&nbsp;Reduce dietary intake of purine</strong> and <strong>restrict alcohol,</strong> <strong>increase renal excretion of urate </strong>by <strong>uricosuric drugs,</strong> e.g.<strong> probenecid,</strong> <strong>reduce urate production</strong> by <strong>allopurinol</strong>, use of <strong>PEG (polyethylene glycol)-uricase </strong>that converts<strong> uric acid to</strong> <strong>allantoin</strong>, which is<strong> more water soluble</strong> and <strong>easily excreted.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>HMG-CoA reductase inhibitors</strong>, commonly known as <strong>statins, </strong>are primarily<strong> used to lower cholesterol levels in the blood</strong>, particularly in conditions like <strong>Familial Hypercholesterolemia,</strong> where there&#39;s a<strong> genetic defect</strong> in <strong>LDL receptors</strong> leading to <strong>elevated cholesterol</strong> <strong>levels.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e: p 275,267.</span></strong></span></span></p>",
    "correct_choice_id": 36013,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "TreatmentBased"
    ]
  },
  {
    "id": 9178,
    "choices": [
      {
        "id": 36679,
        "text": "<p><span style=\"font-size:12.0pt;\">They have cyclopentano perhydro phenanthrene ring system</span></p>"
      },
      {
        "id": 36680,
        "text": "<p><span style=\"font-size:12.0pt;\">It is made up of 3 cyclohexane rings - A, B and C</span></p>"
      },
      {
        "id": 36681,
        "text": "<p><span style=\"font-size:12.0pt;\">An 8-carbon side chain attached to 17th carbon is characteristic of all sterols</span></p>"
      },
      {
        "id": 36682,
        "text": "<p><span style=\"font-size:12.0pt;\">The OH group is beta oriented</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Review the diagram of the cholesterol molecule, as shown in the image and identify incorrect statements about its structure:</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Your%20paragraph%20text%20(3)_xPE2TG8.png\" width=\"1080\" height=\"803\"></p>",
    "unique_key": "Q6452624",
    "question_audio": null,
    "question_video": null,
    "map_id": 30321,
    "difficulty_level": "intermediate",
    "subjects_id": [
      1
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C)&nbsp;An 8-carbon side chain attached to 17th carbon is characteristic of all sterols</strong></span></p><p><span style=\"font-size:12.0pt;\"><strong>&nbsp;</strong></span></p><p><span style=\"font-size:12.0pt;\"><strong>Option C:</strong></span></p><p><br><span style=\"font-size:12.0pt;\"><strong>Option C is incorrect</strong> because <strong>not all sterols have an 8-carbon side chain</strong> at the 17th carbon. While <strong>cholesterol</strong> specifically has an <strong>8-carbon side chain</strong> attached to C-17, other sterols (e.g., plant sterols or bile acids) have <strong>variations in side chain length or structure</strong>. Therefore, this side chain is <strong>not a universal feature</strong> of all sterols.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\"><strong>Option A: Cyclopentano perhydro phenanthrene ring system</strong> \u2013 True. This is the core fused four-ring structure (3 cyclohexane rings + 1 cyclopentane) of <strong>all steroids</strong>, including cholesterol.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Option B: 3 cyclohexane rings \u2013 A, B and C</strong> \u2013True. Rings A, B, and C in cholesterol are indeed <strong>cyclohexane rings</strong>, forming part of the classic <strong>steroid nucleus</strong>.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Option D: The OH group is beta oriented</strong> \u2013True. The <strong>hydroxyl group on C-3</strong> of cholesterol is oriented <strong>upward</strong>, i.e., <strong>beta orientation</strong>, which is <strong>above the plane</strong> of the ring system.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:12.0pt;\">Understand the <strong>structural features of cholesterol</strong>, including its <strong>steroid nucleus</strong> (three cyclohexane + one cyclopentane ring), <strong>C-3 beta-hydroxyl group</strong>, and <strong>C-17 side chain</strong>. While cholesterol has an 8-carbon side chain at C-17, this is <strong>not shared by all sterols</strong>, which may have different modifications depending on function (e.g., hormones, bile acids, vitamin D).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref</strong>: DM Vasudevan 9/e: p 220-223.</span></p>",
    "correct_choice_id": 36681,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "ImageBased"
    ]
  },
  {
    "id": 9202,
    "choices": [
      {
        "id": 36775,
        "text": "<p><span style=\"font-size:12.0pt;\">Statins are competitive inhibitors of HMG CoA reductase</span></p>"
      },
      {
        "id": 36776,
        "text": "<p><span style=\"font-size:12.0pt;\">Insulin increases the activity of HMG CoA reductase</span></p>"
      },
      {
        "id": 36777,
        "text": "<p><span style=\"font-size:12.0pt;\">HMG CoA Reductase active in Fed State</span></p>"
      },
      {
        "id": 36778,
        "text": "<p><span style=\"font-size:12.0pt;\">Short-term regulation by transcription of the gene for HMG CoA reductase</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt;\">Which one of the following is FALSE regarding regulation of cholesterol?</span></p>",
    "unique_key": "Q4872679",
    "question_audio": null,
    "question_video": null,
    "map_id": 30318,
    "difficulty_level": "intermediate",
    "subjects_id": [
      1
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D. Short-term regulation by transcription of the gene for HMG CoA reductase</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D.</strong> Short-term regulation by transcription of the gene for HMG CoA reductase:</span><br><span style=\"font-size:12.0pt;\">False.</span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">Transcriptional regulation of HMG CoA reductase (via SREBP\u2014Sterol Regulatory Element Binding Proteins) is a long-term (chronic) regulation mechanism.</span></li><li><span style=\"font-size:12.0pt;\">Short-term regulation is via covalent modification (phosphorylation/inactivation and dephosphorylation/activation) and feedback inhibition by cholesterol levels.</span></li></ul><p style=\"text-align:justify;\">&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/11/13.jpg\" alt=\"\" width=\"602\" height=\"527\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Thus, this option falsely describes transcriptional regulation as short-term.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Cholesterol synthesis is tightly regulated at multiple levels, with HMG CoA reductase being the rate-limiting enzyme.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Option:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Statins are competitive inhibitors of HMG CoA reductase: True.</strong></span><br><span style=\"font-size:12.0pt;\">Statins competitively inhibit HMG CoA reductase, reducing cholesterol synthesis and are widely used in hypercholesterolemia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Insulin increases the activity of HMG CoA reductase: True.</strong></span><br><span style=\"font-size:12.0pt;\">Insulin promotes the dephosphorylation (activation) of HMG CoA reductase, enhancing cholesterol synthesis, especially in the fed state.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. HMG CoA Reductase active in Fed State: True.</strong></span><br><span style=\"font-size:12.0pt;\">In the fed state, when insulin is high, cholesterol synthesis is active.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span><br><br>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Understand the <strong>multi-level regulation</strong> of HMG-CoA reductase \u2014 the <strong>key control point in cholesterol biosynthesis</strong> \u2014 including:</span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\"><strong>Short-term (minutes):</strong> Phosphorylation/dephosphorylation</span></li><li><span style=\"font-size:12.0pt;\"><strong>Long-term (hours\u2013days):</strong> Gene transcription via SREBP</span></li><li><span style=\"font-size:12.0pt;\"><strong>Drug intervention:</strong> Competitive inhibition by <strong>statins</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref</strong>: DM Vasudevan 9/e: p 223.</span></p>",
    "correct_choice_id": 36778,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "TreatmentBased"
    ]
  },
  {
    "id": 9238,
    "choices": [
      {
        "id": 36919,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A and R both are right, but R is not the correct explanation of A</span></span></span></p>"
      },
      {
        "id": 36920,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A is wrong but R is a right statement</span></span></span></p>"
      },
      {
        "id": 36921,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A as well as R are right, and R is a correct explanation of A</span></span></span></p>"
      },
      {
        "id": 36922,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A and R both are wrong</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Assertion (A):</span></u></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Bile acid protects the body from cholesterol over production.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Reasoning (R):</span></u></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> In liver, choles</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">terol is continuously converted to bile acid.</span></span></span></p>",
    "unique_key": "Q9080546",
    "question_audio": null,
    "question_video": null,
    "map_id": 30320,
    "difficulty_level": "intermediate",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A as well as R are right, and R is a correct explanation of A</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Assertion (A) </strong>is <strong>correct. Bile acids</strong>, which are <strong>derived </strong>from <strong>cholesterol, </strong>play a significant <strong>role </strong>in maintaining <strong>cholesterol homeostasis</strong> within the<strong> body.</strong> By converting <strong>cholesterol into bile acids</strong>, the body can regulate the<strong> levels of cholesterol, preventing</strong> its <strong>overproduction and accumulation</strong>, which can lead to conditions such as<strong> hypercholesterolemia and atherosclerosis.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Reasoning (R)</strong> is also <strong>correct</strong> and provides a <strong>correct explanation for Assertion (A)</strong>. The liver plays a crucial role in <strong>lipid metabolism</strong>, including the <strong>conversion of cholesterol into bile acids</strong>. This conversion is an important regulatory mechanism for <strong>controlling</strong> <strong>cholesterol levels </strong>in the body. <strong>Bile acids </strong>are then <strong>excreted </strong>into the <strong>intestine with bile</strong>, where they <strong>aid</strong> in the <strong>digestion </strong>and <strong>absorption of fats</strong> and <strong>fat-soluble vitamins.</strong> Some <strong>bile acids</strong> are <strong>reabsorbed</strong> from the <strong>intestine</strong> and <strong>returned to the liver,</strong> while others are <strong>lost in the feces</strong>. This<strong> loss of bile acids </strong>from the body necessitates the conversion of<strong> more cholesterol into bile acids,</strong> thus helping to<strong> regulate cholesterol levels </strong>and <strong>prevent overproduction.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Bile acid production </strong>is the most important<strong> catabolic pathway for cholesterol. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Continuous</strong> conversation of <strong>cholesterol into bile acid</strong> in the<strong> liver</strong> prevents the body from becoming<strong> overloaded</strong> with <strong>cholesterol. </strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e: p 237-238</span></strong></span></span></p>",
    "correct_choice_id": 36921,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 9198,
    "choices": [
      {
        "id": 36759,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Isoprenoid units</span></span></span></p>"
      },
      {
        "id": 36760,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Squalene</span></span></span></p>"
      },
      {
        "id": 36761,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Geranyl pyrophosphate</span></span></span></p>"
      },
      {
        "id": 36762,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Farnesyl pyrophosphate</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A pharmaceutical researcher is developing a new class of lipid-lowering drugs aimed at targeting cholesterol biosynthesis. In a team meeting, he presents the biosynthetic pathway of cholesterol to identify potential targets for drug intervention. He highlights a crucial 30-carbon intermediate in the pathway and asks the team to identify this compound, emphasizing its significance in the synthesis of cholesterol:</span></span></span></p>",
    "unique_key": "Q8460421",
    "question_audio": null,
    "question_video": null,
    "map_id": 30317,
    "difficulty_level": "intermediate",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Squalene</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In <strong>cholesterol biosynthesis, 6 numbers of 5-carbon </strong>units are <strong>condensed </strong>to form a <strong>30-carbon compound </strong>known as <strong>Squalene.</strong> </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Condensation of 5 Carbon isoprenoid units to form Squalene (30C):</span></strong></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/19/screenshot-2024-04-19-152527.png\" style=\"height:520px; width:600px\" /></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Two 5C </strong>units <strong>condense </strong>to form a <strong>10 C </strong>compound called as<strong> Geranyl Pyrophosphate</strong>.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>10C </strong>unit, <strong>Geranyl Pyrophosphate </strong>condenses with a <strong>5C isoprenoid </strong>unit to form a <strong>15C </strong>compound called <strong>Farnesyl Diphosphate</strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/19/screenshot-2024-04-19-152606.png\" style=\"height:328px; width:500px\" /></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Two Farnesyl Diphosphate (15C) </strong>condense to form a <strong>30C </strong>compound called <strong>Squalene</strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:16px\"><strong>Other Options:</strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>5C </strong>compound-<strong> </strong><strong>Isoprenoid units</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>10C </strong>compound-<strong> </strong><strong>Geranyl Pyrophosphate.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:&nbsp;&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>5C </strong>compound-<strong> </strong><strong>Farnesyl Diphosphate</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Squalene </strong>is the <strong>correct </strong>answer as it is a <strong>30-carbon </strong>compound that serves as a <strong>key </strong>intermediate in the <strong>cholesterol biosynthesis </strong>pathway. <strong>Squalene </strong>is <strong>synthesized </strong>from the <strong>condensation </strong>of <strong>two farnesyl pyrophosphate molecules </strong>and is <strong>later cyclized </strong>to form <strong>lanosterol</strong>, which undergoes <strong>several </strong>modifications to become <strong>cholesterol</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">: DM Vasudevan 9/e: p 222</span></strong></span></span></p>",
    "correct_choice_id": 36760,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  }
];
        let quizName = 'Lipids';
        let hierarchy = ["Cerebellum", "qBank", "Biochemistry"];
        
        // Handle Custom Quiz Loading
        if (window.location.pathname.endsWith('custom_quiz.html')) {
            const customData = JSON.parse(localStorage.getItem('customQuizData'));
            if (customData) {
                questionsData = customData.questions;
                quizName = customData.name;
                hierarchy = customData.hierarchy;
                document.title = quizName + ' - Brain And Scalpel';
                document.getElementById('totalQuestions').textContent = questionsData.length;
                document.getElementById('quizHierarchy').textContent = hierarchy.join(' > ');
            }
        }

        let currentQuestionIndex = 0;
        let selectedOption = null;
        let currentMode = 'study';
        let timer = null;
        let timeRemaining = 0;
        let questionStartTime = Date.now();
        let quizStartTime = Date.now();
        let isQuizCompleted = false;
        
        let questionStates = new Array(questionsData.length).fill(null).map(() => ({
            status: 'not_attempted',
            bookmarked: false,
            markedForReview: false,
            selectedAnswer: null,
            timeSpent: 0
        }));
        
        let stats = {
            correctAnswers: 0,
            incorrectAnswers: 0,
            totalAttempted: 0,
            totalTime: 0,
            notAttempted: questionsData.length
        };

        const urlParams = new URLSearchParams(window.location.search);
        currentQuestionIndex = Math.min(parseInt(urlParams.get('startAt')) || 0, questionsData.length - 1);

        function goBack() {
            if (isQuizCompleted || confirm('Are you sure you want to leave the quiz? Your progress will be lost.')) {
                window.history.back();
            }
        }

        function selectMode(mode) {
            currentMode = mode;
            document.getElementById('modeModal').style.display = 'none';
            initializeQuiz();
        }

        function initializeQuiz() {
            quizStartTime = Date.now();
            
            const bookmarkBtn = document.getElementById('bookmarkBtn');
            const markReviewBtn = document.getElementById('markReviewBtn');
            const testModeReviewLegend = document.getElementById('testModeReviewLegend');
            const isTestMode = currentMode === 'test' || currentMode === 'timed_exam';
            
            document.getElementById('statsBar').style.display = isTestMode ? 'none' : 'block';
            document.getElementById('studyModeLegend').style.display = isTestMode ? 'none' : 'block';
            document.getElementById('testModeLegend').style.display = isTestMode ? 'block' : 'none';
            document.getElementById('submitSection').style.display = isTestMode ? 'block' : 'none';
            bookmarkBtn.style.display = isTestMode ? 'none' : 'flex';
            markReviewBtn.style.display = isTestMode ? 'flex' : 'none';
            testModeReviewLegend.style.display = isTestMode ? 'flex' : 'none';
            
            if (currentMode === 'timed_study' || currentMode === 'timed_exam') {
                document.getElementById('timerContainer').classList.remove('hidden');
            }
            
            loadBookmarkedQuestions();
            generateQuestionNav();
            updateStats();
            displayQuestion();
        }

        function generateQuestionNav() {
            const nav = document.getElementById('questionNav');
            nav.innerHTML = '';
            
            for (let i = 0; i < questionsData.length; i++) {
                const btn = document.createElement('button');
                btn.textContent = i + 1;
                btn.className = 'w-8 h-8 text-sm font-medium rounded transition-all duration-200';
                btn.onclick = () => jumpToQuestion(i);
                btn.id = `navBtn_${i}`;
                nav.appendChild(btn);
            }
            
            updateQuestionNav();
        }

        function updateQuestionNav() {
            for (let i = 0; i < questionsData.length; i++) {
                const btn = document.getElementById(`navBtn_${i}`);
                const state = questionStates[i];
                let className = '';
                
                if (i === currentQuestionIndex) {
                    className = 'nav-btn-current';
                } else if (state.bookmarked) {
                    className = 'nav-btn-bookmarked';
                } else if (state.markedForReview) {
                    className = 'nav-btn-marked-review';
                } else if (currentMode === 'study' || currentMode === 'timed_study') {
                    if (state.status === 'correct') className = 'nav-btn-correct';
                    else if (state.status === 'incorrect') className = 'nav-btn-incorrect';
                    else className = 'nav-btn-not-attempted hover:bg-white hover:bg-opacity-20';
                } else {
                    if (state.selectedAnswer !== null) className = 'nav-btn-answered';
                    else className = 'nav-btn-not-attempted hover:bg-white hover:bg-opacity-20';
                }
                btn.className = `w-8 h-8 text-sm font-medium rounded ${className}`;
            }
        }

        function jumpToQuestion(index) {
            if (index >= 0 && index < questionsData.length) {
                if (questionStartTime) {
                    questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
                }
                
                currentQuestionIndex = index;
                displayQuestion();
            }
        }

        function updateStats() {
            if (currentMode === 'study' || currentMode === 'timed_study') {
                document.getElementById('correctCount').textContent = stats.correctAnswers;
                document.getElementById('incorrectCount').textContent = stats.incorrectAnswers;
                document.getElementById('totalAttempted').textContent = stats.totalAttempted;
                
                const accuracy = stats.totalAttempted > 0 
                    ? Math.round((stats.correctAnswers / stats.totalAttempted) * 100)
                    : 0;
                document.getElementById('accuracy').textContent = accuracy + '%';
                
                stats.totalTime = questionStates.reduce((acc, state) => acc + state.timeSpent, 0);
                const timeSpent = Math.floor(stats.totalTime / 1000);
                const minutes = Math.floor(timeSpent / 60);
                const seconds = timeSpent % 60;
                document.getElementById('timeSpent').textContent = 
                    minutes + ':' + seconds.toString().padStart(2, '0');
            }
        }

        function setupVideo(videoElement, url) {
            if (Hls.isSupported()) {
                const hls = new Hls();
                hls.loadSource(url);
                hls.attachMedia(videoElement);
            } else if (videoElement.canPlayType('application/vnd.apple.mpegurl')) {
                videoElement.src = url;
            }
        }

        function displayQuestion() {
            if (!questionsData || questionsData.length === 0) {
                document.getElementById('questionText').innerHTML = 'No questions available for this quiz.';
                return;
            };
            
            const question = questionsData[currentQuestionIndex];
            questionStartTime = Date.now();
            
            selectedOption = questionStates[currentQuestionIndex].selectedAnswer;
            
            const progress = ((currentQuestionIndex + 1) / questionsData.length) * 100;
            document.getElementById('progressBar').style.width = progress + '%';
            document.getElementById('currentQuestion').textContent = currentQuestionIndex + 1;
            updateQuestionNav();
            
            document.getElementById('prevBtn').disabled = currentQuestionIndex === 0;
            
            document.getElementById('solutionContainer').classList.add('hidden');
            
            document.getElementById('questionText').innerHTML = question.text || 'No question text available';
            
            let mediaHtml = '';
            if (question.question_audio) mediaHtml += `<div class="glass-light p-4 mb-4"><audio src="${question.question_audio}" controls class="w-full"></audio></div>`;
            if (question.question_video) mediaHtml += `<div class="glass-light p-4 mb-4"><video src="${question.question_video}" controls class="w-full rounded-lg"></video></div>`;
            if (question.question_images) {
                question.question_images.forEach(imgSrc => {
                    if (imgSrc) mediaHtml += `<div class="glass-light p-4 mb-4"><img src="${imgSrc}" alt="Question Image" class="w-full rounded-lg"></div>`;
                });
            }
            document.getElementById('questionMedia').innerHTML = mediaHtml;
            
            const optionsContainer = document.getElementById('optionsContainer');
            optionsContainer.innerHTML = '';
            optionsContainer.classList.remove('answered');
            
            if (question.choices && Array.isArray(question.choices)) {
                question.choices.forEach((choice, index) => {
                    const optionLetter = String.fromCharCode(65 + index);
                    const isSelected = selectedOption === index;
                    
                    const optionDiv = document.createElement('div');
                    optionDiv.innerHTML = `
                        <button type="button" class="option-button ${isSelected ? 'selected' : ''}" data-option-index="${index}">
                            <div class="option-letter">${optionLetter}</div>
                            <div class="option-text">${choice.text || 'Option ' + (index + 1)}</div>
                        </button>
                    `;
                    optionsContainer.appendChild(optionDiv);
                });
                
                optionsContainer.addEventListener('click', function(e) {
                    const optionButton = e.target.closest('.option-button');
                    if (optionButton) {
                        const optionIndex = parseInt(optionButton.getAttribute('data-option-index'));
                        selectOption(optionIndex);
                    }
                });
            }
            
            updateBookmarkButton();
            updateMarkReviewButton();

            if ((currentMode === 'timed_study' || currentMode === 'timed_exam') && !isQuizCompleted) {
                startTimer();
            }
        }

        function selectOption(index) {
            const optionsContainer = document.getElementById('optionsContainer');
            if (optionsContainer.classList.contains('answered')) return;

            if (questionStartTime) {
                questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
                questionStartTime = Date.now();
            }
            
            selectedOption = index;
            questionStates[currentQuestionIndex].selectedAnswer = index;
            
            document.querySelectorAll('.option-button').forEach((btn, i) => {
                btn.classList.toggle('selected', i === index);
            });
            
            if (currentMode === 'study' || currentMode === 'timed_study') {
                setTimeout(processAnswer, 300);
            } else {
                if (questionStates[currentQuestionIndex].status === 'not_attempted') {
                    questionStates[currentQuestionIndex].status = 'answered';
                    stats.totalAttempted++;
                    stats.notAttempted--;
                }
                updateQuestionNav();
            }
        }

        function processAnswer() {
            const question = questionsData[currentQuestionIndex];
            const correctChoiceId = question.correct_choice_id;
            
            if(selectedOption === null) return;

            const selectedChoice = question.choices[selectedOption];
            const isCorrect = selectedChoice.id === correctChoiceId;
            
            if (questionStates[currentQuestionIndex].status === 'not_attempted') {
                stats.totalAttempted++;
                stats.notAttempted--;
                if(isCorrect) stats.correctAnswers++; else stats.incorrectAnswers++;
            }
            questionStates[currentQuestionIndex].status = isCorrect ? 'correct' : 'incorrect';
            
            updateStats();
            showInlineFeedback(isCorrect);
            updateQuestionNav();
        }

        function showInlineFeedback(isCorrect) {
            if (currentMode !== 'study' && currentMode !== 'timed_study') return;

            const optionsContainer = document.getElementById('optionsContainer');
            const optionButtons = optionsContainer.querySelectorAll('.option-button');
            const question = questionsData[currentQuestionIndex];
            const correctChoiceId = question.correct_choice_id;
            let correctOptionIndex = question.choices.findIndex(c => c.id === correctChoiceId);

            optionsContainer.classList.add('answered');

            optionButtons.forEach((btn, index) => {
                btn.classList.remove('selected');
                if (index === correctOptionIndex) btn.classList.add('correct');
                else if (index === selectedOption && !isCorrect) btn.classList.add('incorrect');
            });

            setTimeout(showSolution, 1500);
        }


        function showSolution() {
            if (currentMode !== 'study' && currentMode !== 'timed_study') return;
            
            const question = questionsData[currentQuestionIndex];
            document.getElementById('solutionText').innerHTML = question.solution || 'No solution provided';
            
            const videoContainer = document.getElementById('solutionVideo');
            const videoPlayer = document.getElementById('explanationVideoPlayer');
            const explanationVideo = question.explanation_video;
            
            if (explanationVideo) {
                videoContainer.classList.remove('hidden');
                if (explanationVideo.includes('.m3u8')) setupVideo(videoPlayer, explanationVideo);
                else videoPlayer.src = explanationVideo;
            } else {
                videoContainer.classList.add('hidden');
            }
            
            document.getElementById('solutionContainer').classList.remove('hidden');
        }

        function submitQuiz() {
            if (timer) clearInterval(timer);
            if (!confirm('Are you sure you want to submit the quiz?')) return;
            
            isQuizCompleted = true;
            let correct = 0, incorrect = 0;
            const totalTime = Date.now() - quizStartTime;
            
            questionsData.forEach((question, index) => {
                const state = questionStates[index];
                if (state.selectedAnswer !== null) {
                    if (question.choices[state.selectedAnswer].id === question.correct_choice_id) {
                        correct++;
                        state.status = 'correct';
                    } else {
                        incorrect++;
                        state.status = 'incorrect';
                    }
                }
            });
            
            // Save performance data
            const performanceData = JSON.parse(localStorage.getItem('quizPerformanceData')) || [];
            performanceData.push({
                quizName: quizName,
                hierarchy: hierarchy,
                timestamp: Date.now(),
                totalTime: totalTime,
                stats: {
                    correct: correct,
                    incorrect: incorrect,
                    notAttempted: questionsData.length - (correct + incorrect)
                }
            });
            localStorage.setItem('quizPerformanceData', JSON.stringify(performanceData));

            showPerformanceAnalysis(correct, incorrect, questionsData.length - (correct + incorrect), totalTime);
        }

        function showPerformanceAnalysis(correct, incorrect, notAttempted, totalTime) {
            const modal = document.getElementById('performanceModal');
            const accuracy = (correct + incorrect) > 0 ? Math.round((correct / (correct + incorrect)) * 100) : 0;
            
            const circumference = 2 * Math.PI * 65;
            const scoreCircle = document.getElementById('scoreCircle');
            scoreCircle.style.strokeDasharray = `${circumference} ${circumference}`;
            scoreCircle.style.strokeDashoffset = circumference - (accuracy / 100) * circumference;
            
            document.getElementById('accuracyScore').textContent = `${accuracy}%`;
            document.getElementById('totalQuestionsResult').textContent = questionsData.length;
            document.getElementById('correctResult').textContent = correct;
            document.getElementById('incorrectResult').textContent = incorrect;
            document.getElementById('notAttemptedResult').textContent = notAttempted;
            
            const totalMinutes = Math.floor(totalTime / 60000);
            const totalSeconds = Math.floor((totalTime % 60000) / 1000);
            document.getElementById('totalTimeResult').textContent = `${totalMinutes}:${totalSeconds.toString().padStart(2, '0')}`;
            
            const avgTime = totalTime / questionsData.length;
            const avgMinutes = Math.floor(avgTime / 60000);
            const avgSeconds = Math.floor((avgTime % 60000) / 1000);
            document.getElementById('avgTimeResult').textContent = `${avgMinutes}:${avgSeconds.toString().padStart(2, '0')}`;
            
            modal.classList.remove('hidden');
        }

        function closePerformanceModal() { document.getElementById('performanceModal').classList.add('hidden'); }

        function reviewQuestions() {
            document.getElementById('questionReviewSection').classList.remove('hidden');
            const container = document.getElementById('reviewQuestionsContainer');
            container.innerHTML = '';
            
            questionsData.forEach((question, index) => {
                const state = questionStates[index];
                const correctChoiceId = question.correct_choice_id;
                
                let statusClass = 'not-attempted', statusText = 'Not Attempted';
                if (state.selectedAnswer !== null) {
                    const selectedChoice = question.choices[state.selectedAnswer];
                    if (selectedChoice.id === correctChoiceId) { statusClass = 'correct'; statusText = 'Correct'; }
                     else { statusClass = 'incorrect'; statusText = 'Incorrect'; }
                }
                
                const reviewDiv = document.createElement('div');
                reviewDiv.className = `review-question ${statusClass}`;
                
                let optionsHtml = (question.choices || []).map((choice, choiceIndex) => {
                    const isSelected = state.selectedAnswer === choiceIndex;
                    const isCorrect = choice.id === correctChoiceId;
                    let borderClass = 'border-gray-600';
                    if(isCorrect) borderClass = 'border-green-500';
                    else if(isSelected) borderClass = 'border-red-500';
                    
                    return `<div class="p-3 rounded-lg border ${borderClass}"><span class="font-bold mr-3">${String.fromCharCode(65 + choiceIndex)}</span><span>${choice.text}</span></div>`;
                }).join('');

                const videoHtml = question.explanation_video ? `<div class="mt-4"><video id="review-video-${index}" data-src="${question.explanation_video}" class="w-full rounded-lg" controls></video></div>` : '';

                reviewDiv.innerHTML = `
                    <div class="mb-4">
                        <div class="flex justify-between items-center mb-3">
                            <h4 class="text-lg font-bold text-white">Question ${index + 1}</h4>
                            <span class="text-sm px-3 py-1 rounded-full bg-${statusClass === 'correct' ? 'green' : statusClass === 'incorrect' ? 'red' : 'gray'}-600 text-white">${statusText}</span>
                        </div>
                        <div class="text-white mb-4">${question.text}</div>
                    </div>
                    <div class="space-y-2 mb-4">${optionsHtml}</div>
                    <div class="bg-green-900 bg-opacity-20 p-4 rounded-lg border border-green-700">
                        <h5 class="text-green-400 font-bold mb-2">Explanation:</h5>
                        <div class="text-white text-opacity-90">${question.solution || 'No solution available.'}</div>
                        ${videoHtml}
                    </div>`;
                container.appendChild(reviewDiv);
            });
            initializeReviewVideos();
        }

        function initializeReviewVideos() {
            document.querySelectorAll('video[data-src]').forEach(videoEl => {
                const src = videoEl.dataset.src;
                if (src && src.includes('.m3u8')) {
                    setupVideo(videoEl, src);
                } else if (src) {
                    videoEl.src = src;
                }
            });
        }

        function retakeQuiz() {
            if (confirm('Are you sure you want to retake the quiz? This will reset all your answers.')) {
                if (window.location.pathname.endsWith('custom_quiz.html')) {
                    localStorage.removeItem('customQuizData');
                }
                location.reload();
            }
        }

        function loadBookmarkedQuestions() {
            const bookmarks = JSON.parse(localStorage.getItem('bookmarkedQuestions')) || [];
            bookmarks.forEach(bookmark => {
                if (bookmark.quizFile.includes(quizName.toLowerCase().replace(/ /g, '-'))) {
                    if (bookmark.questionIndex < questionsData.length) {
                        questionStates[bookmark.questionIndex].bookmarked = true;
                    }
                }
            });
        }

        function toggleBookmark() {
            const isBookmarked = !questionStates[currentQuestionIndex].bookmarked;
            questionStates[currentQuestionIndex].bookmarked = isBookmarked;
            
            let bookmarks = JSON.parse(localStorage.getItem('bookmarkedQuestions')) || [];
            
            if (isBookmarked) {
                const bookmarkData = {
                    quizName: quizName,
                    quizFile: window.location.pathname.split('/').pop(),
                    questionIndex: currentQuestionIndex,
                    question: questionsData[currentQuestionIndex],
                    hierarchy: hierarchy,
                    timestamp: Date.now()
                };
                bookmarks.push(bookmarkData);
            } else {
                bookmarks = bookmarks.filter(b => 
                    !(b.quizFile.includes(quizName.toLowerCase().replace(/ /g, '-')) && b.questionIndex === currentQuestionIndex)
                );
            }
            
            localStorage.setItem('bookmarkedQuestions', JSON.stringify(bookmarks));
            updateBookmarkButton();
            updateQuestionNav();
        }

        function updateBookmarkButton() {
            const btn = document.getElementById('bookmarkBtn');
            const text = document.getElementById('bookmarkText');
            const isBookmarked = questionStates[currentQuestionIndex].bookmarked;
            
            btn.className = isBookmarked ? 'gradient-yellow px-6 py-3 text-white transition-all duration-300 flex items-center' : 'glass-light px-6 py-3 text-white hover:bg-yellow-500 hover:bg-opacity-20 transition-all duration-300 flex items-center';
            text.textContent = isBookmarked ? 'Bookmarked' : 'Bookmark';
        }
        
        function toggleMarkForReview() {
            questionStates[currentQuestionIndex].markedForReview = !questionStates[currentQuestionIndex].markedForReview;
            updateMarkReviewButton();
            updateQuestionNav();
        }

        function updateMarkReviewButton() {
            const btn = document.getElementById('markReviewBtn');
            const text = document.getElementById('markReviewText');
            const isMarked = questionStates[currentQuestionIndex].markedForReview;
            
            btn.className = isMarked ? 'gradient-purple px-6 py-3 text-white transition-all duration-300 flex items-center' : 'glass-light px-6 py-3 text-white hover:bg-purple-500 hover:bg-opacity-20 transition-all duration-300 flex items-center';
            text.textContent = isMarked ? 'Marked' : 'Mark for Review';
        }

        function previousQuestion() {
            if (currentQuestionIndex > 0) {
                if (questionStartTime) {
                    questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
                }
                
                currentQuestionIndex--;
                displayQuestion();
            }
        }

        function nextQuestion() {
            if (questionStartTime) {
                questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
            }
            
            if (currentQuestionIndex < questionsData.length - 1) {
                currentQuestionIndex++;
                displayQuestion();
            } else {
                if (currentMode === 'test' || currentMode === 'timed_exam') {
                    if (confirm('You have reached the end of the quiz. Would you like to submit your answers now?')) {
                        submitQuiz();
                    }
                } else {
                    if (confirm('You have completed all questions. Would you like to review from the beginning?')) {
                        currentQuestionIndex = 0;
                        displayQuestion();
                    }
                }
            }
        }

        function startTimer() {
            if (timer) clearInterval(timer);
            timeRemaining = 120; // 2 minutes per question
            updateTimerDisplay();
            
            timer = setInterval(() => {
                timeRemaining--;
                updateTimerDisplay();
                
                if (timeRemaining <= 0) {
                    clearInterval(timer);
                    if (currentMode === 'timed_exam') {
                        submitQuiz();
                    } else {
                        nextQuestion();
                    }
                }
            }, 1000);
        }

        function updateTimerDisplay() {
            const minutes = Math.floor(timeRemaining / 60);
            const seconds = timeRemaining % 60;
            document.getElementById('timeDisplay').textContent = 
                minutes + ':' + seconds.toString().padStart(2, '0');
        }

        document.addEventListener('DOMContentLoaded', () => {
             if (!window.location.pathname.endsWith('custom_quiz.html')) {
                document.getElementById('modeModal').style.display = 'flex';
             } else {
                initializeQuiz();
             }
        });
        
        document.addEventListener('keydown', function(e) {
            if (document.getElementById('modeModal').style.display !== 'none') return;
            if (document.getElementById('performanceModal').classList.contains('hidden') === false) return;
            
            if (e.key >= '1' && e.key <= '4') {
                const optionIndex = parseInt(e.key) - 1;
                const options = document.querySelectorAll('.option-button');
                if (optionIndex < options.length) selectOption(optionIndex);
            } else if (e.key === 'ArrowLeft') {
                previousQuestion();
            } else if (e.key === 'ArrowRight' || e.key === ' ') {
                e.preventDefault();
                nextQuestion();
            } else if (e.key.toLowerCase() === 'b' && (currentMode === 'study' || currentMode === 'timed_study')) {
                toggleBookmark();
            } else if (e.key.toLowerCase() === 'm' && (currentMode === 'test' || currentMode === 'timed_exam')) {
                toggleMarkForReview();
            } else if (e.key.toLowerCase() === 's' && (currentMode === 'test' || currentMode === 'timed_exam')) {
                submitQuiz();
            }
        });
    </script>
</body>
</html>